{"id": "21_43_1_40", "text": "Calmodulin binding to the Fas death domain", "text_with_entity_marker": "[E1]Calmodulin[/E1] binding to the [E2]Fas[/E2] death domain", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Calmodulin", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[26, 29]], "entity_2_idx_in_text_with_entity_marker": [39, 42], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "21_44_3_41", "text": "Here, we demonstrate that CaM binds to Fas directly and identify the CaM-binding site on the cytoplasmic death domain (DD) of Fas", "text_with_entity_marker": "Here, we demonstrate that [E1]CaM[/E1] binds to [E2]Fas[/E2] directly and identify the CaM-binding site on the cytoplasmic death domain (DD) of Fas", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CaM", "entity_1_idx": [[26, 29]], "entity_1_idx_in_text_with_entity_marker": [30, 33], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[39, 42]], "entity_2_idx_in_text_with_entity_marker": [52, 55], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "254_510_3_338", "text": "Here we show that the Fas-FADD death domain (DD) complex forms an asymmetric oligomeric structure composed of 5-7 Fas DD and 5 FADD DD, whose interfaces harbor ALPS-associated mutations", "text_with_entity_marker": "Here we show that the [E1]Fas[/E1]-[E2]FADD[/E2] death domain (DD) complex forms an asymmetric oligomeric structure composed of 5-7 Fas DD and 5 FADD DD, whose interfaces harbor ALPS-associated mutations", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[22, 25]], "entity_1_idx_in_text_with_entity_marker": [26, 29], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[26, 30]], "entity_2_idx_in_text_with_entity_marker": [39, 43], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "343_688_8_452", "text": "Finally, evidence is provided to suggest that the RING domain of Mdm2 not only binds to UbcH5b but also acts as an allosteric activator of UbcH5b.", "text_with_entity_marker": "Finally, evidence is provided to suggest that the RING domain of [E1]Mdm2[/E1] not only binds to [E2]UbcH5b[/E2] but also acts as an allosteric activator of UbcH5b.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Mdm2", "entity_1_idx": [[65, 69]], "entity_1_idx_in_text_with_entity_marker": [69, 73], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "UbcH5b", "entity_2_idx": [[88, 94]], "entity_2_idx_in_text_with_entity_marker": [101, 107], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "262_525_1_350", "text": "Decreased interactions of mutant muscle LIM protein (MLP) with N-RAP and alpha-actinin and their implication for hypertrophic cardiomyopathy.", "text_with_entity_marker": "Decreased interactions of mutant [E1]muscle LIM protein (MLP)[/E1] with [E2]N-RAP[/E2] and alpha-actinin and their implication for hypertrophic cardiomyopathy.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "muscle LIM protein (MLP)", "entity_1_idx": [[33, 57]], "entity_1_idx_in_text_with_entity_marker": [37, 61], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "N-RAP", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "262_525_1_351", "text": "Decreased interactions of mutant muscle LIM protein (MLP) with N-RAP and alpha-actinin and their implication for hypertrophic cardiomyopathy.", "text_with_entity_marker": "Decreased interactions of mutant [E1]muscle LIM protein (MLP)[/E1] with N-RAP and [E2]alpha-actinin[/E2] and their implication for hypertrophic cardiomyopathy.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "muscle LIM protein (MLP)", "entity_1_idx": [[33, 57]], "entity_1_idx_in_text_with_entity_marker": [37, 61], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "alpha-actinin", "entity_2_idx": [[73, 86]], "entity_2_idx_in_text_with_entity_marker": [86, 99], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "51_103_1_75", "text": "Phytochrome B binds with greater apparent affinity than phytochrome A to the basic helix-loop-helix factor PIF3 in a reaction requiring the PAS domain of PIF3.", "text_with_entity_marker": "[E1]Phytochrome B[/E1] binds with greater apparent affinity than phytochrome A to the basic helix-loop-helix factor [E2]PIF3[/E2] in a reaction requiring the PAS domain of PIF3.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Phytochrome B", "entity_1_idx": [[0, 13]], "entity_1_idx_in_text_with_entity_marker": [4, 17], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PIF3", "entity_2_idx": [[107, 111]], "entity_2_idx_in_text_with_entity_marker": [120, 124], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "51_103_1_76", "text": "Phytochrome B binds with greater apparent affinity than phytochrome A to the basic helix-loop-helix factor PIF3 in a reaction requiring the PAS domain of PIF3.", "text_with_entity_marker": "Phytochrome B binds with greater apparent affinity than [E1]phytochrome A[/E1] to the basic helix-loop-helix factor [E2]PIF3[/E2] in a reaction requiring the PAS domain of PIF3.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "phytochrome A", "entity_1_idx": [[56, 69]], "entity_1_idx_in_text_with_entity_marker": [60, 73], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PIF3", "entity_2_idx": [[107, 111]], "entity_2_idx_in_text_with_entity_marker": [120, 124], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "51_104_2_77", "text": "Evidence for a relatively direct pathway has been provided by the binding of one member of the family, phyB, to a promoter-element-bound, basic helix-loop-helix protein, PIF3, specifically upon light-induced conversion of the photoreceptor molecule to its biologically active conformer (Pfr)", "text_with_entity_marker": "Evidence for a relatively direct pathway has been provided by the binding of one member of the family, [E1]phyB[/E1], to a promoter-element-bound, basic helix-loop-helix protein, [E2]PIF3[/E2], specifically upon light-induced conversion of the photoreceptor molecule to its biologically active conformer (Pfr)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "phyB", "entity_1_idx": [[103, 107]], "entity_1_idx_in_text_with_entity_marker": [107, 111], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PIF3", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "134_269_1_184", "text": "A role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling.", "text_with_entity_marker": "A role for [E1]Erbin[/E1] in the regulation of [E2]Nod2[/E2]-dependent NF-kappaB signaling.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Erbin", "entity_1_idx": [[11, 16]], "entity_1_idx_in_text_with_entity_marker": [15, 20], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Nod2", "entity_2_idx": [[38, 42]], "entity_2_idx_in_text_with_entity_marker": [51, 55], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "134_269_1_185", "text": "A role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling.", "text_with_entity_marker": "A role for Erbin in the regulation of [E1]Nod2[/E1]-dependent [E2]NF-kappaB[/E2] signaling.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Nod2", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "NF-kappaB", "entity_2_idx": [[53, 62]], "entity_2_idx_in_text_with_entity_marker": [66, 75], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "134_270_8_186", "text": "These studies identify Erbin as a regulator of Nod2 signaling and demonstrate a novel role for Erbin in inflammatory responses.", "text_with_entity_marker": "These studies identify [E1]Erbin[/E1] as a regulator of [E2]Nod2[/E2] signaling and demonstrate a novel role for Erbin in inflammatory responses.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Erbin", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Nod2", "entity_2_idx": [[47, 51]], "entity_2_idx_in_text_with_entity_marker": [60, 64], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "71_143_1_96", "text": "Structural basis of Vps33A recruitment to the human HOPS complex by Vps16.", "text_with_entity_marker": "Structural basis of Vps33A recruitment to the human HOPS complex by [E1]Vps16[/E1][E2]Vps33A[/E2] recruitment to the human HOPS complex by Vps16.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Vps16", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Vps33A", "entity_2_idx": [[20, 26]], "entity_2_idx_in_text_with_entity_marker": [86, 92], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "71_144_3_97", "text": "We show that HOPS subunit Vps16 recruits Vps33A to the human HOPS complex and that residues 642-736 are necessary and sufficient for this interaction, and we present the crystal structure of Vps33A in complex with Vps16(642-736)", "text_with_entity_marker": "We show that HOPS subunit [E1]Vps16[/E1] recruits [E2]Vps33A[/E2] to the human HOPS complex and that residues 642-736 are necessary and sufficient for this interaction, and we present the crystal structure of Vps33A in complex with Vps16(642-736)", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Vps16", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Vps33A", "entity_2_idx": [[41, 47]], "entity_2_idx_in_text_with_entity_marker": [54, 60], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "219_440_2_288", "text": "Previously, we demonstrated that the PEST-type protein-tyrosine phosphatase, PTP HSCF (hematopoietic stem cell fraction), bound to a novel cytoskeletal associated protein, proline serine threonine phosphatase interacting protein (PST PIP), via an interaction between the proline-rich COOH terminus of the PTP and a site within the putative coiled-coil domain of PST PIP", "text_with_entity_marker": "Previously, we demonstrated that the [E1]PEST-type protein-tyrosine phosphatase[/E1], PTP HSCF (hematopoietic stem cell fraction), bound to a novel cytoskeletal associated protein, [E2]proline serine threonine phosphatase interacting protein (PST PIP)[/E2], via an interaction between the proline-rich COOH terminus of the PTP and a site within the putative coiled-coil domain of PST PIP", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PEST-type protein-tyrosine phosphatase", "entity_1_idx": [[37, 75]], "entity_1_idx_in_text_with_entity_marker": [41, 79], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "proline serine threonine phosphatase interacting protein (PST PIP)", "entity_2_idx": [[172, 238]], "entity_2_idx_in_text_with_entity_marker": [185, 251], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "219_440_2_289", "text": "Previously, we demonstrated that the PEST-type protein-tyrosine phosphatase, PTP HSCF (hematopoietic stem cell fraction), bound to a novel cytoskeletal associated protein, proline serine threonine phosphatase interacting protein (PST PIP), via an interaction between the proline-rich COOH terminus of the PTP and a site within the putative coiled-coil domain of PST PIP", "text_with_entity_marker": "Previously, we demonstrated that the PEST-type protein-tyrosine phosphatase, [E1]PTP HSCF (hematopoietic stem cell fraction)[/E1], bound to a novel cytoskeletal associated protein, [E2]proline serine threonine phosphatase interacting protein (PST PIP)[/E2], via an interaction between the proline-rich COOH terminus of the PTP and a site within the putative coiled-coil domain of PST PIP", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PTP HSCF (hematopoietic stem cell fraction)", "entity_1_idx": [[77, 120]], "entity_1_idx_in_text_with_entity_marker": [81, 124], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "proline serine threonine phosphatase interacting protein (PST PIP)", "entity_2_idx": [[172, 238]], "entity_2_idx_in_text_with_entity_marker": [185, 251], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "87_176_1_115", "text": "Chloroplasts contain a novel type of signal recognition particle (cpSRP) that consists of two proteins, cpSRP54 and cpSRP43", "text_with_entity_marker": "Chloroplasts contain a novel type of signal recognition particle (cpSRP) that consists of two proteins, [E1]cpSRP54[/E1] and [E2]cpSRP43[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cpSRP54", "entity_1_idx": [[104, 111]], "entity_1_idx_in_text_with_entity_marker": [108, 115], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "cpSRP43", "entity_2_idx": [[116, 123]], "entity_2_idx_in_text_with_entity_marker": [129, 136], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "333_667_1_446", "text": "Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding.", "text_with_entity_marker": "Identification of [E1]LIM3[/E1] as the principal determinant of [E2]paxillin[/E2] focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LIM3", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[55, 63]], "entity_2_idx_in_text_with_entity_marker": [68, 76], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "99_199_1_125", "text": "Phosphorylation on threonine 11 of b-dystrobrevin alters its interaction with kinesin heavy chain.", "text_with_entity_marker": "Phosphorylation on threonine 11 of [E1]b-dystrobrevin[/E1] alters its interaction with [E2]kinesin[/E2] heavy chain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "b-dystrobrevin", "entity_1_idx": [[35, 49]], "entity_1_idx_in_text_with_entity_marker": [39, 53], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "kinesin", "entity_2_idx": [[78, 85]], "entity_2_idx_in_text_with_entity_marker": [91, 98], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "99_200_4_126", "text": "We have previously characterized the molecular determinants affecting the b-dystrobrevin-kinesin heavy chain interaction, among which is cAMP-dependent protein kinase [protein kinase A (PKA)] phosphorylation of b-dystrobrevin", "text_with_entity_marker": "We have previously characterized the molecular determinants affecting the b-dystrobrevin-kinesin heavy chain interaction, among which is cAMP-dependent protein kinase [[E1]protein kinase A (PKA)[/E1][E2]b-dystrobrevin[/E2]-kinesin heavy chain interaction, among which is cAMP-dependent protein kinase [protein kinase A (PKA)] phosphorylation of b-dystrobrevin", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "protein kinase A (PKA)", "entity_1_idx": [[168, 190]], "entity_1_idx_in_text_with_entity_marker": [172, 194], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "b-dystrobrevin", "entity_2_idx": [[74, 88]], "entity_2_idx_in_text_with_entity_marker": [203, 217], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "99_200_4_127", "text": "We have previously characterized the molecular determinants affecting the b-dystrobrevin-kinesin heavy chain interaction, among which is cAMP-dependent protein kinase [protein kinase A (PKA)] phosphorylation of b-dystrobrevin", "text_with_entity_marker": "We have previously characterized the molecular determinants affecting the [E1]b-dystrobrevin[/E1]-[E2]kinesin[/E2] heavy chain interaction, among which is cAMP-dependent protein kinase [protein kinase A (PKA)] phosphorylation of b-dystrobrevin", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "b-dystrobrevin", "entity_1_idx": [[74, 88]], "entity_1_idx_in_text_with_entity_marker": [78, 92], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "kinesin", "entity_2_idx": [[89, 96]], "entity_2_idx_in_text_with_entity_marker": [102, 109], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "53_108_3_79", "text": "Here we report the nuclear magnetic resonance (NMR) structure of the membrane-embedded, heterotrimeric assembly formed by association of the DAP12 signaling module with the natural killer (NK) cell-activating receptor NKG2C", "text_with_entity_marker": "Here we report the nuclear magnetic resonance (NMR) structure of the membrane-embedded, heterotrimeric assembly formed by association of the [E1]DAP12[/E1] signaling module with the natural killer (NK) cell-activating receptor [E2]NKG2C[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DAP12", "entity_1_idx": [[141, 146]], "entity_1_idx_in_text_with_entity_marker": [145, 150], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "NKG2C", "entity_2_idx": [[218, 223]], "entity_2_idx_in_text_with_entity_marker": [231, 236], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "104_210_5_135", "text": "Our data reveal the existence of key residues within the conserved GRIP-domain of the golgin and within the GTPase ARL1 that are central to ARL1-GRIP interaction", "text_with_entity_marker": "Our data reveal the existence of key residues within the conserved GRIP-domain of the golgin and within the GTPase [E1]ARL1[/E1][E2]GRIP[/E2]-domain of the golgin and within the GTPase ARL1 that are central to ARL1-GRIP interaction", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ARL1", "entity_1_idx": [[115, 119]], "entity_1_idx_in_text_with_entity_marker": [119, 123], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "GRIP", "entity_2_idx": [[67, 71]], "entity_2_idx_in_text_with_entity_marker": [132, 136], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "92_186_4_120", "text": "We also show that the activity of the activation domain is inhibited by the Hth domain, and that this autoinhibition can be partially relieved by the interaction of Pbx1 with the Hth domain of Meis2", "text_with_entity_marker": "We also show that the activity of the activation domain is inhibited by the Hth domain, and that this autoinhibition can be partially relieved by the interaction of [E1]Pbx1[/E1] with the Hth domain of [E2]Meis2[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Pbx1", "entity_1_idx": [[165, 169]], "entity_1_idx_in_text_with_entity_marker": [169, 173], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Meis2", "entity_2_idx": [[193, 198]], "entity_2_idx_in_text_with_entity_marker": [206, 211], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "166_333_1_214", "text": "Interaction of the Salmonella Typhimurium effector protein SopB with host cell Cdc42 is involved in intracellular replication.", "text_with_entity_marker": "Interaction of the Salmonella Typhimurium effector protein [E1]SopB[/E1] with host cell [E2]Cdc42[/E2] is involved in intracellular replication.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SopB", "entity_1_idx": [[59, 63]], "entity_1_idx_in_text_with_entity_marker": [63, 67], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Cdc42", "entity_2_idx": [[79, 84]], "entity_2_idx_in_text_with_entity_marker": [92, 97], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "166_334_3_215", "text": "Here we show that human Cdc42, but not Rac1, interacts with catalytically inactive SopB when coexpressed in Saccharomyces cerevisiae", "text_with_entity_marker": "Here we show that human [E1]Cdc42[/E1], but not Rac1, interacts with catalytically inactive [E2]SopB[/E2] when coexpressed in Saccharomyces cerevisiae", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Cdc42", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "SopB", "entity_2_idx": [[83, 87]], "entity_2_idx_in_text_with_entity_marker": [96, 100], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "25_51_1_48", "text": "The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis.", "text_with_entity_marker": "The [E1]RIP1[/E1]/[E2]RIP3[/E2] necrosome forms a functional amyloid signaling complex required for programmed necrosis.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "RIP1", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "RIP3", "entity_2_idx": [[9, 13]], "entity_2_idx_in_text_with_entity_marker": [22, 26], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "25_52_5_49", "text": "The endogenous RIP1/RIP3 complex isolated from necrotic cells binds ThT, is ultrastable, and has a fibrillar core structure, whereas necrosis is partially inhibited by ThT, CR, and another amyloid dye, HBX", "text_with_entity_marker": "The endogenous [E1]RIP1[/E1]/[E2]RIP3[/E2] complex isolated from necrotic cells binds ThT, is ultrastable, and has a fibrillar core structure, whereas necrosis is partially inhibited by ThT, CR, and another amyloid dye, HBX", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "RIP1", "entity_1_idx": [[15, 19]], "entity_1_idx_in_text_with_entity_marker": [19, 23], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "RIP3", "entity_2_idx": [[20, 24]], "entity_2_idx_in_text_with_entity_marker": [33, 37], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "119_239_1_163", "text": "Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells.", "text_with_entity_marker": "Mutational analysis of the human [E1]2B4[/E1] (CD244)/[E2]CD48[/E2] interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "2B4", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CD48", "entity_2_idx": [[45, 49]], "entity_2_idx_in_text_with_entity_marker": [58, 62], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "119_240_4_164", "text": "Recent data indicate that 2B4/CD48 interactions regulate NK and T lymphocyte functions", "text_with_entity_marker": "Recent data indicate that [E1]2B4[/E1]/[E2]CD48[/E2] interactions regulate NK and T lymphocyte functions", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "2B4", "entity_1_idx": [[26, 29]], "entity_1_idx_in_text_with_entity_marker": [30, 33], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CD48", "entity_2_idx": [[30, 34]], "entity_2_idx_in_text_with_entity_marker": [43, 47], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "344_689_1_453", "text": "Studies on the role of the hydrophobic domain of Ost4p in interactions with other subunits of yeast oligosaccharyl transferase.", "text_with_entity_marker": "Studies on the role of the hydrophobic domain of [E1]Ost4p[/E1] in interactions with other subunits of yeast [E2]oligosaccharyl transferase[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Ost4p", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "oligosaccharyl transferase", "entity_2_idx": [[100, 126]], "entity_2_idx_in_text_with_entity_marker": [113, 139], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "344_690_8_454", "text": "These findings suggest that a localized region of the putative transmembrane domain of Ost4p mediates in stabilization of the interaction with the two other OT subunits (Ost3p and Stt3p) in a subcomplex in the endoplasmic reticulum membrane.", "text_with_entity_marker": "These findings suggest that a localized region of the putative transmembrane domain of [E1]Ost4p[/E1] mediates in stabilization of the interaction with the two other OT subunits ([E2]Ost3p[/E2] and Stt3p) in a subcomplex in the endoplasmic reticulum membrane.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Ost4p", "entity_1_idx": [[87, 92]], "entity_1_idx_in_text_with_entity_marker": [91, 96], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Ost3p", "entity_2_idx": [[170, 175]], "entity_2_idx_in_text_with_entity_marker": [183, 188], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "344_690_8_455", "text": "These findings suggest that a localized region of the putative transmembrane domain of Ost4p mediates in stabilization of the interaction with the two other OT subunits (Ost3p and Stt3p) in a subcomplex in the endoplasmic reticulum membrane.", "text_with_entity_marker": "These findings suggest that a localized region of the putative transmembrane domain of [E1]Ost4p[/E1] mediates in stabilization of the interaction with the two other OT subunits (Ost3p and [E2]Stt3p[/E2]) in a subcomplex in the endoplasmic reticulum membrane.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Ost4p", "entity_1_idx": [[87, 92]], "entity_1_idx_in_text_with_entity_marker": [91, 96], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Stt3p", "entity_2_idx": [[180, 185]], "entity_2_idx_in_text_with_entity_marker": [193, 198], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "108_217_1_142", "text": "Yeast Krr1p physically and functionally interacts with a novel essential Kri1p, and both proteins are required for 40S ribosome biogenesis in the nucleolus.", "text_with_entity_marker": "Yeast [E1]Krr1p[/E1] physically and functionally interacts with a novel essential [E2]Kri1p[/E2], and both proteins are required for 40S ribosome biogenesis in the nucleolus.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Krr1p", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Kri1p", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "108_218_15_143", "text": "These data lead us to conclude that Krr1p physically and functionally interacts with Kri1p to form a complex which is required for 40S ribosome biogenesis in the nucleolus.", "text_with_entity_marker": "These data lead us to conclude that [E1]Krr1p[/E1] physically and functionally interacts with [E2]Kri1p[/E2] to form a complex which is required for 40S ribosome biogenesis in the nucleolus.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Krr1p", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Kri1p", "entity_2_idx": [[85, 90]], "entity_2_idx_in_text_with_entity_marker": [98, 103], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "137_275_1_190", "text": "Identification of Alix-type and Non-Alix-type ALG-2-binding sites in human phospholipid scramblase 3: differential binding to an alternatively spliced isoform and amino acid-substituted mutants.", "text_with_entity_marker": "Identification of Alix-type and Non-Alix-type [E1]ALG-2[/E1]-binding sites in [E2]human phospholipid scramblase 3[/E2]: differential binding to an alternatively spliced isoform and amino acid-substituted mutants.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ALG-2", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "human phospholipid scramblase 3", "entity_2_idx": [[69, 100]], "entity_2_idx_in_text_with_entity_marker": [82, 113], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "137_276_1_191", "text": "ALG-2, a prototypic member of the penta-EF-hand protein family, interacts with Alix at its C-terminal Pro-rich region containing four tandem PXY repeats", "text_with_entity_marker": "[E1]ALG-2[/E1], a prototypic member of the penta-EF-hand protein family, interacts with [E2]Alix[/E2] at its C-terminal Pro-rich region containing four tandem PXY repeats", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ALG-2", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Alix", "entity_2_idx": [[79, 83]], "entity_2_idx_in_text_with_entity_marker": [92, 96], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "137_276_3_192", "text": "In the present study, we found that ALG-2 interacts with PLSCR3 expressed in HEK293 cells in a Ca(2+)-dependent manner by co-immunoprecipitation, pulldown with glutathione S-transferase (GST) fused ALG-2 and an overlay assay using biotin-labeled ALG-2", "text_with_entity_marker": "In the present study, we found that [E1]ALG-2[/E1] interacts with [E2]PLSCR3[/E2] expressed in HEK293 cells in a Ca(2+)-dependent manner by co-immunoprecipitation, pulldown with glutathione S-transferase (GST) fused ALG-2 and an overlay assay using biotin-labeled ALG-2", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ALG-2", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PLSCR3", "entity_2_idx": [[57, 63]], "entity_2_idx_in_text_with_entity_marker": [70, 76], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "55_111_1_81", "text": "Stress induced and nuclear localized HIPP26 from Arabidopsis thaliana interacts via its heavy metal associated domain with the drought stress related zinc finger transcription factor ATHB29.", "text_with_entity_marker": "Stress induced and nuclear localized [E1]HIPP26[/E1] from Arabidopsis thaliana interacts via its heavy metal associated domain with the drought stress related zinc finger transcription factor [E2]ATHB29[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HIPP26", "entity_1_idx": [[37, 43]], "entity_1_idx_in_text_with_entity_marker": [41, 47], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "ATHB29", "entity_2_idx": [[183, 189]], "entity_2_idx_in_text_with_entity_marker": [196, 202], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "55_112_6_82", "text": "By a yeast-two-hybrid approach a strong interaction of HIPP26 with the zinc finger homeodomain transcription factor ATHB29, which is known to play a role in dehydration stress response could be detected", "text_with_entity_marker": "By a yeast-two-hybrid approach a strong interaction of [E1]HIPP26[/E1] with the zinc finger homeodomain transcription factor [E2]ATHB29[/E2], which is known to play a role in dehydration stress response could be detected", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HIPP26", "entity_1_idx": [[55, 61]], "entity_1_idx_in_text_with_entity_marker": [59, 65], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "ATHB29", "entity_2_idx": [[116, 122]], "entity_2_idx_in_text_with_entity_marker": [129, 135], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "260_521_1_348", "text": "Structural basis for endosomal recruitment of ESCRT-I by ESCRT-0 in yeast.", "text_with_entity_marker": "Structural basis for endosomal recruitment of ESCRT-I by [E1]ESCRT-0[/E1][E2]ESCRT-I[/E2] by ESCRT-0 in yeast.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ESCRT-0", "entity_1_idx": [[57, 64]], "entity_1_idx_in_text_with_entity_marker": [61, 68], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "ESCRT-I", "entity_2_idx": [[46, 53]], "entity_2_idx_in_text_with_entity_marker": [77, 84], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "301_603_1_416", "text": "Interaction of a G-protein beta-subunit with a conserved sequence in Ste20/PAK family protein kinases.", "text_with_entity_marker": "Interaction of a [E1]G-protein[/E1] beta-subunit with a conserved sequence in [E2]Ste20/PAK[/E2] family protein kinases.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "G-protein", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Ste20/PAK", "entity_2_idx": [[69, 78]], "entity_2_idx_in_text_with_entity_marker": [82, 91], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "187_375_1_244", "text": "A divalent FHA/BRCT-binding mechanism couples the MRE11-RAD50-NBS1 complex to damaged chromatin.", "text_with_entity_marker": "A divalent [E1]FHA/BRCT[/E1]-binding mechanism couples the [E2]MRE11-RAD50-NBS1[/E2] complex to damaged chromatin.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FHA/BRCT", "entity_1_idx": [[11, 19]], "entity_1_idx_in_text_with_entity_marker": [15, 23], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "MRE11-RAD50-NBS1", "entity_2_idx": [[50, 66]], "entity_2_idx_in_text_with_entity_marker": [63, 79], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "121_243_1_169", "text": "Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling.", "text_with_entity_marker": "Structure of the [E1]Keap1[/E1]:[E2]Nrf2[/E2] interface provides mechanistic insight into Nrf2 signaling.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Keap1", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Nrf2", "entity_2_idx": [[23, 27]], "entity_2_idx_in_text_with_entity_marker": [36, 40], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "121_244_1_170", "text": "Keap1 is a BTB-Kelch substrate adaptor protein that regulates steady-state levels of Nrf2, a bZIP transcription factor, in response to oxidative stress", "text_with_entity_marker": "[E1]Keap1[/E1] is a BTB-Kelch substrate adaptor protein that regulates steady-state levels of [E2]Nrf2[/E2], a bZIP transcription factor, in response to oxidative stress", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Keap1", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Nrf2", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d135.s1148_AIMed.d135.s1148.p0", "text": "The cell surface form of LT-alpha is assembled during biosynthesis as a heteromeric complex with lymphotoxin-beta (LT-beta), a type II transmembrane protein that is another member of the TNF ligand family.", "text_with_entity_marker": "The cell surface form of [E1]LT-alpha[/E1] is assembled during biosynthesis as a heteromeric complex with [E2]lymphotoxin-beta[/E2] (LT-beta), a type II transmembrane protein that is another member of the TNF ligand family.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LT-alpha", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "lymphotoxin-beta", "entity_2_idx": [[97, 113]], "entity_2_idx_in_text_with_entity_marker": [110, 126], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d135.s1148_AIMed.d135.s1148.p1", "text": "The cell surface form of LT-alpha is assembled during biosynthesis as a heteromeric complex with lymphotoxin-beta (LT-beta), a type II transmembrane protein that is another member of the TNF ligand family.", "text_with_entity_marker": "The cell surface form of [E1]LT-alpha[/E1] is assembled during biosynthesis as a heteromeric complex with lymphotoxin-beta ([E2]LT-beta[/E2]), a type II transmembrane protein that is another member of the TNF ligand family.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LT-alpha", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "LT-beta", "entity_2_idx": [[115, 122]], "entity_2_idx_in_text_with_entity_marker": [128, 135], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d135.s1149_AIMed.d135.s1149.p2", "text": "Secreted LT-alpha is a homotrimer that binds to distinct TNF receptors of 60 and 80 kilodaltons; however, these receptors do not recognize the major cell surface LT-alpha-LT-beta complex.", "text_with_entity_marker": "Secreted LT-alpha is a homotrimer that binds to distinct TNF receptors of 60 and 80 kilodaltons; however, these receptors do not recognize the major cell surface [E1]LT-alpha[/E1]-[E2]LT-beta[/E2] complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LT-alpha", "entity_1_idx": [[162, 170]], "entity_1_idx_in_text_with_entity_marker": [166, 174], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "LT-beta", "entity_2_idx": [[171, 178]], "entity_2_idx_in_text_with_entity_marker": [184, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d131.s1120_AIMed.d131.s1120.p1", "text": "cDNA clones encoding a human IL-10R (hIL-10R) from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds hIL-10 specifically.", "text_with_entity_marker": "cDNA clones encoding a human [E1]IL-10R[/E1] (hIL-10R) from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds [E2]hIL-10[/E2] specifically.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-10R", "entity_1_idx": [[29, 35]], "entity_1_idx_in_text_with_entity_marker": [33, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hIL-10", "entity_2_idx": [[148, 154]], "entity_2_idx_in_text_with_entity_marker": [161, 167], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d131.s1120_AIMed.d131.s1120.p2", "text": "cDNA clones encoding a human IL-10R (hIL-10R) from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds hIL-10 specifically.", "text_with_entity_marker": "cDNA clones encoding a human IL-10R ([E1]hIL-10R[/E1]) from a Burkitt lymphoma cell line, BJAB, express a 90 to 110 kDa polypeptide in COS7 cells that binds [E2]hIL-10[/E2] specifically.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hIL-10R", "entity_1_idx": [[37, 44]], "entity_1_idx_in_text_with_entity_marker": [41, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hIL-10", "entity_2_idx": [[148, 154]], "entity_2_idx_in_text_with_entity_marker": [161, 167], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d131.s1121_AIMed.d131.s1121.p16", "text": "The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (mIL-10R). rIL-10R expressed in an IL-3-dependent mouse pro-B cell line (Ba/F3) binds hIL-10 with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.", "text_with_entity_marker": "The predicted amino acid sequence of hIL-10R is 60% identical and 73% similar to mouse IL-10R (mIL-10R). [E1]rIL-10R[/E1] expressed in an IL-3-dependent mouse pro-B cell line (Ba/F3) binds [E2]hIL-10[/E2] with high affinity (200 to 250 pM), and the transfected cells exhibit a proliferative response to hIL-10.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "rIL-10R", "entity_1_idx": [[105, 112]], "entity_1_idx_in_text_with_entity_marker": [109, 116], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hIL-10", "entity_2_idx": [[180, 186]], "entity_2_idx_in_text_with_entity_marker": [193, 199], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1483_AIMed.d176.s1483.p1", "text": "Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and hsp70.", "text_with_entity_marker": "Interactions of [E1]p60[/E1], a mediator of progesterone receptor assembly, with heat shock proteins [E2]hsp90[/E2] and hsp70.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p60", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1483_AIMed.d176.s1483.p2", "text": "Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and hsp70.", "text_with_entity_marker": "Interactions of [E1]p60[/E1], a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and [E2]hsp70[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p60", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1488_AIMed.d176.s1488.p0", "text": "Since p60 is typically found in a complex with hsp90 and hsp70, we have further characterized its interactions with these proteins.", "text_with_entity_marker": "Since [E1]p60[/E1] is typically found in a complex with [E2]hsp90[/E2] and hsp70, we have further characterized its interactions with these proteins.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p60", "entity_1_idx": [[6, 9]], "entity_1_idx_in_text_with_entity_marker": [10, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[47, 52]], "entity_2_idx_in_text_with_entity_marker": [60, 65], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1488_AIMed.d176.s1488.p1", "text": "Since p60 is typically found in a complex with hsp90 and hsp70, we have further characterized its interactions with these proteins.", "text_with_entity_marker": "Since [E1]p60[/E1] is typically found in a complex with hsp90 and [E2]hsp70[/E2], we have further characterized its interactions with these proteins.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p60", "entity_1_idx": [[6, 9]], "entity_1_idx_in_text_with_entity_marker": [10, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1489_AIMed.d176.s1489.p0", "text": "P60 can bind either hsp70 or hsp90 independently and in an ATP-independent manner.", "text_with_entity_marker": "[E1]P60[/E1] can bind either [E2]hsp70[/E2] or hsp90 independently and in an ATP-independent manner.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "P60", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[20, 25]], "entity_2_idx_in_text_with_entity_marker": [33, 38], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1489_AIMed.d176.s1489.p1", "text": "P60 can bind either hsp70 or hsp90 independently and in an ATP-independent manner.", "text_with_entity_marker": "[E1]P60[/E1] can bind either hsp70 or [E2]hsp90[/E2] independently and in an ATP-independent manner.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "P60", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[29, 34]], "entity_2_idx_in_text_with_entity_marker": [42, 47], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1490_AIMed.d176.s1490.p12", "text": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "text_with_entity_marker": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an [E1]hsp90[/E1]-[E2]p60[/E2]-hsp70 complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hsp90", "entity_1_idx": [[123, 128]], "entity_1_idx_in_text_with_entity_marker": [127, 132], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p60", "entity_2_idx": [[129, 132]], "entity_2_idx_in_text_with_entity_marker": [142, 145], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1491_AIMed.d176.s1491.p0", "text": "Mutational analysis of p60 indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and hsp70.", "text_with_entity_marker": "Mutational analysis of [E1]p60[/E1] indicates that the N terminus is required for [E2]hsp70[/E2] binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and hsp70.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p60", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1491_AIMed.d176.s1491.p1", "text": "Mutational analysis of p60 indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and hsp70.", "text_with_entity_marker": "Mutational analysis of [E1]p60[/E1] indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding [E2]hsp90[/E2] and hsp70.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p60", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1491_AIMed.d176.s1491.p2", "text": "Mutational analysis of p60 indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and hsp70.", "text_with_entity_marker": "Mutational analysis of [E1]p60[/E1] indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and [E2]hsp70[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p60", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1492_AIMed.d176.s1492.p0", "text": "The hsp90-p60-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.", "text_with_entity_marker": "The [E1]hsp90[/E1]-[E2]p60[/E2]-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hsp90", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p60", "entity_2_idx": [[10, 13]], "entity_2_idx_in_text_with_entity_marker": [23, 26], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1493_AIMed.d176.s1493.p0", "text": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "text_with_entity_marker": "The interactions of [E1]hsp70[/E1] and [E2]hsp90[/E2] in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hsp70", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[30, 35]], "entity_2_idx_in_text_with_entity_marker": [43, 48], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d37.s315_AIMed.d37.s315.p25", "text": "We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-MIP-1beta binding: MCP-2, MCP-3, MCP-4, MCP-1, and eotaxin binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.", "text_with_entity_marker": "We found that in addition to MIP-1beta, MIP-1alpha, and RANTES, five other CC-chemokines could compete for [(125)I]-[E1]MIP-1beta[/E1] binding: MCP-2, MCP-3, MCP-4, MCP-1, and [E2]eotaxin[/E2] binding was characterized by IC(50) values of 0.22, 2.14, 5.89, 29.9, and 21.7 nmol/L, respectively.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "MIP-1beta", "entity_1_idx": [[116, 125]], "entity_1_idx_in_text_with_entity_marker": [120, 129], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "eotaxin", "entity_2_idx": [[167, 174]], "entity_2_idx_in_text_with_entity_marker": [180, 187], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d37.s316_AIMed.d37.s316.p0", "text": "Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.", "text_with_entity_marker": "Among these ligands, [E1]MCP-3[/E1] had the remarkable property of binding [E2]CCR5[/E2] with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MCP-3", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCR5", "entity_2_idx": [[66, 70]], "entity_2_idx_in_text_with_entity_marker": [79, 83], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d37.s316_AIMed.d37.s316.p11", "text": "Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.", "text_with_entity_marker": "Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, [E1]MCP-3[/E1] could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for [E2]CCR5[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MCP-3", "entity_1_idx": [[131, 136]], "entity_1_idx_in_text_with_entity_marker": [135, 140], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCR5", "entity_2_idx": [[252, 256]], "entity_2_idx_in_text_with_entity_marker": [265, 269], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d37.s316_AIMed.d37.s316.p12", "text": "Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of CCR5 by MIP-1beta and may therefore be considered as a natural antagonist for CCR5.", "text_with_entity_marker": "Among these ligands, MCP-3 had the remarkable property of binding CCR5 with high affinity without eliciting a functional response, MCP-3 could also inhibit the activation of [E1]CCR5[/E1] by [E2]MIP-1beta[/E2] and may therefore be considered as a natural antagonist for CCR5.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CCR5", "entity_1_idx": [[174, 178]], "entity_1_idx_in_text_with_entity_marker": [178, 182], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MIP-1beta", "entity_2_idx": [[182, 191]], "entity_2_idx_in_text_with_entity_marker": [195, 204], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d37.s319_AIMed.d37.s319.p0", "text": "MCP-3 could compete efficiently for gp120 binding but was, however, found to be a weak inhibitor of HIV infection, probably as a consequence of its inability to downregulate the receptor.", "text_with_entity_marker": "[E1]MCP-3[/E1] could compete efficiently for [E2]gp120[/E2] binding but was, however, found to be a weak inhibitor of HIV infection, probably as a consequence of its inability to downregulate the receptor.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MCP-3", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gp120", "entity_2_idx": [[36, 41]], "entity_2_idx_in_text_with_entity_marker": [49, 54], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1165_AIMed.d138.s1165.p0", "text": "Interaction of mammalian splicing factor SF3a with U2 snRNP and relation of its 60-kD subunit to yeast PRP9.", "text_with_entity_marker": "Interaction of mammalian splicing factor [E1]SF3a[/E1] with [E2]U2 snRNP[/E2] and relation of its 60-kD subunit to yeast PRP9.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SF3a", "entity_1_idx": [[41, 45]], "entity_1_idx_in_text_with_entity_marker": [45, 49], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[51, 59]], "entity_2_idx_in_text_with_entity_marker": [64, 72], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p0", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "[E1]SF3a[/E1] interacts with [E2]U2 snRNP[/E2] in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SF3a", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[20, 28]], "entity_2_idx_in_text_with_entity_marker": [33, 41], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d177.s1503_AIMed.d177.s1503.p0", "text": "We have selected such mutations in the transcription factor E2F1 that affect its ability to heterodimerize with DP1.", "text_with_entity_marker": "We have selected such mutations in the transcription factor [E1]E2F1[/E1] that affect its ability to heterodimerize with [E2]DP1[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "E2F1", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "DP1", "entity_2_idx": [[112, 115]], "entity_2_idx_in_text_with_entity_marker": [125, 128], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d112.s944_AIMed.d112.s944.p0", "text": "Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53/56Lyn and a 120-kDa phosphoprotein.", "text_with_entity_marker": "Human spleen tyrosine kinase [E1]p72Syk[/E1] associates with the Src-family kinase [E2]p53[/E2]/56Lyn and a 120-kDa phosphoprotein.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p72Syk", "entity_1_idx": [[29, 35]], "entity_1_idx_in_text_with_entity_marker": [33, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[74, 77]], "entity_2_idx_in_text_with_entity_marker": [87, 90], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d112.s944_AIMed.d112.s944.p1", "text": "Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53/56Lyn and a 120-kDa phosphoprotein.", "text_with_entity_marker": "Human spleen tyrosine kinase [E1]p72Syk[/E1] associates with the Src-family kinase p53/[E2]56Lyn[/E2] and a 120-kDa phosphoprotein.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p72Syk", "entity_1_idx": [[29, 35]], "entity_1_idx_in_text_with_entity_marker": [33, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "56Lyn", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d112.s944_AIMed.d112.s944.p2", "text": "Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53/56Lyn and a 120-kDa phosphoprotein.", "text_with_entity_marker": "Human spleen tyrosine kinase [E1]p72Syk[/E1] associates with the Src-family kinase p53/56Lyn and a [E2]120-kDa phosphoprotein[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p72Syk", "entity_1_idx": [[29, 35]], "entity_1_idx_in_text_with_entity_marker": [33, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "120-kDa phosphoprotein", "entity_2_idx": [[90, 112]], "entity_2_idx_in_text_with_entity_marker": [103, 125], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d112.s946_AIMed.d112.s946.p0", "text": "Here we show that Syk and Lyn from human B lymphocytes can interact directly.", "text_with_entity_marker": "Here we show that [E1]Syk[/E1] and [E2]Lyn[/E2] from human B lymphocytes can interact directly.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Syk", "entity_1_idx": [[18, 21]], "entity_1_idx_in_text_with_entity_marker": [22, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Lyn", "entity_2_idx": [[26, 29]], "entity_2_idx_in_text_with_entity_marker": [39, 42], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d112.s947_AIMed.d112.s947.p0", "text": "Syk and Lyn coimmunoprecipitated from mature and activated B-cell lines, and gel-purified Syk and Lyn reassociated in vitro, demonstrating their direct interaction.", "text_with_entity_marker": "[E1]Syk[/E1] and [E2]Lyn[/E2] coimmunoprecipitated from mature and activated B-cell lines, and gel-purified Syk and Lyn reassociated in vitro, demonstrating their direct interaction.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Syk", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Lyn", "entity_2_idx": [[8, 11]], "entity_2_idx_in_text_with_entity_marker": [21, 24], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d112.s947_AIMed.d112.s947.p5", "text": "Syk and Lyn coimmunoprecipitated from mature and activated B-cell lines, and gel-purified Syk and Lyn reassociated in vitro, demonstrating their direct interaction.", "text_with_entity_marker": "Syk and Lyn coimmunoprecipitated from mature and activated B-cell lines, and gel-purified [E1]Syk[/E1] and [E2]Lyn[/E2] reassociated in vitro, demonstrating their direct interaction.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Syk", "entity_1_idx": [[90, 93]], "entity_1_idx_in_text_with_entity_marker": [94, 97], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Lyn", "entity_2_idx": [[98, 101]], "entity_2_idx_in_text_with_entity_marker": [111, 114], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d112.s948_AIMed.d112.s948.p0", "text": "This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.", "text_with_entity_marker": "This [E1]Syk[/E1]-[E2]Lyn[/E2] interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Syk", "entity_1_idx": [[5, 8]], "entity_1_idx_in_text_with_entity_marker": [9, 12], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Lyn", "entity_2_idx": [[9, 12]], "entity_2_idx_in_text_with_entity_marker": [22, 25], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d112.s948_AIMed.d112.s948.p9", "text": "This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since Syk-Lyn associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.", "text_with_entity_marker": "This Syk-Lyn interaction may be dependent on the stage of B-cell differentiation, since [E1]Syk[/E1]-[E2]Lyn[/E2] associations were not detected in pre-B and myeloma cell lines and Syk from an immature B-cell line did not reassociate with Lyn in vitro.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Syk", "entity_1_idx": [[88, 91]], "entity_1_idx_in_text_with_entity_marker": [92, 95], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Lyn", "entity_2_idx": [[92, 95]], "entity_2_idx_in_text_with_entity_marker": [105, 108], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d112.s953_AIMed.d112.s953.p2", "text": "The 120-kDa serine/threonine phosphorylated protein that coprecipitated with PLC gamma 1 resembled the Syk-associated pp120 by several criteria.", "text_with_entity_marker": "The 120-kDa serine/threonine phosphorylated protein that coprecipitated with PLC gamma 1 resembled the [E1]Syk[/E1]-associated [E2]pp120[/E2] by several criteria.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Syk", "entity_1_idx": [[103, 106]], "entity_1_idx_in_text_with_entity_marker": [107, 110], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pp120", "entity_2_idx": [[118, 123]], "entity_2_idx_in_text_with_entity_marker": [131, 136], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d120.s1013_AIMed.d120.s1013.p0", "text": "Specific binding of the transglutaminase, platelet factor XIII, to HSP27.", "text_with_entity_marker": "Specific binding of the transglutaminase, [E1]platelet factor XIII[/E1], to [E2]HSP27[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "platelet factor XIII", "entity_1_idx": [[42, 62]], "entity_1_idx_in_text_with_entity_marker": [46, 66], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "HSP27", "entity_2_idx": [[67, 72]], "entity_2_idx_in_text_with_entity_marker": [80, 85], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d120.s1020_AIMed.d120.s1020.p0", "text": "Immunoblotting studies were used to confirm the binding of FXIII from fresh platelet lysates to the HSP27 fusion protein.", "text_with_entity_marker": "Immunoblotting studies were used to confirm the binding of [E1]FXIII[/E1] from fresh platelet lysates to the [E2]HSP27[/E2] fusion protein.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FXIII", "entity_1_idx": [[59, 64]], "entity_1_idx_in_text_with_entity_marker": [63, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "HSP27", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d120.s1021_AIMed.d120.s1021.p0", "text": "FXIII also was shown to coprecipitate with HSP27 in immunoprecipitation studies and to colocalize with HSP27 in immunofluorescence studies of intact glass-activated platelets.", "text_with_entity_marker": "[E1]FXIII[/E1] also was shown to coprecipitate with [E2]HSP27[/E2] in immunoprecipitation studies and to colocalize with HSP27 in immunofluorescence studies of intact glass-activated platelets.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FXIII", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "HSP27", "entity_2_idx": [[43, 48]], "entity_2_idx_in_text_with_entity_marker": [56, 61], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d120.s1022_AIMed.d120.s1022.p0", "text": "The data thus demonstrate specific binding of platelet FXIII to HSP27 and suggest that HSP27 may participate in the cellular localization and/or enzymatic regulation of platelet FXIII.", "text_with_entity_marker": "The data thus demonstrate specific binding of platelet [E1]FXIII[/E1] to [E2]HSP27[/E2] and suggest that HSP27 may participate in the cellular localization and/or enzymatic regulation of platelet FXIII.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FXIII", "entity_1_idx": [[55, 60]], "entity_1_idx_in_text_with_entity_marker": [59, 64], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "HSP27", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d120.s1022_AIMed.d120.s1022.p5", "text": "The data thus demonstrate specific binding of platelet FXIII to HSP27 and suggest that HSP27 may participate in the cellular localization and/or enzymatic regulation of platelet FXIII.", "text_with_entity_marker": "The data thus demonstrate specific binding of platelet FXIII to HSP27 and suggest that [E1]HSP27[/E1] may participate in the cellular localization and/or enzymatic regulation of platelet [E2]FXIII[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HSP27", "entity_1_idx": [[87, 92]], "entity_1_idx_in_text_with_entity_marker": [91, 96], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FXIII", "entity_2_idx": [[178, 183]], "entity_2_idx_in_text_with_entity_marker": [191, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s320_AIMed.d38.s320.p0", "text": "Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3.", "text_with_entity_marker": "Molecular cloning of a novel human CC chemokine ([E1]Eotaxin-3[/E1]) that is a functional ligand of [E2]CC chemokine receptor 3[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Eotaxin-3", "entity_1_idx": [[49, 58]], "entity_1_idx_in_text_with_entity_marker": [53, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CC chemokine receptor 3", "entity_2_idx": [[91, 114]], "entity_2_idx_in_text_with_entity_marker": [104, 127], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s328_AIMed.d38.s328.p1", "text": "Eotaxin-3 competed the binding of (125)I-eotaxin to CCR3-expressing L1.2 cells with an IC(50) of 13 nM.", "text_with_entity_marker": "[E1]Eotaxin-3[/E1] competed the binding of (125)I-eotaxin to [E2]CCR3[/E2]-expressing L1.2 cells with an IC(50) of 13 nM.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Eotaxin-3", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCR3", "entity_2_idx": [[52, 56]], "entity_2_idx_in_text_with_entity_marker": [65, 69], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s328_AIMed.d38.s328.p2", "text": "Eotaxin-3 competed the binding of (125)I-eotaxin to CCR3-expressing L1.2 cells with an IC(50) of 13 nM.", "text_with_entity_marker": "Eotaxin-3 competed the binding of (125)[E1]I-eotaxin[/E1] to [E2]CCR3[/E2]-expressing L1.2 cells with an IC(50) of 13 nM.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "I-eotaxin", "entity_1_idx": [[39, 48]], "entity_1_idx_in_text_with_entity_marker": [43, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCR3", "entity_2_idx": [[52, 56]], "entity_2_idx_in_text_with_entity_marker": [65, 69], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s330_AIMed.d38.s330.p0", "text": "Collectively, eotaxin-3 is yet another functional ligand for CCR3.", "text_with_entity_marker": "Collectively, [E1]eotaxin-3[/E1] is yet another functional ligand for [E2]CCR3[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "eotaxin-3", "entity_1_idx": [[14, 23]], "entity_1_idx_in_text_with_entity_marker": [18, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCR3", "entity_2_idx": [[61, 65]], "entity_2_idx_in_text_with_entity_marker": [74, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s331_AIMed.d38.s331.p0", "text": "The potency of eotaxin-3 as a CCR3 ligand seems, however, to be approximately 10-fold less than that of eotaxin.", "text_with_entity_marker": "The potency of [E1]eotaxin-3[/E1] as a [E2]CCR3[/E2] ligand seems, however, to be approximately 10-fold less than that of eotaxin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "eotaxin-3", "entity_1_idx": [[15, 24]], "entity_1_idx_in_text_with_entity_marker": [19, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCR3", "entity_2_idx": [[30, 34]], "entity_2_idx_in_text_with_entity_marker": [43, 47], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s331_AIMed.d38.s331.p2", "text": "The potency of eotaxin-3 as a CCR3 ligand seems, however, to be approximately 10-fold less than that of eotaxin.", "text_with_entity_marker": "The potency of eotaxin-3 as a [E1]CCR3[/E1] ligand seems, however, to be approximately 10-fold less than that of [E2]eotaxin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "CCR3", "entity_1_idx": [[30, 34]], "entity_1_idx_in_text_with_entity_marker": [34, 38], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "eotaxin", "entity_2_idx": [[104, 111]], "entity_2_idx_in_text_with_entity_marker": [117, 124], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d74.s627_AIMed.d74.s627.p0", "text": "Two cDNA clones encoding a receptor for human granulocyte-macrophage colony-stimulating factor (hGM-CSF-R) were isolated by expression screening of a library made from human placental mRNA.", "text_with_entity_marker": "Two cDNA clones encoding a receptor for human [E1]granulocyte-macrophage colony-stimulating factor[/E1] ([E2]hGM-CSF-R[/E2]) were isolated by expression screening of a library made from human placental mRNA.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "granulocyte-macrophage colony-stimulating factor", "entity_1_idx": [[46, 94]], "entity_1_idx_in_text_with_entity_marker": [50, 98], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hGM-CSF-R", "entity_2_idx": [[96, 105]], "entity_2_idx_in_text_with_entity_marker": [109, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d223.s1934_AIMed.d223.s1934.p0", "text": "Interaction between cell cycle regulator, E2F-1, and NF-kappaB mediates repression of HIV-1 gene transcription.", "text_with_entity_marker": "Interaction between cell cycle regulator, [E1]E2F-1[/E1], and [E2]NF-kappaB[/E2] mediates repression of HIV-1 gene transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "E2F-1", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "NF-kappaB", "entity_2_idx": [[53, 62]], "entity_2_idx_in_text_with_entity_marker": [66, 75], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d223.s1936_AIMed.d223.s1936.p0", "text": "Some of these extracellular stimuli arrest cells in the G1 phase of the mitotic division cycle and modulate the activity of the tumor suppressor protein Rb and its partner E2F-1.", "text_with_entity_marker": "Some of these extracellular stimuli arrest cells in the G1 phase of the mitotic division cycle and modulate the activity of the tumor suppressor protein [E1]Rb[/E1] and its partner [E2]E2F-1[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Rb", "entity_1_idx": [[153, 155]], "entity_1_idx_in_text_with_entity_marker": [157, 159], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "E2F-1", "entity_2_idx": [[172, 177]], "entity_2_idx_in_text_with_entity_marker": [185, 190], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d223.s1938_AIMed.d223.s1938.p1", "text": "Here, we demonstrate that E2F-1 may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the NF-kappaB enhancer region and to interact with the NF-kappaB subunit, p50.", "text_with_entity_marker": "Here, we demonstrate that [E1]E2F-1[/E1] may regulate the activity of the HIV-1 long terminal repeat through its ability to bind sequences in the NF-kappaB enhancer region and to interact with the [E2]NF-kappaB[/E2] subunit, p50.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "E2F-1", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "NF-kappaB", "entity_2_idx": [[188, 197]], "entity_2_idx_in_text_with_entity_marker": [201, 210], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d223.s1944_AIMed.d223.s1944.p0", "text": "The results of this study suggest that NF-kappaB activity may be regulated by its interaction with the cell cycle regulatory protein, E2F-1.", "text_with_entity_marker": "The results of this study suggest that [E1]NF-kappaB[/E1] activity may be regulated by its interaction with the cell cycle regulatory protein, [E2]E2F-1[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "NF-kappaB", "entity_1_idx": [[39, 48]], "entity_1_idx_in_text_with_entity_marker": [43, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "E2F-1", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d34.s288_AIMed.d34.s288.p1", "text": "We report an interaction between the human PS1 or PS2 hydrophilic loop and Rab11, a small GTPase belonging to the Ras-related superfamily.", "text_with_entity_marker": "We report an interaction between the human [E1]PS1[/E1] or PS2 hydrophilic loop and [E2]Rab11[/E2], a small GTPase belonging to the Ras-related superfamily.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PS1", "entity_1_idx": [[43, 46]], "entity_1_idx_in_text_with_entity_marker": [47, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rab11", "entity_2_idx": [[75, 80]], "entity_2_idx_in_text_with_entity_marker": [88, 93], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d34.s288_AIMed.d34.s288.p2", "text": "We report an interaction between the human PS1 or PS2 hydrophilic loop and Rab11, a small GTPase belonging to the Ras-related superfamily.", "text_with_entity_marker": "We report an interaction between the human PS1 or [E1]PS2[/E1] hydrophilic loop and [E2]Rab11[/E2], a small GTPase belonging to the Ras-related superfamily.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PS2", "entity_1_idx": [[50, 53]], "entity_1_idx_in_text_with_entity_marker": [54, 57], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rab11", "entity_2_idx": [[75, 80]], "entity_2_idx_in_text_with_entity_marker": [88, 93], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d77.s654_AIMed.d77.s654.p0", "text": "We show that the carboxy terminal \"tail\" of DPI associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, K2, K5, and K6.", "text_with_entity_marker": "We show that the carboxy terminal \"tail\" of [E1]DPI[/E1] associates directly with the amino terminal \"head\" of type II epidermal keratins, including [E2]K1[/E2], K2, K5, and K6.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "DPI", "entity_1_idx": [[44, 47]], "entity_1_idx_in_text_with_entity_marker": [48, 51], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "K1", "entity_2_idx": [[140, 142]], "entity_2_idx_in_text_with_entity_marker": [153, 155], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d77.s654_AIMed.d77.s654.p1", "text": "We show that the carboxy terminal \"tail\" of DPI associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, K2, K5, and K6.", "text_with_entity_marker": "We show that the carboxy terminal \"tail\" of [E1]DPI[/E1] associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, [E2]K2[/E2], K5, and K6.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "DPI", "entity_1_idx": [[44, 47]], "entity_1_idx_in_text_with_entity_marker": [48, 51], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "K2", "entity_2_idx": [[144, 146]], "entity_2_idx_in_text_with_entity_marker": [157, 159], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d77.s654_AIMed.d77.s654.p2", "text": "We show that the carboxy terminal \"tail\" of DPI associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, K2, K5, and K6.", "text_with_entity_marker": "We show that the carboxy terminal \"tail\" of [E1]DPI[/E1] associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, K2, [E2]K5[/E2], and K6.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "DPI", "entity_1_idx": [[44, 47]], "entity_1_idx_in_text_with_entity_marker": [48, 51], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "K5", "entity_2_idx": [[148, 150]], "entity_2_idx_in_text_with_entity_marker": [161, 163], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d77.s654_AIMed.d77.s654.p3", "text": "We show that the carboxy terminal \"tail\" of DPI associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, K2, K5, and K6.", "text_with_entity_marker": "We show that the carboxy terminal \"tail\" of [E1]DPI[/E1] associates directly with the amino terminal \"head\" of type II epidermal keratins, including K1, K2, K5, and [E2]K6[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "DPI", "entity_1_idx": [[44, 47]], "entity_1_idx_in_text_with_entity_marker": [48, 51], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "K6", "entity_2_idx": [[156, 158]], "entity_2_idx_in_text_with_entity_marker": [169, 171], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d77.s655_AIMed.d77.s655.p0", "text": "We have engineered and purified recombinant K5 head and DPI tail, and we demonstrate direct interaction in vitro by solution-binding assays and by ligand blot assays.", "text_with_entity_marker": "We have engineered and purified recombinant [E1]K5[/E1] head and [E2]DPI[/E2] tail, and we demonstrate direct interaction in vitro by solution-binding assays and by ligand blot assays.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "K5", "entity_1_idx": [[44, 46]], "entity_1_idx_in_text_with_entity_marker": [48, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "DPI", "entity_2_idx": [[56, 59]], "entity_2_idx_in_text_with_entity_marker": [69, 72], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d77.s657_AIMed.d77.s657.p0", "text": "We have identified an 18-amino acid residue stretch in the K5 head that is conserved only among type II epidermal keratins and that appears to play some role in DPI tail binding.", "text_with_entity_marker": "We have identified an 18-amino acid residue stretch in the [E1]K5[/E1] head that is conserved only among type II epidermal keratins and that appears to play some role in [E2]DPI[/E2] tail binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "K5", "entity_1_idx": [[59, 61]], "entity_1_idx_in_text_with_entity_marker": [63, 65], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "DPI", "entity_2_idx": [[161, 164]], "entity_2_idx_in_text_with_entity_marker": [174, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d29.s244_AIMed.d29.s244.p6", "text": "This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (CXCR1) and B (CXCR2) and to the Duffy antigen.", "text_with_entity_marker": "This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to [E1]IL-8[/E1] receptor subtypes A ([E2]CXCR1[/E2]) and B (CXCR2) and to the Duffy antigen.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-8", "entity_1_idx": [[130, 134]], "entity_1_idx_in_text_with_entity_marker": [134, 138], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CXCR1", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d29.s244_AIMed.d29.s244.p7", "text": "This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (CXCR1) and B (CXCR2) and to the Duffy antigen.", "text_with_entity_marker": "This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to [E1]IL-8[/E1] receptor subtypes A (CXCR1) and B ([E2]CXCR2[/E2]) and to the Duffy antigen.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-8", "entity_1_idx": [[130, 134]], "entity_1_idx_in_text_with_entity_marker": [134, 138], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CXCR2", "entity_2_idx": [[170, 175]], "entity_2_idx_in_text_with_entity_marker": [183, 188], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d29.s244_AIMed.d29.s244.p8", "text": "This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (CXCR1) and B (CXCR2) and to the Duffy antigen.", "text_with_entity_marker": "This work shows that single and double Ala substitutions of His18 and Phe21 in IL-8 reduced up to 77-fold the binding affinity to [E1]IL-8[/E1] receptor subtypes A (CXCR1) and B (CXCR2) and to the [E2]Duffy antigen[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-8", "entity_1_idx": [[130, 134]], "entity_1_idx_in_text_with_entity_marker": [134, 138], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Duffy antigen", "entity_2_idx": [[188, 201]], "entity_2_idx_in_text_with_entity_marker": [201, 214], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d29.s249_AIMed.d29.s249.p0", "text": "This study demonstrates that IL-8 recognizes and activates CXCR1, CXCR2, and the Duffy antigen by distinct mechanisms.", "text_with_entity_marker": "This study demonstrates that [E1]IL-8[/E1] recognizes and activates [E2]CXCR1[/E2], CXCR2, and the Duffy antigen by distinct mechanisms.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-8", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CXCR1", "entity_2_idx": [[59, 64]], "entity_2_idx_in_text_with_entity_marker": [72, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d29.s249_AIMed.d29.s249.p1", "text": "This study demonstrates that IL-8 recognizes and activates CXCR1, CXCR2, and the Duffy antigen by distinct mechanisms.", "text_with_entity_marker": "This study demonstrates that [E1]IL-8[/E1] recognizes and activates CXCR1, [E2]CXCR2[/E2], and the Duffy antigen by distinct mechanisms.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-8", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CXCR2", "entity_2_idx": [[66, 71]], "entity_2_idx_in_text_with_entity_marker": [79, 84], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d29.s249_AIMed.d29.s249.p2", "text": "This study demonstrates that IL-8 recognizes and activates CXCR1, CXCR2, and the Duffy antigen by distinct mechanisms.", "text_with_entity_marker": "This study demonstrates that [E1]IL-8[/E1] recognizes and activates CXCR1, CXCR2, and the [E2]Duffy antigen[/E2] by distinct mechanisms.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-8", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Duffy antigen", "entity_2_idx": [[81, 94]], "entity_2_idx_in_text_with_entity_marker": [94, 107], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d81.s688_AIMed.d81.s688.p0", "text": "RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death.", "text_with_entity_marker": "[E1]RIP[/E1]: a novel protein containing a death domain that interacts with [E2]Fas[/E2]/APO-1 (CD95) in yeast and causes cell death.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RIP", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[67, 70]], "entity_2_idx_in_text_with_entity_marker": [80, 83], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d81.s688_AIMed.d81.s688.p1", "text": "RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death.", "text_with_entity_marker": "[E1]RIP[/E1]: a novel protein containing a death domain that interacts with Fas/[E2]APO-1[/E2] (CD95) in yeast and causes cell death.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RIP", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "APO-1", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d81.s688_AIMed.d81.s688.p2", "text": "RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death.", "text_with_entity_marker": "[E1]RIP[/E1]: a novel protein containing a death domain that interacts with Fas/APO-1 ([E2]CD95[/E2]) in yeast and causes cell death.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RIP", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD95", "entity_2_idx": [[78, 82]], "entity_2_idx_in_text_with_entity_marker": [91, 95], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d81.s690_AIMed.d81.s690.p0", "text": "Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of Fas: Fas itself, and a novel 74 kDa protein we have named RIP, for receptor interacting protein.", "text_with_entity_marker": "Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of [E1]Fas[/E1]: [E2]Fas[/E2] itself, and a novel 74 kDa protein we have named RIP, for receptor interacting protein.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[158, 161]], "entity_1_idx_in_text_with_entity_marker": [162, 165], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[163, 166]], "entity_2_idx_in_text_with_entity_marker": [176, 179], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d81.s690_AIMed.d81.s690.p1", "text": "Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of Fas: Fas itself, and a novel 74 kDa protein we have named RIP, for receptor interacting protein.", "text_with_entity_marker": "Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of [E1]Fas[/E1]: Fas itself, and a novel 74 kDa protein we have named [E2]RIP[/E2], for receptor interacting protein.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[158, 161]], "entity_1_idx_in_text_with_entity_marker": [162, 165], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[216, 219]], "entity_2_idx_in_text_with_entity_marker": [229, 232], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d81.s690_AIMed.d81.s690.p2", "text": "Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of Fas: Fas itself, and a novel 74 kDa protein we have named RIP, for receptor interacting protein.", "text_with_entity_marker": "Using a genetic selection based on protein-protein interaction in yeast, we have identified two gene products that associate with the intracellular domain of [E1]Fas[/E1]: Fas itself, and a novel 74 kDa protein we have named RIP, for [E2]receptor interacting protein[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[158, 161]], "entity_1_idx_in_text_with_entity_marker": [162, 165], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "receptor interacting protein", "entity_2_idx": [[225, 253]], "entity_2_idx_in_text_with_entity_marker": [238, 266], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d81.s691_AIMed.d81.s691.p1", "text": "RIP also interacts weakly with the p55 tumor necrosis factor receptor (TNFR1) intracellular domain, but not with a mutant version of Fas corresponding to the murine lprcg mutation.", "text_with_entity_marker": "[E1]RIP[/E1] also interacts weakly with the p55 tumor necrosis factor receptor ([E2]TNFR1[/E2]) intracellular domain, but not with a mutant version of Fas corresponding to the murine lprcg mutation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RIP", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNFR1", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d172.s1447_AIMed.d172.s1447.p0", "text": "The tyrosine kinases Flt4, Flt1, and Flk1 (or KDR) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.", "text_with_entity_marker": "The tyrosine kinases [E1]Flt4[/E1], [E2]Flt1[/E2], and Flk1 (or KDR) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Flt4", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Flt1", "entity_2_idx": [[27, 31]], "entity_2_idx_in_text_with_entity_marker": [40, 44], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d172.s1447_AIMed.d172.s1447.p1", "text": "The tyrosine kinases Flt4, Flt1, and Flk1 (or KDR) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.", "text_with_entity_marker": "The tyrosine kinases [E1]Flt4[/E1], Flt1, and [E2]Flk1[/E2] (or KDR) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Flt4", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Flk1", "entity_2_idx": [[37, 41]], "entity_2_idx_in_text_with_entity_marker": [50, 54], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d172.s1447_AIMed.d172.s1447.p2", "text": "The tyrosine kinases Flt4, Flt1, and Flk1 (or KDR) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.", "text_with_entity_marker": "The tyrosine kinases [E1]Flt4[/E1], Flt1, and Flk1 (or [E2]KDR[/E2]) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Flt4", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KDR", "entity_2_idx": [[46, 49]], "entity_2_idx_in_text_with_entity_marker": [59, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d172.s1447_AIMed.d172.s1447.p3", "text": "The tyrosine kinases Flt4, Flt1, and Flk1 (or KDR) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.", "text_with_entity_marker": "The tyrosine kinases Flt4, [E1]Flt1[/E1], and [E2]Flk1[/E2] (or KDR) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Flt1", "entity_1_idx": [[27, 31]], "entity_1_idx_in_text_with_entity_marker": [31, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Flk1", "entity_2_idx": [[37, 41]], "entity_2_idx_in_text_with_entity_marker": [50, 54], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d172.s1447_AIMed.d172.s1447.p4", "text": "The tyrosine kinases Flt4, Flt1, and Flk1 (or KDR) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.", "text_with_entity_marker": "The tyrosine kinases Flt4, [E1]Flt1[/E1], and Flk1 (or [E2]KDR[/E2]) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Flt1", "entity_1_idx": [[27, 31]], "entity_1_idx_in_text_with_entity_marker": [31, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KDR", "entity_2_idx": [[46, 49]], "entity_2_idx_in_text_with_entity_marker": [59, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d172.s1447_AIMed.d172.s1447.p5", "text": "The tyrosine kinases Flt4, Flt1, and Flk1 (or KDR) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.", "text_with_entity_marker": "The tyrosine kinases Flt4, Flt1, and [E1]Flk1[/E1] (or [E2]KDR[/E2]) constitute a family of endothelial cell-specific receptors with seven immunoglobulin-like domains and a split kinase domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Flk1", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KDR", "entity_2_idx": [[46, 49]], "entity_2_idx_in_text_with_entity_marker": [59, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d172.s1452_AIMed.d172.s1452.p0", "text": "VRP fails to bind appreciably to the extracellular domain of Flt1 or Flk1.", "text_with_entity_marker": "[E1]VRP[/E1] fails to bind appreciably to the extracellular domain of [E2]Flt1[/E2] or Flk1.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "VRP", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Flt1", "entity_2_idx": [[61, 65]], "entity_2_idx_in_text_with_entity_marker": [74, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d172.s1452_AIMed.d172.s1452.p1", "text": "VRP fails to bind appreciably to the extracellular domain of Flt1 or Flk1.", "text_with_entity_marker": "[E1]VRP[/E1] fails to bind appreciably to the extracellular domain of Flt1 or [E2]Flk1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "VRP", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Flk1", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d172.s1452_AIMed.d172.s1452.p2", "text": "VRP fails to bind appreciably to the extracellular domain of Flt1 or Flk1.", "text_with_entity_marker": "VRP fails to bind appreciably to the extracellular domain of [E1]Flt1[/E1] or [E2]Flk1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Flt1", "entity_1_idx": [[61, 65]], "entity_1_idx_in_text_with_entity_marker": [65, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Flk1", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d145.s1229_AIMed.d145.s1229.p0", "text": "The novel fold of the TNF receptor structure is likely to be representative of the nerve growth factor (NGF)/TNF receptor family as a whole.", "text_with_entity_marker": "The novel fold of the TNF receptor structure is likely to be representative of the [E1]nerve growth factor[/E1] ([E2]NGF[/E2])/TNF receptor family as a whole.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nerve growth factor", "entity_1_idx": [[83, 102]], "entity_1_idx_in_text_with_entity_marker": [87, 106], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "NGF", "entity_2_idx": [[104, 107]], "entity_2_idx_in_text_with_entity_marker": [117, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d81.s689_AIMed.d81.s689.p0", "text": "Ligation of the extracellular domain of the cell surface receptor Fas/APO-1 (CD95) elicits a characteristic programmed death response in susceptible cells.", "text_with_entity_marker": "Ligation of the extracellular domain of the cell surface receptor [E1]Fas[/E1]/[E2]APO-1[/E2] (CD95) elicits a characteristic programmed death response in susceptible cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "APO-1", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d81.s689_AIMed.d81.s689.p1", "text": "Ligation of the extracellular domain of the cell surface receptor Fas/APO-1 (CD95) elicits a characteristic programmed death response in susceptible cells.", "text_with_entity_marker": "Ligation of the extracellular domain of the cell surface receptor [E1]Fas[/E1]/APO-1 ([E2]CD95[/E2]) elicits a characteristic programmed death response in susceptible cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD95", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d81.s689_AIMed.d81.s689.p2", "text": "Ligation of the extracellular domain of the cell surface receptor Fas/APO-1 (CD95) elicits a characteristic programmed death response in susceptible cells.", "text_with_entity_marker": "Ligation of the extracellular domain of the cell surface receptor Fas/[E1]APO-1[/E1] ([E2]CD95[/E2]) elicits a characteristic programmed death response in susceptible cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "APO-1", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD95", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d81.s692_AIMed.d81.s692.p0", "text": "RIP contains an N-terminal region with homology to protein kinases and a C-terminal region containing a cytoplasmic motif (death domain) present in the Fas and TNFR1 intracellular domains.", "text_with_entity_marker": "[E1]RIP[/E1] contains an N-terminal region with homology to protein kinases and a C-terminal region containing a cytoplasmic motif (death domain) present in the [E2]Fas[/E2] and TNFR1 intracellular domains.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RIP", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[152, 155]], "entity_2_idx_in_text_with_entity_marker": [165, 168], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d81.s692_AIMed.d81.s692.p1", "text": "RIP contains an N-terminal region with homology to protein kinases and a C-terminal region containing a cytoplasmic motif (death domain) present in the Fas and TNFR1 intracellular domains.", "text_with_entity_marker": "[E1]RIP[/E1] contains an N-terminal region with homology to protein kinases and a C-terminal region containing a cytoplasmic motif (death domain) present in the Fas and [E2]TNFR1[/E2] intracellular domains.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RIP", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNFR1", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d81.s692_AIMed.d81.s692.p2", "text": "RIP contains an N-terminal region with homology to protein kinases and a C-terminal region containing a cytoplasmic motif (death domain) present in the Fas and TNFR1 intracellular domains.", "text_with_entity_marker": "RIP contains an N-terminal region with homology to protein kinases and a C-terminal region containing a cytoplasmic motif (death domain) present in the [E1]Fas[/E1] and [E2]TNFR1[/E2] intracellular domains.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[152, 155]], "entity_1_idx_in_text_with_entity_marker": [156, 159], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNFR1", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d19.s162_AIMed.d19.s162.p0", "text": "Several genes are involved in this process, and two have been the focus of recent interest: the natural resistance-associated protein (NRAMP1) gene and the genes coding for the vitamin D receptor.", "text_with_entity_marker": "Several genes are involved in this process, and two have been the focus of recent interest: the [E1]natural resistance-associated protein[/E1] ([E2]NRAMP1[/E2]) gene and the genes coding for the vitamin D receptor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "natural resistance-associated protein", "entity_1_idx": [[96, 133]], "entity_1_idx_in_text_with_entity_marker": [100, 137], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "NRAMP1", "entity_2_idx": [[135, 141]], "entity_2_idx_in_text_with_entity_marker": [148, 154], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d19.s162_AIMed.d19.s162.p1", "text": "Several genes are involved in this process, and two have been the focus of recent interest: the natural resistance-associated protein (NRAMP1) gene and the genes coding for the vitamin D receptor.", "text_with_entity_marker": "Several genes are involved in this process, and two have been the focus of recent interest: the [E1]natural resistance-associated protein[/E1] (NRAMP1) gene and the genes coding for the [E2]vitamin D receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "natural resistance-associated protein", "entity_1_idx": [[96, 133]], "entity_1_idx_in_text_with_entity_marker": [100, 137], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "vitamin D receptor", "entity_2_idx": [[177, 195]], "entity_2_idx_in_text_with_entity_marker": [190, 208], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d19.s162_AIMed.d19.s162.p2", "text": "Several genes are involved in this process, and two have been the focus of recent interest: the natural resistance-associated protein (NRAMP1) gene and the genes coding for the vitamin D receptor.", "text_with_entity_marker": "Several genes are involved in this process, and two have been the focus of recent interest: the natural resistance-associated protein ([E1]NRAMP1[/E1]) gene and the genes coding for the [E2]vitamin D receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NRAMP1", "entity_1_idx": [[135, 141]], "entity_1_idx_in_text_with_entity_marker": [139, 145], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "vitamin D receptor", "entity_2_idx": [[177, 195]], "entity_2_idx_in_text_with_entity_marker": [190, 208], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d65.s555_AIMed.d65.s555.p0", "text": "The Fos/Jun and ATF/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.", "text_with_entity_marker": "The [E1]Fos[/E1]/[E2]Jun[/E2] and ATF/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fos", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Jun", "entity_2_idx": [[8, 11]], "entity_2_idx_in_text_with_entity_marker": [21, 24], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d65.s555_AIMed.d65.s555.p1", "text": "The Fos/Jun and ATF/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.", "text_with_entity_marker": "The [E1]Fos[/E1]/Jun and [E2]ATF[/E2]/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fos", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ATF", "entity_2_idx": [[16, 19]], "entity_2_idx_in_text_with_entity_marker": [29, 32], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d65.s555_AIMed.d65.s555.p2", "text": "The Fos/Jun and ATF/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.", "text_with_entity_marker": "The [E1]Fos[/E1]/Jun and ATF/[E2]CREB[/E2] families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fos", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[20, 24]], "entity_2_idx_in_text_with_entity_marker": [33, 37], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d65.s555_AIMed.d65.s555.p3", "text": "The Fos/Jun and ATF/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.", "text_with_entity_marker": "The Fos/[E1]Jun[/E1] and [E2]ATF[/E2]/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Jun", "entity_1_idx": [[8, 11]], "entity_1_idx_in_text_with_entity_marker": [12, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ATF", "entity_2_idx": [[16, 19]], "entity_2_idx_in_text_with_entity_marker": [29, 32], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d65.s555_AIMed.d65.s555.p4", "text": "The Fos/Jun and ATF/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.", "text_with_entity_marker": "The Fos/[E1]Jun[/E1] and ATF/[E2]CREB[/E2] families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Jun", "entity_1_idx": [[8, 11]], "entity_1_idx_in_text_with_entity_marker": [12, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[20, 24]], "entity_2_idx_in_text_with_entity_marker": [33, 37], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d65.s555_AIMed.d65.s555.p5", "text": "The Fos/Jun and ATF/CREB families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.", "text_with_entity_marker": "The Fos/Jun and [E1]ATF[/E1]/[E2]CREB[/E2] families of transcription factors function in coupling extracellular signals to alterations in expression of specific target genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ATF", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[20, 24]], "entity_2_idx_in_text_with_entity_marker": [33, 37], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d65.s560_AIMed.d65.s560.p0", "text": "These findings indicate that the Fos/Jun and ATF/CREB families of transcription factors are not as distinct as was previously thought.", "text_with_entity_marker": "These findings indicate that the [E1]Fos[/E1]/[E2]Jun[/E2] and ATF/CREB families of transcription factors are not as distinct as was previously thought.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fos", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Jun", "entity_2_idx": [[37, 40]], "entity_2_idx_in_text_with_entity_marker": [50, 53], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d65.s560_AIMed.d65.s560.p1", "text": "These findings indicate that the Fos/Jun and ATF/CREB families of transcription factors are not as distinct as was previously thought.", "text_with_entity_marker": "These findings indicate that the [E1]Fos[/E1]/Jun and [E2]ATF[/E2]/CREB families of transcription factors are not as distinct as was previously thought.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fos", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ATF", "entity_2_idx": [[45, 48]], "entity_2_idx_in_text_with_entity_marker": [58, 61], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d65.s560_AIMed.d65.s560.p2", "text": "These findings indicate that the Fos/Jun and ATF/CREB families of transcription factors are not as distinct as was previously thought.", "text_with_entity_marker": "These findings indicate that the [E1]Fos[/E1]/Jun and ATF/[E2]CREB[/E2] families of transcription factors are not as distinct as was previously thought.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fos", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[49, 53]], "entity_2_idx_in_text_with_entity_marker": [62, 66], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d65.s560_AIMed.d65.s560.p3", "text": "These findings indicate that the Fos/Jun and ATF/CREB families of transcription factors are not as distinct as was previously thought.", "text_with_entity_marker": "These findings indicate that the Fos/[E1]Jun[/E1] and [E2]ATF[/E2]/CREB families of transcription factors are not as distinct as was previously thought.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Jun", "entity_1_idx": [[37, 40]], "entity_1_idx_in_text_with_entity_marker": [41, 44], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ATF", "entity_2_idx": [[45, 48]], "entity_2_idx_in_text_with_entity_marker": [58, 61], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d65.s560_AIMed.d65.s560.p4", "text": "These findings indicate that the Fos/Jun and ATF/CREB families of transcription factors are not as distinct as was previously thought.", "text_with_entity_marker": "These findings indicate that the Fos/[E1]Jun[/E1] and ATF/[E2]CREB[/E2] families of transcription factors are not as distinct as was previously thought.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Jun", "entity_1_idx": [[37, 40]], "entity_1_idx_in_text_with_entity_marker": [41, 44], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[49, 53]], "entity_2_idx_in_text_with_entity_marker": [62, 66], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d65.s560_AIMed.d65.s560.p5", "text": "These findings indicate that the Fos/Jun and ATF/CREB families of transcription factors are not as distinct as was previously thought.", "text_with_entity_marker": "These findings indicate that the Fos/Jun and [E1]ATF[/E1]/[E2]CREB[/E2] families of transcription factors are not as distinct as was previously thought.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ATF", "entity_1_idx": [[45, 48]], "entity_1_idx_in_text_with_entity_marker": [49, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[49, 53]], "entity_2_idx_in_text_with_entity_marker": [62, 66], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d220.s1911_AIMed.d220.s1911.p0", "text": "Two distinct ligand binding domains of TRKB were isolated from proteolytic digests of the receptor by affinity separation on immobilized BDNF.", "text_with_entity_marker": "Two distinct ligand binding domains of [E1]TRKB[/E1] were isolated from proteolytic digests of the receptor by affinity separation on immobilized [E2]BDNF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRKB", "entity_1_idx": [[39, 43]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BDNF", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d198.s1686_AIMed.d198.s1686.p0", "text": "Mutagenesis studies of the human erythropoietin receptor. Establishment of structure-function relationships.", "text_with_entity_marker": "Mutagenesis studies of the human [E1-E2]erythropoietin[/E1] receptor[/E2]. Establishment of structure-function relationships.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "erythropoietin", "entity_1_idx": [[33, 47]], "entity_1_idx_in_text_with_entity_marker": [40, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "erythropoietin[/E1] receptor", "entity_2_idx": [[33, 56]], "entity_2_idx_in_text_with_entity_marker": [40, 68], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d198.s1690_AIMed.d198.s1690.p0", "text": "Site-specific mutants were expressed in Escherichia coli as soluble EBP and analyzed for EPO binding in several different assay formats.", "text_with_entity_marker": "Site-specific mutants were expressed in Escherichia coli as soluble [E1]EBP[/E1] and analyzed for [E2]EPO[/E2] binding in several different assay formats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "EBP", "entity_1_idx": [[68, 71]], "entity_1_idx_in_text_with_entity_marker": [72, 75], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "EPO", "entity_2_idx": [[89, 92]], "entity_2_idx_in_text_with_entity_marker": [102, 105], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d198.s1691_AIMed.d198.s1691.p0", "text": "In addition, selected mutant proteins were expressed as full-length EPOR on the surface of COS cells and analyzed for 125I-EPO binding in receptor binding assays.", "text_with_entity_marker": "In addition, selected mutant proteins were expressed as full-length [E1]EPOR[/E1] on the surface of COS cells and analyzed for 125I-[E2]EPO[/E2] binding in receptor binding assays.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "EPOR", "entity_1_idx": [[68, 72]], "entity_1_idx_in_text_with_entity_marker": [72, 76], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "EPO", "entity_2_idx": [[123, 126]], "entity_2_idx_in_text_with_entity_marker": [136, 139], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d4.s37_AIMed.d4.s37.p0", "text": "Positive inotropic responses mediated by endothelin ET(A) and ET(B) receptors in human myocardial trabeculae.", "text_with_entity_marker": "Positive inotropic responses mediated by endothelin [E1]ET(A)[/E1] and [E2]ET(B)[/E2] receptors in human myocardial trabeculae.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ET(A)", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ET(B)", "entity_2_idx": [[62, 67]], "entity_2_idx_in_text_with_entity_marker": [75, 80], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d4.s38_AIMed.d4.s38.p0", "text": "The aim of the present study was to determine possible inotropic effects mediated by endothelin ET(A) and ET(B) receptors in human myocardial trabeculae from the right atrium and the left ventricle.", "text_with_entity_marker": "The aim of the present study was to determine possible inotropic effects mediated by endothelin [E1]ET(A)[/E1] and [E2]ET(B)[/E2] receptors in human myocardial trabeculae from the right atrium and the left ventricle.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ET(A)", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ET(B)", "entity_2_idx": [[106, 111]], "entity_2_idx_in_text_with_entity_marker": [119, 124], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d4.s40_AIMed.d4.s40.p0", "text": "Endothelin-1 (ET-1) and ET-3 had a strong positive inotropic effect in all trabeculae.", "text_with_entity_marker": "[E1]Endothelin-1[/E1] ([E2]ET-1[/E2]) and ET-3 had a strong positive inotropic effect in all trabeculae.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Endothelin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ET-1", "entity_2_idx": [[14, 18]], "entity_2_idx_in_text_with_entity_marker": [27, 31], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d4.s40_AIMed.d4.s40.p1", "text": "Endothelin-1 (ET-1) and ET-3 had a strong positive inotropic effect in all trabeculae.", "text_with_entity_marker": "[E1]Endothelin-1[/E1] (ET-1) and [E2]ET-3[/E2] had a strong positive inotropic effect in all trabeculae.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Endothelin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ET-3", "entity_2_idx": [[24, 28]], "entity_2_idx_in_text_with_entity_marker": [37, 41], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d4.s40_AIMed.d4.s40.p2", "text": "Endothelin-1 (ET-1) and ET-3 had a strong positive inotropic effect in all trabeculae.", "text_with_entity_marker": "Endothelin-1 ([E1]ET-1[/E1]) and [E2]ET-3[/E2] had a strong positive inotropic effect in all trabeculae.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ET-1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ET-3", "entity_2_idx": [[24, 28]], "entity_2_idx_in_text_with_entity_marker": [37, 41], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d4.s41_AIMed.d4.s41.p0", "text": "ET-1 was significantly more potent than ET-3 in both atrial (P < 0.001) and ventricular (P < 0.05) trabeculae.", "text_with_entity_marker": "[E1]ET-1[/E1] was significantly more potent than [E2]ET-3[/E2] in both atrial (P < 0.001) and ventricular (P < 0.05) trabeculae.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ET-1", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ET-3", "entity_2_idx": [[40, 44]], "entity_2_idx_in_text_with_entity_marker": [53, 57], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d4.s42_AIMed.d4.s42.p0", "text": "Preincubation with the ET(A) receptor antagonist FR139317 (1 microM) decreased significantly (P < 0.005) the potency of ET- I in both atrial and ventricular trabeculae, without any significant changes in Emax (maximum effect obtained with an agonist).", "text_with_entity_marker": "Preincubation with the [E1]ET(A) receptor[/E1] antagonist FR139317 (1 microM) decreased significantly (P < 0.005) the potency of [E2]ET- I[/E2] in both atrial and ventricular trabeculae, without any significant changes in Emax (maximum effect obtained with an agonist).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ET(A) receptor", "entity_1_idx": [[23, 37]], "entity_1_idx_in_text_with_entity_marker": [27, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ET- I", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d4.s43_AIMed.d4.s43.p0", "text": "The ET(B) receptor agonist IRL 1620 had a positive inotropic effect only in some trabeculae, and the ET(B) receptor antagonist BQ 788 (1 microM) almost completely blocked this effect.", "text_with_entity_marker": "The [E1]ET(B) receptor[/E1] agonist IRL 1620 had a positive inotropic effect only in some trabeculae, and the [E2]ET(B) receptor[/E2] antagonist BQ 788 (1 microM) almost completely blocked this effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ET(B) receptor", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ET(B) receptor", "entity_2_idx": [[101, 115]], "entity_2_idx_in_text_with_entity_marker": [114, 128], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d4.s44_AIMed.d4.s44.p0", "text": "These results suggest that both ET(A) and ET(B) receptors mediate positive inotropic responses at both the atrial and ventricular level in the human heart.", "text_with_entity_marker": "These results suggest that both [E1]ET(A)[/E1] and [E2]ET(B)[/E2] receptors mediate positive inotropic responses at both the atrial and ventricular level in the human heart.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ET(A)", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ET(B)", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d15.s126_AIMed.d15.s126.p0", "text": "We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely interleukin (IL)-8, interferon-gamma and IL-2 versus IL-10.", "text_with_entity_marker": "We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely [E1]interleukin (IL)-8[/E1], [E2]interferon-gamma[/E2] and IL-2 versus IL-10.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interleukin (IL)-8", "entity_1_idx": [[194, 212]], "entity_1_idx_in_text_with_entity_marker": [198, 216], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "interferon-gamma", "entity_2_idx": [[214, 230]], "entity_2_idx_in_text_with_entity_marker": [227, 243], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d15.s126_AIMed.d15.s126.p1", "text": "We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely interleukin (IL)-8, interferon-gamma and IL-2 versus IL-10.", "text_with_entity_marker": "We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely [E1]interleukin (IL)-8[/E1], interferon-gamma and [E2]IL-2[/E2] versus IL-10.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interleukin (IL)-8", "entity_1_idx": [[194, 212]], "entity_1_idx_in_text_with_entity_marker": [198, 216], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[235, 239]], "entity_2_idx_in_text_with_entity_marker": [248, 252], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d15.s126_AIMed.d15.s126.p2", "text": "We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely interleukin (IL)-8, interferon-gamma and IL-2 versus IL-10.", "text_with_entity_marker": "We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely [E1]interleukin (IL)-8[/E1], interferon-gamma and IL-2 versus [E2]IL-10[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interleukin (IL)-8", "entity_1_idx": [[194, 212]], "entity_1_idx_in_text_with_entity_marker": [198, 216], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[247, 252]], "entity_2_idx_in_text_with_entity_marker": [260, 265], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d15.s126_AIMed.d15.s126.p3", "text": "We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely interleukin (IL)-8, interferon-gamma and IL-2 versus IL-10.", "text_with_entity_marker": "We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely interleukin (IL)-8, [E1]interferon-gamma[/E1] and [E2]IL-2[/E2] versus IL-10.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interferon-gamma", "entity_1_idx": [[214, 230]], "entity_1_idx_in_text_with_entity_marker": [218, 234], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[235, 239]], "entity_2_idx_in_text_with_entity_marker": [248, 252], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d15.s126_AIMed.d15.s126.p4", "text": "We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely interleukin (IL)-8, interferon-gamma and IL-2 versus IL-10.", "text_with_entity_marker": "We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely interleukin (IL)-8, [E1]interferon-gamma[/E1] and IL-2 versus [E2]IL-10[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interferon-gamma", "entity_1_idx": [[214, 230]], "entity_1_idx_in_text_with_entity_marker": [218, 234], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[247, 252]], "entity_2_idx_in_text_with_entity_marker": [260, 265], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d15.s126_AIMed.d15.s126.p5", "text": "We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely interleukin (IL)-8, interferon-gamma and IL-2 versus IL-10.", "text_with_entity_marker": "We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate, namely interleukin (IL)-8, interferon-gamma and [E1]IL-2[/E1] versus [E2]IL-10[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-2", "entity_1_idx": [[235, 239]], "entity_1_idx_in_text_with_entity_marker": [239, 243], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[247, 252]], "entity_2_idx_in_text_with_entity_marker": [260, 265], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d15.s128_AIMed.d15.s128.p0", "text": "MATERIALS AND METHODS: We measured levels of IL-8, interferon-gamma, IL-2 and IL-10 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.", "text_with_entity_marker": "MATERIALS AND METHODS: We measured levels of [E1]IL-8[/E1], [E2]interferon-gamma[/E2], IL-2 and IL-10 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-8", "entity_1_idx": [[45, 49]], "entity_1_idx_in_text_with_entity_marker": [49, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "interferon-gamma", "entity_2_idx": [[51, 67]], "entity_2_idx_in_text_with_entity_marker": [64, 80], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d15.s128_AIMed.d15.s128.p1", "text": "MATERIALS AND METHODS: We measured levels of IL-8, interferon-gamma, IL-2 and IL-10 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.", "text_with_entity_marker": "MATERIALS AND METHODS: We measured levels of [E1]IL-8[/E1], interferon-gamma, [E2]IL-2[/E2] and IL-10 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-8", "entity_1_idx": [[45, 49]], "entity_1_idx_in_text_with_entity_marker": [49, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d15.s128_AIMed.d15.s128.p2", "text": "MATERIALS AND METHODS: We measured levels of IL-8, interferon-gamma, IL-2 and IL-10 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.", "text_with_entity_marker": "MATERIALS AND METHODS: We measured levels of [E1]IL-8[/E1], interferon-gamma, IL-2 and [E2]IL-10[/E2] in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-8", "entity_1_idx": [[45, 49]], "entity_1_idx_in_text_with_entity_marker": [49, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d15.s128_AIMed.d15.s128.p3", "text": "MATERIALS AND METHODS: We measured levels of IL-8, interferon-gamma, IL-2 and IL-10 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.", "text_with_entity_marker": "MATERIALS AND METHODS: We measured levels of IL-8, [E1]interferon-gamma[/E1], [E2]IL-2[/E2] and IL-10 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interferon-gamma", "entity_1_idx": [[51, 67]], "entity_1_idx_in_text_with_entity_marker": [55, 71], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d15.s128_AIMed.d15.s128.p4", "text": "MATERIALS AND METHODS: We measured levels of IL-8, interferon-gamma, IL-2 and IL-10 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.", "text_with_entity_marker": "MATERIALS AND METHODS: We measured levels of IL-8, [E1]interferon-gamma[/E1], IL-2 and [E2]IL-10[/E2] in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interferon-gamma", "entity_1_idx": [[51, 67]], "entity_1_idx_in_text_with_entity_marker": [55, 71], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d15.s128_AIMed.d15.s128.p5", "text": "MATERIALS AND METHODS: We measured levels of IL-8, interferon-gamma, IL-2 and IL-10 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.", "text_with_entity_marker": "MATERIALS AND METHODS: We measured levels of IL-8, interferon-gamma, [E1]IL-2[/E1] and [E2]IL-10[/E2] in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-2", "entity_1_idx": [[69, 73]], "entity_1_idx_in_text_with_entity_marker": [73, 77], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d15.s131_AIMed.d15.s131.p0", "text": "Interferon-gamma, IL-2 and IL-10 levels were statistically greater in patients.", "text_with_entity_marker": "[E1]Interferon-gamma[/E1], [E2]IL-2[/E2] and IL-10 levels were statistically greater in patients.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Interferon-gamma", "entity_1_idx": [[0, 16]], "entity_1_idx_in_text_with_entity_marker": [4, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[18, 22]], "entity_2_idx_in_text_with_entity_marker": [31, 35], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d15.s131_AIMed.d15.s131.p1", "text": "Interferon-gamma, IL-2 and IL-10 levels were statistically greater in patients.", "text_with_entity_marker": "[E1]Interferon-gamma[/E1], IL-2 and [E2]IL-10[/E2] levels were statistically greater in patients.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Interferon-gamma", "entity_1_idx": [[0, 16]], "entity_1_idx_in_text_with_entity_marker": [4, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[27, 32]], "entity_2_idx_in_text_with_entity_marker": [40, 45], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d15.s131_AIMed.d15.s131.p2", "text": "Interferon-gamma, IL-2 and IL-10 levels were statistically greater in patients.", "text_with_entity_marker": "Interferon-gamma, [E1]IL-2[/E1] and [E2]IL-10[/E2] levels were statistically greater in patients.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-2", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[27, 32]], "entity_2_idx_in_text_with_entity_marker": [40, 45], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d206.s1781_AIMed.d206.s1781.p0", "text": "There was extensive co-localisation of CD9 and beta 1 integrins on microvilli and at cell-cell borders of basal keratinocytes; however, in contrast to the integrins, CD9 was not found in focal adhesions.", "text_with_entity_marker": "There was extensive co-localisation of [E1]CD9[/E1] and beta 1 integrins on microvilli and at cell-cell borders of basal keratinocytes; however, in contrast to the integrins, [E2]CD9[/E2] was not found in focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD9", "entity_1_idx": [[39, 42]], "entity_1_idx_in_text_with_entity_marker": [43, 46], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD9", "entity_2_idx": [[166, 169]], "entity_2_idx_in_text_with_entity_marker": [179, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d206.s1784_AIMed.d206.s1784.p0", "text": "Antibodies to CD9 did not affect the proportion of keratinocytes that adhered to laminin 1, type IV collagen and fibronectin, but did inhibit motility of keratinocytes on tissue culture plastic.", "text_with_entity_marker": "Antibodies to [E1]CD9[/E1] did not affect the proportion of keratinocytes that adhered to [E2]laminin 1[/E2], type IV collagen and fibronectin, but did inhibit motility of keratinocytes on tissue culture plastic.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD9", "entity_1_idx": [[14, 17]], "entity_1_idx_in_text_with_entity_marker": [18, 21], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "laminin 1", "entity_2_idx": [[81, 90]], "entity_2_idx_in_text_with_entity_marker": [94, 103], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d206.s1784_AIMed.d206.s1784.p1", "text": "Antibodies to CD9 did not affect the proportion of keratinocytes that adhered to laminin 1, type IV collagen and fibronectin, but did inhibit motility of keratinocytes on tissue culture plastic.", "text_with_entity_marker": "Antibodies to [E1]CD9[/E1] did not affect the proportion of keratinocytes that adhered to laminin 1, [E2]type IV collagen[/E2] and fibronectin, but did inhibit motility of keratinocytes on tissue culture plastic.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD9", "entity_1_idx": [[14, 17]], "entity_1_idx_in_text_with_entity_marker": [18, 21], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "type IV collagen", "entity_2_idx": [[92, 108]], "entity_2_idx_in_text_with_entity_marker": [105, 121], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d206.s1784_AIMed.d206.s1784.p2", "text": "Antibodies to CD9 did not affect the proportion of keratinocytes that adhered to laminin 1, type IV collagen and fibronectin, but did inhibit motility of keratinocytes on tissue culture plastic.", "text_with_entity_marker": "Antibodies to [E1]CD9[/E1] did not affect the proportion of keratinocytes that adhered to laminin 1, type IV collagen and [E2]fibronectin[/E2], but did inhibit motility of keratinocytes on tissue culture plastic.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD9", "entity_1_idx": [[14, 17]], "entity_1_idx_in_text_with_entity_marker": [18, 21], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "fibronectin", "entity_2_idx": [[113, 124]], "entity_2_idx_in_text_with_entity_marker": [126, 137], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d206.s1784_AIMed.d206.s1784.p3", "text": "Antibodies to CD9 did not affect the proportion of keratinocytes that adhered to laminin 1, type IV collagen and fibronectin, but did inhibit motility of keratinocytes on tissue culture plastic.", "text_with_entity_marker": "Antibodies to CD9 did not affect the proportion of keratinocytes that adhered to [E1]laminin 1[/E1], [E2]type IV collagen[/E2] and fibronectin, but did inhibit motility of keratinocytes on tissue culture plastic.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "laminin 1", "entity_1_idx": [[81, 90]], "entity_1_idx_in_text_with_entity_marker": [85, 94], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "type IV collagen", "entity_2_idx": [[92, 108]], "entity_2_idx_in_text_with_entity_marker": [105, 121], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d206.s1784_AIMed.d206.s1784.p4", "text": "Antibodies to CD9 did not affect the proportion of keratinocytes that adhered to laminin 1, type IV collagen and fibronectin, but did inhibit motility of keratinocytes on tissue culture plastic.", "text_with_entity_marker": "Antibodies to CD9 did not affect the proportion of keratinocytes that adhered to [E1]laminin 1[/E1], type IV collagen and [E2]fibronectin[/E2], but did inhibit motility of keratinocytes on tissue culture plastic.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "laminin 1", "entity_1_idx": [[81, 90]], "entity_1_idx_in_text_with_entity_marker": [85, 94], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "fibronectin", "entity_2_idx": [[113, 124]], "entity_2_idx_in_text_with_entity_marker": [126, 137], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d206.s1784_AIMed.d206.s1784.p5", "text": "Antibodies to CD9 did not affect the proportion of keratinocytes that adhered to laminin 1, type IV collagen and fibronectin, but did inhibit motility of keratinocytes on tissue culture plastic.", "text_with_entity_marker": "Antibodies to CD9 did not affect the proportion of keratinocytes that adhered to laminin 1, [E1]type IV collagen[/E1] and [E2]fibronectin[/E2], but did inhibit motility of keratinocytes on tissue culture plastic.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "type IV collagen", "entity_1_idx": [[92, 108]], "entity_1_idx_in_text_with_entity_marker": [96, 112], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "fibronectin", "entity_2_idx": [[113, 124]], "entity_2_idx_in_text_with_entity_marker": [126, 137], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d206.s1785_AIMed.d206.s1785.p0", "text": "Like antibodies to the beta 1 integrin subunit, anti-CD9 inhibited suspension-induced terminal differentiation.", "text_with_entity_marker": "Like antibodies to the [E1]beta 1 integrin[/E1] subunit, anti-[E2]CD9[/E2] inhibited suspension-induced terminal differentiation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta 1 integrin", "entity_1_idx": [[23, 38]], "entity_1_idx_in_text_with_entity_marker": [27, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD9", "entity_2_idx": [[53, 56]], "entity_2_idx_in_text_with_entity_marker": [66, 69], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d158.s1336_AIMed.d158.s1336.p0", "text": "Overexpression of the intact RIP protein induces both NF-kappa B activation and apoptosis.", "text_with_entity_marker": "Overexpression of the intact [E1]RIP[/E1] protein induces both [E2]NF-kappa B[/E2] activation and apoptosis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RIP", "entity_1_idx": [[29, 32]], "entity_1_idx_in_text_with_entity_marker": [33, 36], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "NF-kappa B", "entity_2_idx": [[54, 64]], "entity_2_idx_in_text_with_entity_marker": [67, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d158.s1337_AIMed.d158.s1337.p0", "text": "However, expression of the death domain of RIP Induces apoptosis, but potently inhibits NF-kappa B activation by TNF.", "text_with_entity_marker": "However, expression of the death domain of [E1]RIP[/E1] Induces apoptosis, but potently inhibits [E2]NF-kappa B[/E2] activation by TNF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RIP", "entity_1_idx": [[43, 46]], "entity_1_idx_in_text_with_entity_marker": [47, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "NF-kappa B", "entity_2_idx": [[88, 98]], "entity_2_idx_in_text_with_entity_marker": [101, 111], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d158.s1338_AIMed.d158.s1338.p0", "text": "These results suggest that distinct domains of RIP participate in the TNF signaling cascades leading to apoptosis and NF-kappa B activation.", "text_with_entity_marker": "These results suggest that distinct domains of [E1]RIP[/E1] participate in the TNF signaling cascades leading to apoptosis and [E2]NF-kappa B[/E2] activation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RIP", "entity_1_idx": [[47, 50]], "entity_1_idx_in_text_with_entity_marker": [51, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "NF-kappa B", "entity_2_idx": [[118, 128]], "entity_2_idx_in_text_with_entity_marker": [131, 141], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d105.s886_AIMed.d105.s886.p0", "text": "We expressed differently tagged forms of gp130 and used them in solution-phase binding assays to show that the soluble extracellular domains of gp130 undergo dimerization in the absence of membranes.", "text_with_entity_marker": "We expressed differently tagged forms of [E1]gp130[/E1] and used them in solution-phase binding assays to show that the soluble extracellular domains of [E2]gp130[/E2] undergo dimerization in the absence of membranes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gp130", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gp130", "entity_2_idx": [[144, 149]], "entity_2_idx_in_text_with_entity_marker": [157, 162], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d105.s890_AIMed.d105.s890.p0", "text": "The binding properties of these variants in vitro, and the result of using a neutralizing monoclonal antibody directed against site 3, lead to the conclusion that gp130 dimer is formed through direct binding at two independent and differently oriented sites on IL-6.", "text_with_entity_marker": "The binding properties of these variants in vitro, and the result of using a neutralizing monoclonal antibody directed against site 3, lead to the conclusion that [E1]gp130[/E1] dimer is formed through direct binding at two independent and differently oriented sites on [E2]IL-6[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gp130", "entity_1_idx": [[163, 168]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[261, 265]], "entity_2_idx_in_text_with_entity_marker": [274, 278], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d47.s412_AIMed.d47.s412.p0", "text": "Bone morphogenetic proteins (BMPs) belong to the large transforming growth factor-beta (TGF-beta) superfamily of multifunctional cytokines.", "text_with_entity_marker": "Bone morphogenetic proteins (BMPs) belong to the large [E1]transforming growth factor-beta[/E1] ([E2]TGF-beta[/E2]) superfamily of multifunctional cytokines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "transforming growth factor-beta", "entity_1_idx": [[55, 86]], "entity_1_idx_in_text_with_entity_marker": [59, 90], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TGF-beta", "entity_2_idx": [[88, 96]], "entity_2_idx_in_text_with_entity_marker": [101, 109], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d137.s1156_AIMed.d137.s1156.p0", "text": "We had previously shown that the ubiquitous Oct1 and the lymphoid-specific Oct2 transcription factors stimulate transcription at the level of stable preinitiation complex formation.", "text_with_entity_marker": "We had previously shown that the ubiquitous [E1]Oct1[/E1] and the lymphoid-specific [E2]Oct2[/E2] transcription factors stimulate transcription at the level of stable preinitiation complex formation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Oct1", "entity_1_idx": [[44, 48]], "entity_1_idx_in_text_with_entity_marker": [48, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Oct2", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d137.s1157_AIMed.d137.s1157.p0", "text": "We have therefore investigated whether the octamer binding proteins might physically interact with TBP, the TATA box binding protein component of the TFIID factor.", "text_with_entity_marker": "We have therefore investigated whether the octamer binding proteins might physically interact with [E1]TBP[/E1], the [E2]TATA box binding protein[/E2] component of the TFIID factor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TBP", "entity_1_idx": [[99, 102]], "entity_1_idx_in_text_with_entity_marker": [103, 106], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TATA box binding protein", "entity_2_idx": [[108, 132]], "entity_2_idx_in_text_with_entity_marker": [121, 145], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d137.s1157_AIMed.d137.s1157.p1", "text": "We have therefore investigated whether the octamer binding proteins might physically interact with TBP, the TATA box binding protein component of the TFIID factor.", "text_with_entity_marker": "We have therefore investigated whether the octamer binding proteins might physically interact with [E1]TBP[/E1], the TATA box binding protein component of the [E2]TFIID[/E2] factor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TBP", "entity_1_idx": [[99, 102]], "entity_1_idx_in_text_with_entity_marker": [103, 106], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[150, 155]], "entity_2_idx_in_text_with_entity_marker": [163, 168], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d137.s1157_AIMed.d137.s1157.p2", "text": "We have therefore investigated whether the octamer binding proteins might physically interact with TBP, the TATA box binding protein component of the TFIID factor.", "text_with_entity_marker": "We have therefore investigated whether the octamer binding proteins might physically interact with TBP, the [E1]TATA box binding protein[/E1] component of the [E2]TFIID[/E2] factor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TATA box binding protein", "entity_1_idx": [[108, 132]], "entity_1_idx_in_text_with_entity_marker": [112, 136], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[150, 155]], "entity_2_idx_in_text_with_entity_marker": [163, 168], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d137.s1164_AIMed.d137.s1164.p0", "text": "Co-transfection of human TBP and Oct2 expression vectors into B cells resulted in a synergistic activation of an octamer motif containing promoter.", "text_with_entity_marker": "Co-transfection of human [E1]TBP[/E1] and [E2]Oct2[/E2] expression vectors into B cells resulted in a synergistic activation of an octamer motif containing promoter.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TBP", "entity_1_idx": [[25, 28]], "entity_1_idx_in_text_with_entity_marker": [29, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Oct2", "entity_2_idx": [[33, 37]], "entity_2_idx_in_text_with_entity_marker": [46, 50], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p0", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the [E1]myogenic basic helix-loop-helix[/E1] ([E2]bHLH[/E2]) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myogenic basic helix-loop-helix", "entity_1_idx": [[79, 110]], "entity_1_idx_in_text_with_entity_marker": [83, 114], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "bHLH", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p1", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the [E1]myogenic basic helix-loop-helix[/E1] (bHLH) protein [E2]MyoD[/E2] and the pocket proteins pRb, p107 and pRb2/p130.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myogenic basic helix-loop-helix", "entity_1_idx": [[79, 110]], "entity_1_idx_in_text_with_entity_marker": [83, 114], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MyoD", "entity_2_idx": [[126, 130]], "entity_2_idx_in_text_with_entity_marker": [139, 143], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p2", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the [E1]myogenic basic helix-loop-helix[/E1] (bHLH) protein MyoD and the pocket proteins [E2]pRb[/E2], p107 and pRb2/p130.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myogenic basic helix-loop-helix", "entity_1_idx": [[79, 110]], "entity_1_idx_in_text_with_entity_marker": [83, 114], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pRb", "entity_2_idx": [[155, 158]], "entity_2_idx_in_text_with_entity_marker": [168, 171], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p3", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the [E1]myogenic basic helix-loop-helix[/E1] (bHLH) protein MyoD and the pocket proteins pRb, [E2]p107[/E2] and pRb2/p130.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myogenic basic helix-loop-helix", "entity_1_idx": [[79, 110]], "entity_1_idx_in_text_with_entity_marker": [83, 114], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p107", "entity_2_idx": [[160, 164]], "entity_2_idx_in_text_with_entity_marker": [173, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p4", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the [E1]myogenic basic helix-loop-helix[/E1] (bHLH) protein MyoD and the pocket proteins pRb, p107 and [E2]pRb2[/E2]/p130.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myogenic basic helix-loop-helix", "entity_1_idx": [[79, 110]], "entity_1_idx_in_text_with_entity_marker": [83, 114], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pRb2", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p5", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the [E1]myogenic basic helix-loop-helix[/E1] (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/[E2]p130[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myogenic basic helix-loop-helix", "entity_1_idx": [[79, 110]], "entity_1_idx_in_text_with_entity_marker": [83, 114], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p130", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p6", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ([E1]bHLH[/E1]) protein [E2]MyoD[/E2] and the pocket proteins pRb, p107 and pRb2/p130.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "bHLH", "entity_1_idx": [[112, 116]], "entity_1_idx_in_text_with_entity_marker": [116, 120], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MyoD", "entity_2_idx": [[126, 130]], "entity_2_idx_in_text_with_entity_marker": [139, 143], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p7", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ([E1]bHLH[/E1]) protein MyoD and the pocket proteins [E2]pRb[/E2], p107 and pRb2/p130.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "bHLH", "entity_1_idx": [[112, 116]], "entity_1_idx_in_text_with_entity_marker": [116, 120], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pRb", "entity_2_idx": [[155, 158]], "entity_2_idx_in_text_with_entity_marker": [168, 171], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p8", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ([E1]bHLH[/E1]) protein MyoD and the pocket proteins pRb, [E2]p107[/E2] and pRb2/p130.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "bHLH", "entity_1_idx": [[112, 116]], "entity_1_idx_in_text_with_entity_marker": [116, 120], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p107", "entity_2_idx": [[160, 164]], "entity_2_idx_in_text_with_entity_marker": [173, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p9", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ([E1]bHLH[/E1]) protein MyoD and the pocket proteins pRb, p107 and [E2]pRb2[/E2]/p130.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "bHLH", "entity_1_idx": [[112, 116]], "entity_1_idx_in_text_with_entity_marker": [116, 120], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pRb2", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p10", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ([E1]bHLH[/E1]) protein MyoD and the pocket proteins pRb, p107 and pRb2/[E2]p130[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "bHLH", "entity_1_idx": [[112, 116]], "entity_1_idx_in_text_with_entity_marker": [116, 120], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p130", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p11", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein [E1]MyoD[/E1] and the pocket proteins [E2]pRb[/E2], p107 and pRb2/p130.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD", "entity_1_idx": [[126, 130]], "entity_1_idx_in_text_with_entity_marker": [130, 134], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pRb", "entity_2_idx": [[155, 158]], "entity_2_idx_in_text_with_entity_marker": [168, 171], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p12", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein [E1]MyoD[/E1] and the pocket proteins pRb, [E2]p107[/E2] and pRb2/p130.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD", "entity_1_idx": [[126, 130]], "entity_1_idx_in_text_with_entity_marker": [130, 134], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p107", "entity_2_idx": [[160, 164]], "entity_2_idx_in_text_with_entity_marker": [173, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p13", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein [E1]MyoD[/E1] and the pocket proteins pRb, p107 and [E2]pRb2[/E2]/p130.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD", "entity_1_idx": [[126, 130]], "entity_1_idx_in_text_with_entity_marker": [130, 134], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pRb2", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p14", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein [E1]MyoD[/E1] and the pocket proteins pRb, p107 and pRb2/[E2]p130[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD", "entity_1_idx": [[126, 130]], "entity_1_idx_in_text_with_entity_marker": [130, 134], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p130", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p15", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins [E1]pRb[/E1], [E2]p107[/E2] and pRb2/p130.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "pRb", "entity_1_idx": [[155, 158]], "entity_1_idx_in_text_with_entity_marker": [159, 162], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p107", "entity_2_idx": [[160, 164]], "entity_2_idx_in_text_with_entity_marker": [173, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p16", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins [E1]pRb[/E1], p107 and [E2]pRb2[/E2]/p130.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "pRb", "entity_1_idx": [[155, 158]], "entity_1_idx_in_text_with_entity_marker": [159, 162], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pRb2", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p17", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins [E1]pRb[/E1], p107 and pRb2/[E2]p130[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "pRb", "entity_1_idx": [[155, 158]], "entity_1_idx_in_text_with_entity_marker": [159, 162], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p130", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p18", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, [E1]p107[/E1] and [E2]pRb2[/E2]/p130.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p107", "entity_1_idx": [[160, 164]], "entity_1_idx_in_text_with_entity_marker": [164, 168], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pRb2", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p19", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, [E1]p107[/E1] and pRb2/[E2]p130[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p107", "entity_1_idx": [[160, 164]], "entity_1_idx_in_text_with_entity_marker": [164, 168], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p130", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1788_AIMed.d207.s1788.p20", "text": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and pRb2/p130.", "text_with_entity_marker": "Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix (bHLH) protein MyoD and the pocket proteins pRb, p107 and [E1]pRb2[/E1]/[E2]p130[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "pRb2", "entity_1_idx": [[169, 173]], "entity_1_idx_in_text_with_entity_marker": [173, 177], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p130", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1793_AIMed.d207.s1793.p0", "text": "In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor MyoD downstream effector p21 are induced.", "text_with_entity_marker": "In differentiating C2C12 cells, [E1]E2F[/E1] complexes switch and DNA synthesis in response to serum are prevented when [E2]MyoD[/E2] DNA binding activity and the cdks inhibitor MyoD downstream effector p21 are induced.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E2F", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MyoD", "entity_2_idx": [[111, 115]], "entity_2_idx_in_text_with_entity_marker": [124, 128], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1793_AIMed.d207.s1793.p1", "text": "In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor MyoD downstream effector p21 are induced.", "text_with_entity_marker": "In differentiating C2C12 cells, [E1]E2F[/E1] complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor [E2]MyoD[/E2] downstream effector p21 are induced.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E2F", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MyoD", "entity_2_idx": [[160, 164]], "entity_2_idx_in_text_with_entity_marker": [173, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1793_AIMed.d207.s1793.p2", "text": "In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor MyoD downstream effector p21 are induced.", "text_with_entity_marker": "In differentiating C2C12 cells, [E1]E2F[/E1] complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor MyoD downstream effector [E2]p21[/E2] are induced.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E2F", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1793_AIMed.d207.s1793.p3", "text": "In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor MyoD downstream effector p21 are induced.", "text_with_entity_marker": "In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when [E1]MyoD[/E1] DNA binding activity and the cdks inhibitor [E2]MyoD[/E2] downstream effector p21 are induced.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MyoD", "entity_2_idx": [[160, 164]], "entity_2_idx_in_text_with_entity_marker": [173, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1793_AIMed.d207.s1793.p4", "text": "In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor MyoD downstream effector p21 are induced.", "text_with_entity_marker": "In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when [E1]MyoD[/E1] DNA binding activity and the cdks inhibitor MyoD downstream effector [E2]p21[/E2] are induced.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1793_AIMed.d207.s1793.p5", "text": "In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor MyoD downstream effector p21 are induced.", "text_with_entity_marker": "In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor [E1]MyoD[/E1] downstream effector [E2]p21[/E2] are induced.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD", "entity_1_idx": [[160, 164]], "entity_1_idx_in_text_with_entity_marker": [164, 168], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1796_AIMed.d207.s1796.p0", "text": "Our data indicate that, in differentiating myocytes, one mechanism through which MyoD induces permanent cell cycle arrest involves p21 upregulation and suppression of the proliferation-associated cdks-containing E2F complexes formation.", "text_with_entity_marker": "Our data indicate that, in differentiating myocytes, one mechanism through which [E1]MyoD[/E1] induces permanent cell cycle arrest involves [E2]p21[/E2] upregulation and suppression of the proliferation-associated cdks-containing E2F complexes formation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[131, 134]], "entity_2_idx_in_text_with_entity_marker": [144, 147], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1796_AIMed.d207.s1796.p1", "text": "Our data indicate that, in differentiating myocytes, one mechanism through which MyoD induces permanent cell cycle arrest involves p21 upregulation and suppression of the proliferation-associated cdks-containing E2F complexes formation.", "text_with_entity_marker": "Our data indicate that, in differentiating myocytes, one mechanism through which [E1]MyoD[/E1] induces permanent cell cycle arrest involves p21 upregulation and suppression of the proliferation-associated cdks-containing [E2]E2F[/E2] complexes formation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "E2F", "entity_2_idx": [[212, 215]], "entity_2_idx_in_text_with_entity_marker": [225, 228], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1796_AIMed.d207.s1796.p2", "text": "Our data indicate that, in differentiating myocytes, one mechanism through which MyoD induces permanent cell cycle arrest involves p21 upregulation and suppression of the proliferation-associated cdks-containing E2F complexes formation.", "text_with_entity_marker": "Our data indicate that, in differentiating myocytes, one mechanism through which MyoD induces permanent cell cycle arrest involves [E1]p21[/E1] upregulation and suppression of the proliferation-associated cdks-containing [E2]E2F[/E2] complexes formation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21", "entity_1_idx": [[131, 134]], "entity_1_idx_in_text_with_entity_marker": [135, 138], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "E2F", "entity_2_idx": [[212, 215]], "entity_2_idx_in_text_with_entity_marker": [225, 228], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p0", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines [E1]IL-1alpha[/E1], [E2]IL-1beta[/E2], IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1alpha", "entity_1_idx": [[10, 19]], "entity_1_idx_in_text_with_entity_marker": [14, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1beta", "entity_2_idx": [[21, 29]], "entity_2_idx_in_text_with_entity_marker": [34, 42], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p1", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines [E1]IL-1alpha[/E1], IL-1beta, [E2]IL-6[/E2], IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1alpha", "entity_1_idx": [[10, 19]], "entity_1_idx_in_text_with_entity_marker": [14, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[31, 35]], "entity_2_idx_in_text_with_entity_marker": [44, 48], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p2", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines [E1]IL-1alpha[/E1], IL-1beta, IL-6, [E2]IL-8[/E2], IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1alpha", "entity_1_idx": [[10, 19]], "entity_1_idx_in_text_with_entity_marker": [14, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-8", "entity_2_idx": [[37, 41]], "entity_2_idx_in_text_with_entity_marker": [50, 54], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p3", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines [E1]IL-1alpha[/E1], IL-1beta, IL-6, IL-8, [E2]IL-10[/E2] (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1alpha", "entity_1_idx": [[10, 19]], "entity_1_idx_in_text_with_entity_marker": [14, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[43, 48]], "entity_2_idx_in_text_with_entity_marker": [56, 61], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p4", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines [E1]IL-1alpha[/E1], IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), [E2]endothelin-1[/E2], and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1alpha", "entity_1_idx": [[10, 19]], "entity_1_idx_in_text_with_entity_marker": [14, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "endothelin-1", "entity_2_idx": [[71, 83]], "entity_2_idx_in_text_with_entity_marker": [84, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p5", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines [E1]IL-1alpha[/E1], IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and [E2]soluble cell adhesion molecules[/E2] (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1alpha", "entity_1_idx": [[10, 19]], "entity_1_idx_in_text_with_entity_marker": [14, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "soluble cell adhesion molecules", "entity_2_idx": [[89, 120]], "entity_2_idx_in_text_with_entity_marker": [102, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p6", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines [E1]IL-1alpha[/E1], IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ([E2]sCAM[/E2]) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1alpha", "entity_1_idx": [[10, 19]], "entity_1_idx_in_text_with_entity_marker": [14, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sCAM", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p7", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines [E1]IL-1alpha[/E1], IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and [E2]sE-selectin[/E2], sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1alpha", "entity_1_idx": [[10, 19]], "entity_1_idx_in_text_with_entity_marker": [14, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sE-selectin", "entity_2_idx": [[136, 147]], "entity_2_idx_in_text_with_entity_marker": [149, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p8", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines [E1]IL-1alpha[/E1], IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, [E2]sICAM-1[/E2], and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1alpha", "entity_1_idx": [[10, 19]], "entity_1_idx_in_text_with_entity_marker": [14, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sICAM-1", "entity_2_idx": [[149, 156]], "entity_2_idx_in_text_with_entity_marker": [162, 169], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p9", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines [E1]IL-1alpha[/E1], IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and [E2]sVCAM-1[/E2] (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1alpha", "entity_1_idx": [[10, 19]], "entity_1_idx_in_text_with_entity_marker": [14, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sVCAM-1", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p10", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, [E1]IL-1beta[/E1], [E2]IL-6[/E2], IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1beta", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[31, 35]], "entity_2_idx_in_text_with_entity_marker": [44, 48], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p11", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, [E1]IL-1beta[/E1], IL-6, [E2]IL-8[/E2], IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1beta", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-8", "entity_2_idx": [[37, 41]], "entity_2_idx_in_text_with_entity_marker": [50, 54], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p12", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, [E1]IL-1beta[/E1], IL-6, IL-8, [E2]IL-10[/E2] (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1beta", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[43, 48]], "entity_2_idx_in_text_with_entity_marker": [56, 61], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p13", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, [E1]IL-1beta[/E1], IL-6, IL-8, IL-10 (Immunotech, France), [E2]endothelin-1[/E2], and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1beta", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "endothelin-1", "entity_2_idx": [[71, 83]], "entity_2_idx_in_text_with_entity_marker": [84, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p14", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, [E1]IL-1beta[/E1], IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and [E2]soluble cell adhesion molecules[/E2] (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1beta", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "soluble cell adhesion molecules", "entity_2_idx": [[89, 120]], "entity_2_idx_in_text_with_entity_marker": [102, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p15", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, [E1]IL-1beta[/E1], IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ([E2]sCAM[/E2]) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1beta", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sCAM", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p16", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, [E1]IL-1beta[/E1], IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and [E2]sE-selectin[/E2], sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1beta", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sE-selectin", "entity_2_idx": [[136, 147]], "entity_2_idx_in_text_with_entity_marker": [149, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p17", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, [E1]IL-1beta[/E1], IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, [E2]sICAM-1[/E2], and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1beta", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sICAM-1", "entity_2_idx": [[149, 156]], "entity_2_idx_in_text_with_entity_marker": [162, 169], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p18", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, [E1]IL-1beta[/E1], IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and [E2]sVCAM-1[/E2] (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1beta", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sVCAM-1", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p19", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, [E1]IL-6[/E1], [E2]IL-8[/E2], IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-6", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-8", "entity_2_idx": [[37, 41]], "entity_2_idx_in_text_with_entity_marker": [50, 54], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p20", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, [E1]IL-6[/E1], IL-8, [E2]IL-10[/E2] (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-6", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[43, 48]], "entity_2_idx_in_text_with_entity_marker": [56, 61], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p21", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, [E1]IL-6[/E1], IL-8, IL-10 (Immunotech, France), [E2]endothelin-1[/E2], and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-6", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "endothelin-1", "entity_2_idx": [[71, 83]], "entity_2_idx_in_text_with_entity_marker": [84, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p22", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, [E1]IL-6[/E1], IL-8, IL-10 (Immunotech, France), endothelin-1, and [E2]soluble cell adhesion molecules[/E2] (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-6", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "soluble cell adhesion molecules", "entity_2_idx": [[89, 120]], "entity_2_idx_in_text_with_entity_marker": [102, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p23", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, [E1]IL-6[/E1], IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ([E2]sCAM[/E2]) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-6", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sCAM", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p24", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, [E1]IL-6[/E1], IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and [E2]sE-selectin[/E2], sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-6", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sE-selectin", "entity_2_idx": [[136, 147]], "entity_2_idx_in_text_with_entity_marker": [149, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p25", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, [E1]IL-6[/E1], IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, [E2]sICAM-1[/E2], and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-6", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sICAM-1", "entity_2_idx": [[149, 156]], "entity_2_idx_in_text_with_entity_marker": [162, 169], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p26", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, [E1]IL-6[/E1], IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and [E2]sVCAM-1[/E2] (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-6", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sVCAM-1", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p27", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, [E1]IL-8[/E1], [E2]IL-10[/E2] (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-8", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[43, 48]], "entity_2_idx_in_text_with_entity_marker": [56, 61], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p28", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, [E1]IL-8[/E1], IL-10 (Immunotech, France), [E2]endothelin-1[/E2], and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-8", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "endothelin-1", "entity_2_idx": [[71, 83]], "entity_2_idx_in_text_with_entity_marker": [84, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p29", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, [E1]IL-8[/E1], IL-10 (Immunotech, France), endothelin-1, and [E2]soluble cell adhesion molecules[/E2] (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-8", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "soluble cell adhesion molecules", "entity_2_idx": [[89, 120]], "entity_2_idx_in_text_with_entity_marker": [102, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p30", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, [E1]IL-8[/E1], IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ([E2]sCAM[/E2]) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-8", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sCAM", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p31", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, [E1]IL-8[/E1], IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and [E2]sE-selectin[/E2], sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-8", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sE-selectin", "entity_2_idx": [[136, 147]], "entity_2_idx_in_text_with_entity_marker": [149, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p32", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, [E1]IL-8[/E1], IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, [E2]sICAM-1[/E2], and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-8", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sICAM-1", "entity_2_idx": [[149, 156]], "entity_2_idx_in_text_with_entity_marker": [162, 169], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p33", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, [E1]IL-8[/E1], IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and [E2]sVCAM-1[/E2] (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-8", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sVCAM-1", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p34", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, [E1]IL-10[/E1] (Immunotech, France), [E2]endothelin-1[/E2], and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-10", "entity_1_idx": [[43, 48]], "entity_1_idx_in_text_with_entity_marker": [47, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "endothelin-1", "entity_2_idx": [[71, 83]], "entity_2_idx_in_text_with_entity_marker": [84, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p35", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, [E1]IL-10[/E1] (Immunotech, France), endothelin-1, and [E2]soluble cell adhesion molecules[/E2] (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-10", "entity_1_idx": [[43, 48]], "entity_1_idx_in_text_with_entity_marker": [47, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "soluble cell adhesion molecules", "entity_2_idx": [[89, 120]], "entity_2_idx_in_text_with_entity_marker": [102, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p36", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, [E1]IL-10[/E1] (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ([E2]sCAM[/E2]) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-10", "entity_1_idx": [[43, 48]], "entity_1_idx_in_text_with_entity_marker": [47, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sCAM", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p37", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, [E1]IL-10[/E1] (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and [E2]sE-selectin[/E2], sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-10", "entity_1_idx": [[43, 48]], "entity_1_idx_in_text_with_entity_marker": [47, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sE-selectin", "entity_2_idx": [[136, 147]], "entity_2_idx_in_text_with_entity_marker": [149, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p38", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, [E1]IL-10[/E1] (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, [E2]sICAM-1[/E2], and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-10", "entity_1_idx": [[43, 48]], "entity_1_idx_in_text_with_entity_marker": [47, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sICAM-1", "entity_2_idx": [[149, 156]], "entity_2_idx_in_text_with_entity_marker": [162, 169], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p39", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, [E1]IL-10[/E1] (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and [E2]sVCAM-1[/E2] (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-10", "entity_1_idx": [[43, 48]], "entity_1_idx_in_text_with_entity_marker": [47, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sVCAM-1", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p40", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), [E1]endothelin-1[/E1], and [E2]soluble cell adhesion molecules[/E2] (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "endothelin-1", "entity_1_idx": [[71, 83]], "entity_1_idx_in_text_with_entity_marker": [75, 87], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "soluble cell adhesion molecules", "entity_2_idx": [[89, 120]], "entity_2_idx_in_text_with_entity_marker": [102, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p41", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), [E1]endothelin-1[/E1], and soluble cell adhesion molecules ([E2]sCAM[/E2]) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "endothelin-1", "entity_1_idx": [[71, 83]], "entity_1_idx_in_text_with_entity_marker": [75, 87], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sCAM", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p42", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), [E1]endothelin-1[/E1], and soluble cell adhesion molecules (sCAM) sP- and [E2]sE-selectin[/E2], sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "endothelin-1", "entity_1_idx": [[71, 83]], "entity_1_idx_in_text_with_entity_marker": [75, 87], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sE-selectin", "entity_2_idx": [[136, 147]], "entity_2_idx_in_text_with_entity_marker": [149, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p43", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), [E1]endothelin-1[/E1], and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, [E2]sICAM-1[/E2], and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "endothelin-1", "entity_1_idx": [[71, 83]], "entity_1_idx_in_text_with_entity_marker": [75, 87], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sICAM-1", "entity_2_idx": [[149, 156]], "entity_2_idx_in_text_with_entity_marker": [162, 169], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p44", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), [E1]endothelin-1[/E1], and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and [E2]sVCAM-1[/E2] (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "endothelin-1", "entity_1_idx": [[71, 83]], "entity_1_idx_in_text_with_entity_marker": [75, 87], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sVCAM-1", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p45", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and [E1]soluble cell adhesion molecules[/E1] ([E2]sCAM[/E2]) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "soluble cell adhesion molecules", "entity_1_idx": [[89, 120]], "entity_1_idx_in_text_with_entity_marker": [93, 124], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sCAM", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p46", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and [E1]soluble cell adhesion molecules[/E1] (sCAM) sP- and [E2]sE-selectin[/E2], sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "soluble cell adhesion molecules", "entity_1_idx": [[89, 120]], "entity_1_idx_in_text_with_entity_marker": [93, 124], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sE-selectin", "entity_2_idx": [[136, 147]], "entity_2_idx_in_text_with_entity_marker": [149, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p47", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and [E1]soluble cell adhesion molecules[/E1] (sCAM) sP- and sE-selectin, [E2]sICAM-1[/E2], and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "soluble cell adhesion molecules", "entity_1_idx": [[89, 120]], "entity_1_idx_in_text_with_entity_marker": [93, 124], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sICAM-1", "entity_2_idx": [[149, 156]], "entity_2_idx_in_text_with_entity_marker": [162, 169], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p48", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and [E1]soluble cell adhesion molecules[/E1] (sCAM) sP- and sE-selectin, sICAM-1, and [E2]sVCAM-1[/E2] (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "soluble cell adhesion molecules", "entity_1_idx": [[89, 120]], "entity_1_idx_in_text_with_entity_marker": [93, 124], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sVCAM-1", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p49", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ([E1]sCAM[/E1]) sP- and [E2]sE-selectin[/E2], sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "sCAM", "entity_1_idx": [[122, 126]], "entity_1_idx_in_text_with_entity_marker": [126, 130], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sE-selectin", "entity_2_idx": [[136, 147]], "entity_2_idx_in_text_with_entity_marker": [149, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p50", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ([E1]sCAM[/E1]) sP- and sE-selectin, [E2]sICAM-1[/E2], and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "sCAM", "entity_1_idx": [[122, 126]], "entity_1_idx_in_text_with_entity_marker": [126, 130], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sICAM-1", "entity_2_idx": [[149, 156]], "entity_2_idx_in_text_with_entity_marker": [162, 169], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p51", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules ([E1]sCAM[/E1]) sP- and sE-selectin, sICAM-1, and [E2]sVCAM-1[/E2] (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "sCAM", "entity_1_idx": [[122, 126]], "entity_1_idx_in_text_with_entity_marker": [126, 130], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sVCAM-1", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p52", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and [E1]sE-selectin[/E1], [E2]sICAM-1[/E2], and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "sE-selectin", "entity_1_idx": [[136, 147]], "entity_1_idx_in_text_with_entity_marker": [140, 151], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sICAM-1", "entity_2_idx": [[149, 156]], "entity_2_idx_in_text_with_entity_marker": [162, 169], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p53", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and [E1]sE-selectin[/E1], sICAM-1, and [E2]sVCAM-1[/E2] (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "sE-selectin", "entity_1_idx": [[136, 147]], "entity_1_idx_in_text_with_entity_marker": [140, 151], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sVCAM-1", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s151_AIMed.d18.s151.p54", "text": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, sICAM-1, and sVCAM-1 (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "text_with_entity_marker": "Cytokines IL-1alpha, IL-1beta, IL-6, IL-8, IL-10 (Immunotech, France), endothelin-1, and soluble cell adhesion molecules (sCAM) sP- and sE-selectin, [E1]sICAM-1[/E1], and [E2]sVCAM-1[/E2] (R&D, UK) have been determined using ELISA kits (photometer, Biomek-1000, Beckman, USA).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "sICAM-1", "entity_1_idx": [[149, 156]], "entity_1_idx_in_text_with_entity_marker": [153, 160], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sVCAM-1", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s156_AIMed.d18.s156.p0", "text": "Endothelin-1 and sP- and sE-selectin levels were not related to function of lymphocytes (by MDM data) as seen in both tests; it is probable that another cell-cell communication mechanism had been switched on.", "text_with_entity_marker": "[E1]Endothelin-1[/E1] and sP- and [E2]sE-selectin[/E2] levels were not related to function of lymphocytes (by MDM data) as seen in both tests; it is probable that another cell-cell communication mechanism had been switched on.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Endothelin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sE-selectin", "entity_2_idx": [[25, 36]], "entity_2_idx_in_text_with_entity_marker": [38, 49], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s157_AIMed.d18.s157.p0", "text": "We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of IL-1beta, IL-6, and IL-10, which are the active participants in the pro- and anti-inflammatory program in atherogenesis.", "text_with_entity_marker": "We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of [E1]IL-1beta[/E1], [E2]IL-6[/E2], and IL-10, which are the active participants in the pro- and anti-inflammatory program in atherogenesis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1beta", "entity_1_idx": [[109, 117]], "entity_1_idx_in_text_with_entity_marker": [113, 121], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[119, 123]], "entity_2_idx_in_text_with_entity_marker": [132, 136], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s157_AIMed.d18.s157.p1", "text": "We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of IL-1beta, IL-6, and IL-10, which are the active participants in the pro- and anti-inflammatory program in atherogenesis.", "text_with_entity_marker": "We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of [E1]IL-1beta[/E1], IL-6, and [E2]IL-10[/E2], which are the active participants in the pro- and anti-inflammatory program in atherogenesis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1beta", "entity_1_idx": [[109, 117]], "entity_1_idx_in_text_with_entity_marker": [113, 121], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[129, 134]], "entity_2_idx_in_text_with_entity_marker": [142, 147], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d18.s157_AIMed.d18.s157.p2", "text": "We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of IL-1beta, IL-6, and IL-10, which are the active participants in the pro- and anti-inflammatory program in atherogenesis.", "text_with_entity_marker": "We established a strong correlation between chromatin activity of lymphocytes and the serum concentration of IL-1beta, [E1]IL-6[/E1], and [E2]IL-10[/E2], which are the active participants in the pro- and anti-inflammatory program in atherogenesis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-6", "entity_1_idx": [[119, 123]], "entity_1_idx_in_text_with_entity_marker": [123, 127], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[129, 134]], "entity_2_idx_in_text_with_entity_marker": [142, 147], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d168.s1412_AIMed.d168.s1412.p0", "text": "Identification of a critical ligand binding determinant of the human erythropoietin receptor. Evidence for common ligand binding motifs in the cytokine receptor family.", "text_with_entity_marker": "Identification of a critical ligand binding determinant of the human [E1-E2]erythropoietin[/E1] receptor[/E2]. Evidence for common ligand binding motifs in the cytokine receptor family.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "erythropoietin", "entity_1_idx": [[69, 83]], "entity_1_idx_in_text_with_entity_marker": [76, 90], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "erythropoietin[/E1] receptor", "entity_2_idx": [[69, 92]], "entity_2_idx_in_text_with_entity_marker": [76, 104], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d45.s391_AIMed.d45.s391.p0", "text": "IFN-gamma SC1 was derived by linking the two peptide chains of the IFN-gamma dimer by a seven-residue linker and changing His111 in the first chain to an aspartic acid residue.", "text_with_entity_marker": "[E1-E2]IFN-gamma[/E1] SC1[/E2] was derived by linking the two peptide chains of the IFN-gamma dimer by a seven-residue linker and changing His111 in the first chain to an aspartic acid residue.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IFN-gamma", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [7, 16], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFN-gamma[/E1] SC1", "entity_2_idx": [[0, 13]], "entity_2_idx_in_text_with_entity_marker": [7, 25], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d45.s391_AIMed.d45.s391.p1", "text": "IFN-gamma SC1 was derived by linking the two peptide chains of the IFN-gamma dimer by a seven-residue linker and changing His111 in the first chain to an aspartic acid residue.", "text_with_entity_marker": "[E1]IFN-gamma[/E1] SC1 was derived by linking the two peptide chains of the [E2]IFN-gamma[/E2] dimer by a seven-residue linker and changing His111 in the first chain to an aspartic acid residue.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IFN-gamma", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFN-gamma", "entity_2_idx": [[67, 76]], "entity_2_idx_in_text_with_entity_marker": [80, 89], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d45.s391_AIMed.d45.s391.p2", "text": "IFN-gamma SC1 was derived by linking the two peptide chains of the IFN-gamma dimer by a seven-residue linker and changing His111 in the first chain to an aspartic acid residue.", "text_with_entity_marker": "[E1]IFN-gamma SC1[/E1] was derived by linking the two peptide chains of the [E2]IFN-gamma[/E2] dimer by a seven-residue linker and changing His111 in the first chain to an aspartic acid residue.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IFN-gamma SC1", "entity_1_idx": [[0, 13]], "entity_1_idx_in_text_with_entity_marker": [4, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFN-gamma", "entity_2_idx": [[67, 76]], "entity_2_idx_in_text_with_entity_marker": [80, 89], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d45.s393_AIMed.d45.s393.p0", "text": "The crystal structure of IFN-gamma SC1 has been determined at 2.9 A resolution from crystals grown in 1.4 M citrate solutions at pH 7.6.", "text_with_entity_marker": "The crystal structure of [E1-E2]IFN-gamma[/E1] SC1[/E2] has been determined at 2.9 A resolution from crystals grown in 1.4 M citrate solutions at pH 7.6.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IFN-gamma", "entity_1_idx": [[25, 34]], "entity_1_idx_in_text_with_entity_marker": [32, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFN-gamma[/E1] SC1", "entity_2_idx": [[25, 38]], "entity_2_idx_in_text_with_entity_marker": [32, 50], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d45.s394_AIMed.d45.s394.p0", "text": "Comparison of the wild-type receptor-binding domain and the Asp111-containing domain of IFN-gamma SC1 show that they are structurally equivalent but have very different electrostatic surface potentials.", "text_with_entity_marker": "Comparison of the wild-type receptor-binding domain and the Asp111-containing domain of [E1-E2]IFN-gamma[/E1] SC1[/E2] show that they are structurally equivalent but have very different electrostatic surface potentials.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IFN-gamma", "entity_1_idx": [[88, 97]], "entity_1_idx_in_text_with_entity_marker": [95, 104], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFN-gamma[/E1] SC1", "entity_2_idx": [[88, 101]], "entity_2_idx_in_text_with_entity_marker": [95, 113], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d45.s397_AIMed.d45.s397.p0", "text": "Thus, IFN-gamma R alpha binding does not result in a large conformational change in the AB loop as previously suggested.", "text_with_entity_marker": "Thus, [E1-E2]IFN-gamma[/E1] R alpha[/E2] binding does not result in a large conformational change in the AB loop as previously suggested.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IFN-gamma", "entity_1_idx": [[6, 15]], "entity_1_idx_in_text_with_entity_marker": [13, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFN-gamma[/E1] R alpha", "entity_2_idx": [[6, 23]], "entity_2_idx_in_text_with_entity_marker": [13, 35], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d45.s398_AIMed.d45.s398.p0", "text": "The structure also reveals the final six C-terminal amino acid residues of IFN-gamma SC1 (residues 253-258) that have not been observed in any other reported IFN-gamma structures.", "text_with_entity_marker": "The structure also reveals the final six C-terminal amino acid residues of [E1-E2]IFN-gamma[/E1] SC1[/E2] (residues 253-258) that have not been observed in any other reported IFN-gamma structures.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IFN-gamma", "entity_1_idx": [[75, 84]], "entity_1_idx_in_text_with_entity_marker": [82, 91], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFN-gamma[/E1] SC1", "entity_2_idx": [[75, 88]], "entity_2_idx_in_text_with_entity_marker": [82, 100], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d45.s398_AIMed.d45.s398.p1", "text": "The structure also reveals the final six C-terminal amino acid residues of IFN-gamma SC1 (residues 253-258) that have not been observed in any other reported IFN-gamma structures.", "text_with_entity_marker": "The structure also reveals the final six C-terminal amino acid residues of [E1]IFN-gamma[/E1] SC1 (residues 253-258) that have not been observed in any other reported [E2]IFN-gamma[/E2] structures.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IFN-gamma", "entity_1_idx": [[75, 84]], "entity_1_idx_in_text_with_entity_marker": [79, 88], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFN-gamma", "entity_2_idx": [[158, 167]], "entity_2_idx_in_text_with_entity_marker": [171, 180], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d45.s398_AIMed.d45.s398.p2", "text": "The structure also reveals the final six C-terminal amino acid residues of IFN-gamma SC1 (residues 253-258) that have not been observed in any other reported IFN-gamma structures.", "text_with_entity_marker": "The structure also reveals the final six C-terminal amino acid residues of [E1]IFN-gamma SC1[/E1] (residues 253-258) that have not been observed in any other reported [E2]IFN-gamma[/E2] structures.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IFN-gamma SC1", "entity_1_idx": [[75, 88]], "entity_1_idx_in_text_with_entity_marker": [79, 92], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFN-gamma", "entity_2_idx": [[158, 167]], "entity_2_idx_in_text_with_entity_marker": [171, 180], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d45.s401_AIMed.d45.s401.p0", "text": "The current data are consistent with the main role of the IFN-gamma dimer being to decrease the dissociation constant of IFN-gamma for its cellular receptors.", "text_with_entity_marker": "The current data are consistent with the main role of the [E1]IFN-gamma[/E1] dimer being to decrease the dissociation constant of [E2]IFN-gamma[/E2] for its cellular receptors.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IFN-gamma", "entity_1_idx": [[58, 67]], "entity_1_idx_in_text_with_entity_marker": [62, 71], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFN-gamma", "entity_2_idx": [[121, 130]], "entity_2_idx_in_text_with_entity_marker": [134, 143], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p2", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the [E1]p55[/E1] TNF receptor-associated proteins [E2]TRADD[/E2] and FADD.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p55", "entity_1_idx": [[82, 85]], "entity_1_idx_in_text_with_entity_marker": [86, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[119, 124]], "entity_2_idx_in_text_with_entity_marker": [132, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p4", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the TNF-dependent activation of [E1]acid SMase[/E1] (A-SMase) through the p55 TNF receptor-associated proteins [E2]TRADD[/E2] and FADD.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "acid SMase", "entity_1_idx": [[49, 59]], "entity_1_idx_in_text_with_entity_marker": [53, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[119, 124]], "entity_2_idx_in_text_with_entity_marker": [132, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p5", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the TNF-dependent activation of acid SMase ([E1]A-SMase[/E1]) through the p55 TNF receptor-associated proteins [E2]TRADD[/E2] and FADD.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "A-SMase", "entity_1_idx": [[61, 68]], "entity_1_idx_in_text_with_entity_marker": [65, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[119, 124]], "entity_2_idx_in_text_with_entity_marker": [132, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p7", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the [E1]p55[/E1] TNF receptor-associated proteins TRADD and [E2]FADD[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p55", "entity_1_idx": [[82, 85]], "entity_1_idx_in_text_with_entity_marker": [86, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[129, 133]], "entity_2_idx_in_text_with_entity_marker": [142, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p9", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the TNF-dependent activation of [E1]acid SMase[/E1] (A-SMase) through the p55 TNF receptor-associated proteins TRADD and [E2]FADD[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "acid SMase", "entity_1_idx": [[49, 59]], "entity_1_idx_in_text_with_entity_marker": [53, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[129, 133]], "entity_2_idx_in_text_with_entity_marker": [142, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p10", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the TNF-dependent activation of acid SMase ([E1]A-SMase[/E1]) through the p55 TNF receptor-associated proteins TRADD and [E2]FADD[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "A-SMase", "entity_1_idx": [[61, 68]], "entity_1_idx_in_text_with_entity_marker": [65, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[129, 133]], "entity_2_idx_in_text_with_entity_marker": [142, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p13", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the [E1]TNF[/E1]-dependent activation of [E2]acid SMase[/E2] (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TNF", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acid SMase", "entity_2_idx": [[49, 59]], "entity_2_idx_in_text_with_entity_marker": [62, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p14", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the [E1]TNF[/E1]-dependent activation of acid SMase ([E2]A-SMase[/E2]) through the p55 TNF receptor-associated proteins TRADD and FADD.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TNF", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A-SMase", "entity_2_idx": [[61, 68]], "entity_2_idx_in_text_with_entity_marker": [74, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p15", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the [E1]p55[/E1] [E2]TNF receptor[/E2]-associated proteins TRADD and FADD.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p55", "entity_1_idx": [[82, 85]], "entity_1_idx_in_text_with_entity_marker": [86, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF receptor", "entity_2_idx": [[86, 98]], "entity_2_idx_in_text_with_entity_marker": [99, 111], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s1_BioInfer.d242.s1.p0", "text": "TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase.", "text_with_entity_marker": "TNF receptor death domain-associated proteins [E1]TRADD[/E1] and FADD signal activation of [E2]acid sphingomyelinase[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acid sphingomyelinase", "entity_2_idx": [[82, 103]], "entity_2_idx_in_text_with_entity_marker": [95, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s1_BioInfer.d242.s1.p3", "text": "TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase.", "text_with_entity_marker": "TNF receptor death domain-associated proteins TRADD and [E1]FADD[/E1] signal activation of [E2]acid sphingomyelinase[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acid sphingomyelinase", "entity_2_idx": [[82, 103]], "entity_2_idx_in_text_with_entity_marker": [95, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p0", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in [E1]Tax[/E1] critical for binding CBP/[E2]p300[/E2] to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Tax", "entity_1_idx": [[123, 126]], "entity_1_idx_in_text_with_entity_marker": [127, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p300", "entity_2_idx": [[152, 156]], "entity_2_idx_in_text_with_entity_marker": [165, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p6", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in [E1]Tax[/E1] critical for binding [E2]CBP[/E2]/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Tax", "entity_1_idx": [[123, 126]], "entity_1_idx_in_text_with_entity_marker": [127, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[148, 151]], "entity_2_idx_in_text_with_entity_marker": [161, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p7", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in [E1]Tax[/E1] critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for [E2]CREB[/E2] binding and Tax subunit dimerization.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Tax", "entity_1_idx": [[123, 126]], "entity_1_idx_in_text_with_entity_marker": [127, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[324, 328]], "entity_2_idx_in_text_with_entity_marker": [337, 341], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d234.s0_BioInfer.d234.s0.p9", "text": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.", "text_with_entity_marker": "Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in [E1]Tax[/E1] critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and [E2]Tax[/E2] subunit dimerization.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Tax", "entity_1_idx": [[123, 126]], "entity_1_idx_in_text_with_entity_marker": [127, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tax", "entity_2_idx": [[341, 344]], "entity_2_idx_in_text_with_entity_marker": [354, 357], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d82.s0_BioInfer.d82.s0.p0", "text": "A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the twinstar locus, a gene that encodes a Drosophila member of the cofilin/ADF family of actin-severing proteins.", "text_with_entity_marker": "A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the twinstar locus, a gene that encodes a Drosophila member of the [E1]cofilin/ADF[/E1] family of [E2]actin[/E2]-severing proteins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin/ADF", "entity_1_idx": [[178, 189]], "entity_1_idx_in_text_with_entity_marker": [182, 193], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[200, 205]], "entity_2_idx_in_text_with_entity_marker": [213, 218], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d810.s0_BioInfer.d810.s0.p0", "text": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "text_with_entity_marker": "We have cloned a Saccharomyces cerevisiae gene ([E1]COF1[/E1]) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast [E2]cofilin[/E2]; Cof); its aa sequence is 35% identical to porcine Cof.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "COF1", "entity_1_idx": [[48, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 56], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "cofilin", "entity_2_idx": [[135, 142]], "entity_2_idx_in_text_with_entity_marker": [148, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d810.s0_BioInfer.d810.s0.p2", "text": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "text_with_entity_marker": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) [E1]actin-binding protein[/E1] of 143 amino acid (aa) residues (yeast [E2]cofilin[/E2]; Cof); its aa sequence is 35% identical to porcine Cof.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[74, 95]], "entity_1_idx_in_text_with_entity_marker": [78, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[135, 142]], "entity_2_idx_in_text_with_entity_marker": [148, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d810.s0_BioInfer.d810.s0.p3", "text": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "text_with_entity_marker": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast [E1]cofilin[/E1]; Cof); its aa sequence is 35% identical to porcine [E2]Cof[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[135, 142]], "entity_1_idx_in_text_with_entity_marker": [139, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cof", "entity_2_idx": [[194, 197]], "entity_2_idx_in_text_with_entity_marker": [207, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d810.s0_BioInfer.d810.s0.p4", "text": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "text_with_entity_marker": "We have cloned a Saccharomyces cerevisiae gene ([E1]COF1[/E1]) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; [E2]Cof[/E2]); its aa sequence is 35% identical to porcine Cof.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "COF1", "entity_1_idx": [[48, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 56], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Cof", "entity_2_idx": [[144, 147]], "entity_2_idx_in_text_with_entity_marker": [157, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d810.s0_BioInfer.d810.s0.p7", "text": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "text_with_entity_marker": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) [E1]actin-binding protein[/E1] of 143 amino acid (aa) residues (yeast cofilin; [E2]Cof[/E2]); its aa sequence is 35% identical to porcine Cof.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[74, 95]], "entity_1_idx_in_text_with_entity_marker": [78, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Cof", "entity_2_idx": [[144, 147]], "entity_2_idx_in_text_with_entity_marker": [157, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d810.s0_BioInfer.d810.s0.p8", "text": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.", "text_with_entity_marker": "We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; [E1]Cof[/E1]); its aa sequence is 35% identical to porcine [E2]Cof[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Cof", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cof", "entity_2_idx": [[194, 197]], "entity_2_idx_in_text_with_entity_marker": [207, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s0_BioInfer.d519.s0.p0", "text": "Requirement of the yeast MSH3 and MSH6 genes for MSH2-dependent genomic stability.", "text_with_entity_marker": "Requirement of the yeast MSH3 and [E1]MSH6[/E1] genes for [E2]MSH2[/E2]-dependent genomic stability.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH6", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[49, 53]], "entity_2_idx_in_text_with_entity_marker": [62, 66], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s0_BioInfer.d519.s0.p1", "text": "Requirement of the yeast MSH3 and MSH6 genes for MSH2-dependent genomic stability.", "text_with_entity_marker": "Requirement of the yeast [E1]MSH3[/E1] and MSH6 genes for [E2]MSH2[/E2]-dependent genomic stability.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH3", "entity_1_idx": [[25, 29]], "entity_1_idx_in_text_with_entity_marker": [29, 33], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[49, 53]], "entity_2_idx_in_text_with_entity_marker": [62, 66], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p0", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that [E1]MSH2[/E1] functions in mismatch repair in conjunction with MSH3 or [E2]MSH6[/E2] and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[108, 112]], "entity_2_idx_in_text_with_entity_marker": [121, 125], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p6", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that [E1]MSH2[/E1] functions in mismatch repair in conjunction with [E2]MSH3[/E2] or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH3", "entity_2_idx": [[100, 104]], "entity_2_idx_in_text_with_entity_marker": [113, 117], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p10", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and [E1]MSH6[/E1] constitute alternate pathways of [E2]MSH2[/E2]-dependent mismatch repair.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH6", "entity_1_idx": [[131, 135]], "entity_1_idx_in_text_with_entity_marker": [135, 139], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p14", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that [E1]MSH3[/E1] and MSH6 constitute alternate pathways of [E2]MSH2[/E2]-dependent mismatch repair.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH3", "entity_1_idx": [[122, 126]], "entity_1_idx_in_text_with_entity_marker": [126, 130], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d674.s0_BioInfer.d674.s0.p0", "text": "The protein has the two conserved domains identified as actin and phosphatidylinositol 4,5-biphosphate (PIP2) binding sites found in members of the cofilin family.", "text_with_entity_marker": "The protein has the two conserved domains identified as [E1]actin[/E1] and phosphatidylinositol 4,5-biphosphate (PIP2) binding sites found in members of the [E2]cofilin[/E2] family.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[56, 61]], "entity_1_idx_in_text_with_entity_marker": [60, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[148, 155]], "entity_2_idx_in_text_with_entity_marker": [161, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d710.s0_BioInfer.d710.s0.p1", "text": "These results show that cofilin/ADF is an important regulator of actin-based cell motility during Drosophila development.", "text_with_entity_marker": "These results show that [E1]cofilin[/E1]/ADF is an important regulator of [E2]actin[/E2]-based cell motility during Drosophila development.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[24, 31]], "entity_1_idx_in_text_with_entity_marker": [28, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d710.s0_BioInfer.d710.s0.p2", "text": "These results show that cofilin/ADF is an important regulator of actin-based cell motility during Drosophila development.", "text_with_entity_marker": "These results show that cofilin/[E1]ADF[/E1] is an important regulator of [E2]actin[/E2]-based cell motility during Drosophila development.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d520.s0_BioInfer.d520.s0.p0", "text": "Requirement of yeast fimbrin for actin organization and morphogenesis in vivo.", "text_with_entity_marker": "Requirement of yeast [E1]fimbrin[/E1] for [E2]actin[/E2] organization and morphogenesis in vivo.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[21, 28]], "entity_1_idx_in_text_with_entity_marker": [25, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[33, 38]], "entity_2_idx_in_text_with_entity_marker": [46, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d48.s0_BioInfer.d48.s0.p0", "text": "A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of talin and vinculin on the structure, chain dynamics, elasticity and viscoelasticity of actin filaments with time.", "text_with_entity_marker": "A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of talin and [E1]vinculin[/E1] on the structure, chain dynamics, elasticity and viscoelasticity of [E2]actin[/E2] filaments with time.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[158, 166]], "entity_1_idx_in_text_with_entity_marker": [162, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[235, 240]], "entity_2_idx_in_text_with_entity_marker": [248, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d48.s0_BioInfer.d48.s0.p2", "text": "A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of talin and vinculin on the structure, chain dynamics, elasticity and viscoelasticity of actin filaments with time.", "text_with_entity_marker": "A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of [E1]talin[/E1] and vinculin on the structure, chain dynamics, elasticity and viscoelasticity of [E2]actin[/E2] filaments with time.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[148, 153]], "entity_1_idx_in_text_with_entity_marker": [152, 157], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[235, 240]], "entity_2_idx_in_text_with_entity_marker": [248, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d48.s1_BioInfer.d48.s1.p0", "text": "The viscoelasticity of entangled actin networks: the influence of defects and modulation by talin and vinculin.", "text_with_entity_marker": "The viscoelasticity of entangled [E1]actin[/E1] networks: the influence of defects and modulation by [E2]talin[/E2] and vinculin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d48.s1_BioInfer.d48.s1.p1", "text": "The viscoelasticity of entangled actin networks: the influence of defects and modulation by talin and vinculin.", "text_with_entity_marker": "The viscoelasticity of entangled [E1]actin[/E1] networks: the influence of defects and modulation by talin and [E2]vinculin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[102, 110]], "entity_2_idx_in_text_with_entity_marker": [115, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p5", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian actin-binding proteins such as profilin and CapG but also [E1]fragmin[/E1] from Physarum polycephalum are similar targets for PIP2-stimulated [E2]pp60[/E2](c-src) phosphorylation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "fragmin", "entity_1_idx": [[74, 81]], "entity_1_idx_in_text_with_entity_marker": [78, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pp60", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p6", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian actin-binding proteins such as profilin and CapG but also [E1]fragmin[/E1] from Physarum polycephalum are similar targets for PIP2-stimulated pp60([E2]c-src[/E2]) phosphorylation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "fragmin", "entity_1_idx": [[74, 81]], "entity_1_idx_in_text_with_entity_marker": [78, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-src", "entity_2_idx": [[154, 159]], "entity_2_idx_in_text_with_entity_marker": [167, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p7", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian [E1]actin-binding proteins[/E1] such as profilin and CapG but also [E2]fragmin[/E2] from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[16, 38]], "entity_1_idx_in_text_with_entity_marker": [20, 42], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "fragmin", "entity_2_idx": [[74, 81]], "entity_2_idx_in_text_with_entity_marker": [87, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p11", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian actin-binding proteins such as [E1]profilin[/E1] and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated [E2]pp60[/E2](c-src) phosphorylation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[47, 55]], "entity_1_idx_in_text_with_entity_marker": [51, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pp60", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p13", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian actin-binding proteins such as [E1]profilin[/E1] and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60([E2]c-src[/E2]) phosphorylation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[47, 55]], "entity_1_idx_in_text_with_entity_marker": [51, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-src", "entity_2_idx": [[154, 159]], "entity_2_idx_in_text_with_entity_marker": [167, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d469.s0_BioInfer.d469.s0.p14", "text": "Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "text_with_entity_marker": "Other mammalian [E1]actin-binding proteins[/E1] such as [E2]profilin[/E2] and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[16, 38]], "entity_1_idx_in_text_with_entity_marker": [20, 42], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[47, 55]], "entity_2_idx_in_text_with_entity_marker": [60, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d330.s0_BioInfer.d330.s0.p2", "text": "In COS-7 cells overexpressing a N-WASP mutant lacking the proline-rich domain (Deltap) unable to interact with profilin, the actin tail formation of intracellular Shigella was inhibited.", "text_with_entity_marker": "In COS-7 cells overexpressing a [E1]N-WASP[/E1] mutant lacking the proline-rich domain (Deltap) unable to interact with [E2]profilin[/E2], the actin tail formation of intracellular Shigella was inhibited.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "N-WASP", "entity_1_idx": [[32, 38], [79, 85]], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[111, 119]], "entity_2_idx_in_text_with_entity_marker": [124, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d816.s0_BioInfer.d816.s0.p0", "text": "We investigated actin filament turnover rates, length, number, barbed end exposure, and binding of cofilin in bovine arterial endothelial cells moving at different speeds depending on their position in a confluent monolayer.", "text_with_entity_marker": "We investigated [E1]actin[/E1] filament turnover rates, length, number, barbed end exposure, and binding of [E2]cofilin[/E2] in bovine arterial endothelial cells moving at different speeds depending on their position in a confluent monolayer.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[99, 106]], "entity_2_idx_in_text_with_entity_marker": [112, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d137.s0_BioInfer.d137.s0.p0", "text": "Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.", "text_with_entity_marker": "Characterization of gelsolin truncates that inhibit [E1]actin[/E1] depolymerization by severing activity of gelsolin and [E2]cofilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[112, 119]], "entity_2_idx_in_text_with_entity_marker": [125, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d137.s0_BioInfer.d137.s0.p2", "text": "Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.", "text_with_entity_marker": "Characterization of [E1]gelsolin[/E1] truncates that inhibit actin depolymerization by severing activity of gelsolin and [E2]cofilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[112, 119]], "entity_2_idx_in_text_with_entity_marker": [125, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d137.s0_BioInfer.d137.s0.p3", "text": "Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.", "text_with_entity_marker": "Characterization of gelsolin truncates that inhibit [E1]actin[/E1] depolymerization by severing activity of [E2]gelsolin[/E2] and cofilin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[99, 107]], "entity_2_idx_in_text_with_entity_marker": [112, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d137.s0_BioInfer.d137.s0.p4", "text": "Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.", "text_with_entity_marker": "Characterization of [E1]gelsolin[/E1] truncates that inhibit [E2]actin[/E2] depolymerization by severing activity of gelsolin and cofilin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[52, 57]], "entity_2_idx_in_text_with_entity_marker": [65, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d137.s0_BioInfer.d137.s0.p5", "text": "Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.", "text_with_entity_marker": "Characterization of [E1]gelsolin[/E1] truncates that inhibit actin depolymerization by severing activity of [E2]gelsolin[/E2] and cofilin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[99, 107]], "entity_2_idx_in_text_with_entity_marker": [112, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d42.s0_BioInfer.d42.s0.p3", "text": "Although talin has been suggested to act as a linkage protein mediating the attachment of GPIIb-IIIa to actin filaments, direct binding of GPIIb-IIIa to this cytoskeletal protein has not been demonstrated.", "text_with_entity_marker": "Although [E1]talin[/E1] has been suggested to act as a linkage protein mediating the attachment of GPIIb-IIIa to actin filaments, direct binding of [E2]GPIIb[/E2]-IIIa to this cytoskeletal protein has not been demonstrated.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "GPIIb", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d42.s0_BioInfer.d42.s0.p7", "text": "Although talin has been suggested to act as a linkage protein mediating the attachment of GPIIb-IIIa to actin filaments, direct binding of GPIIb-IIIa to this cytoskeletal protein has not been demonstrated.", "text_with_entity_marker": "Although [E1]talin[/E1] has been suggested to act as a linkage protein mediating the attachment of GPIIb-IIIa to actin filaments, direct binding of [E2]GP[/E2]IIb-IIIa to this cytoskeletal protein has not been demonstrated.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "GP", "entity_2_idx": [[139, 141], [145, 149]], "entity_2_idx_in_text_with_entity_marker": [152, 154], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d42.s0_BioInfer.d42.s0.p10", "text": "Although talin has been suggested to act as a linkage protein mediating the attachment of GPIIb-IIIa to actin filaments, direct binding of GPIIb-IIIa to this cytoskeletal protein has not been demonstrated.", "text_with_entity_marker": "Although [E1]talin[/E1] has been suggested to act as a linkage protein mediating the attachment of [E2]GP[/E2]IIb-IIIa to actin filaments, direct binding of GPIIb-IIIa to this cytoskeletal protein has not been demonstrated.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "GP", "entity_2_idx": [[90, 92], [96, 100]], "entity_2_idx_in_text_with_entity_marker": [103, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d42.s0_BioInfer.d42.s0.p11", "text": "Although talin has been suggested to act as a linkage protein mediating the attachment of GPIIb-IIIa to actin filaments, direct binding of GPIIb-IIIa to this cytoskeletal protein has not been demonstrated.", "text_with_entity_marker": "Although talin has been suggested to act as a linkage protein mediating the attachment of [E1]GP[/E1]IIb-IIIa to [E2]actin[/E2] filaments, direct binding of GPIIb-IIIa to this cytoskeletal protein has not been demonstrated.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "GP", "entity_1_idx": [[90, 92], [96, 100]], "entity_1_idx_in_text_with_entity_marker": [94, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[104, 109]], "entity_2_idx_in_text_with_entity_marker": [117, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d42.s0_BioInfer.d42.s0.p12", "text": "Although talin has been suggested to act as a linkage protein mediating the attachment of GPIIb-IIIa to actin filaments, direct binding of GPIIb-IIIa to this cytoskeletal protein has not been demonstrated.", "text_with_entity_marker": "Although [E1]talin[/E1] has been suggested to act as a linkage protein mediating the attachment of [E2]GPIIb[/E2]-IIIa to actin filaments, direct binding of GPIIb-IIIa to this cytoskeletal protein has not been demonstrated.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "GPIIb", "entity_2_idx": [[90, 95]], "entity_2_idx_in_text_with_entity_marker": [103, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d42.s0_BioInfer.d42.s0.p13", "text": "Although talin has been suggested to act as a linkage protein mediating the attachment of GPIIb-IIIa to actin filaments, direct binding of GPIIb-IIIa to this cytoskeletal protein has not been demonstrated.", "text_with_entity_marker": "Although talin has been suggested to act as a linkage protein mediating the attachment of [E1]GPIIb[/E1]-IIIa to [E2]actin[/E2] filaments, direct binding of GPIIb-IIIa to this cytoskeletal protein has not been demonstrated.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "GPIIb", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[104, 109]], "entity_2_idx_in_text_with_entity_marker": [117, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d42.s0_BioInfer.d42.s0.p14", "text": "Although talin has been suggested to act as a linkage protein mediating the attachment of GPIIb-IIIa to actin filaments, direct binding of GPIIb-IIIa to this cytoskeletal protein has not been demonstrated.", "text_with_entity_marker": "Although [E1]talin[/E1] has been suggested to act as a linkage protein mediating the attachment of GPIIb-IIIa to [E2]actin[/E2] filaments, direct binding of GPIIb-IIIa to this cytoskeletal protein has not been demonstrated.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[104, 109]], "entity_2_idx_in_text_with_entity_marker": [117, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d39.s0_BioInfer.d39.s0.p1", "text": "Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and actin-binding protein).", "text_with_entity_marker": "Although binding patterns of different sera were not identical, almost all sera caused [E1]IgG[/E1] binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as [E2]talin[/E2] and actin-binding protein).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IgG", "entity_1_idx": [[87, 90]], "entity_1_idx_in_text_with_entity_marker": [91, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[209, 214]], "entity_2_idx_in_text_with_entity_marker": [222, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d39.s0_BioInfer.d39.s0.p2", "text": "Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and actin-binding protein).", "text_with_entity_marker": "Although binding patterns of different sera were not identical, almost all sera caused [E1]IgG[/E1] binding to platelet components of 87-90 kD, 140 kD (identified as [E2]vinculin[/E2]) and 220-240 kD (tentatively identified as talin and actin-binding protein).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IgG", "entity_1_idx": [[87, 90]], "entity_1_idx_in_text_with_entity_marker": [91, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[157, 165]], "entity_2_idx_in_text_with_entity_marker": [170, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d129.s0_BioInfer.d129.s0.p2", "text": "CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.", "text_with_entity_marker": "[E1]CD26[/E1], a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with [E2]adenosine deaminase[/E2] (ADA) on the surface of T cells and T cell lines.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "adenosine deaminase", "entity_2_idx": [[97, 116]], "entity_2_idx_in_text_with_entity_marker": [110, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d129.s0_BioInfer.d129.s0.p3", "text": "CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.", "text_with_entity_marker": "CD26, a T cell activation Ag, also known as [E1]dipeptidyl peptidase IV[/E1], is directly associated with adenosine deaminase ([E2]ADA[/E2]) on the surface of T cells and T cell lines.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "dipeptidyl peptidase IV", "entity_1_idx": [[44, 67]], "entity_1_idx_in_text_with_entity_marker": [48, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADA", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d129.s0_BioInfer.d129.s0.p4", "text": "CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.", "text_with_entity_marker": "CD26, a T cell activation Ag, also known as [E1]dipeptidyl peptidase IV[/E1], is directly associated with [E2]adenosine deaminase[/E2] (ADA) on the surface of T cells and T cell lines.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "dipeptidyl peptidase IV", "entity_1_idx": [[44, 67]], "entity_1_idx_in_text_with_entity_marker": [48, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "adenosine deaminase", "entity_2_idx": [[97, 116]], "entity_2_idx_in_text_with_entity_marker": [110, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s0_BioInfer.d49.s0.p0", "text": "A model is proposed for the function of profilin in actin-based motility.", "text_with_entity_marker": "A model is proposed for the function of [E1]profilin[/E1] in [E2]actin[/E2]-based motility.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[40, 48]], "entity_1_idx_in_text_with_entity_marker": [44, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[52, 57]], "entity_2_idx_in_text_with_entity_marker": [65, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p0", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of [E1]profilin[/E1] promote extensive [E2]actin[/E2] assembly off of the pool of actin-T beta 4 complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[80, 88]], "entity_1_idx_in_text_with_entity_marker": [84, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[107, 112]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p5", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive [E1]actin[/E1] assembly off of the pool of [E2]actin[/E2]-T beta 4 complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[107, 112]], "entity_1_idx_in_text_with_entity_marker": [111, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[141, 146]], "entity_2_idx_in_text_with_entity_marker": [154, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p7", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive [E1]actin[/E1] assembly off of the pool of actin-[E2]T beta 4[/E2] complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[107, 112]], "entity_1_idx_in_text_with_entity_marker": [111, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "T beta 4", "entity_2_idx": [[147, 155]], "entity_2_idx_in_text_with_entity_marker": [160, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p10", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of [E1]actin[/E1]-[E2]T beta 4[/E2] complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[141, 146]], "entity_1_idx_in_text_with_entity_marker": [145, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "T beta 4", "entity_2_idx": [[147, 155]], "entity_2_idx_in_text_with_entity_marker": [160, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s2_BioInfer.d49.s2.p1", "text": "How profilin promotes actin filament assembly in the presence of thymosin beta 4.", "text_with_entity_marker": "How [E1]profilin[/E1] promotes [E2]actin[/E2] filament assembly in the presence of thymosin beta 4.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[4, 12]], "entity_1_idx_in_text_with_entity_marker": [8, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[22, 27]], "entity_2_idx_in_text_with_entity_marker": [35, 40], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s3_BioInfer.d49.s3.p0", "text": "The role of profilin in the regulation of actin assembly has been reexamined.", "text_with_entity_marker": "The role of [E1]profilin[/E1] in the regulation of [E2]actin[/E2] assembly has been reexamined.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s4_BioInfer.d49.s4.p0", "text": "When barbed ends are capped, profilin simply sequesters globular actin.", "text_with_entity_marker": "When barbed ends are capped, [E1]profilin[/E1] simply sequesters globular [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[29, 37]], "entity_1_idx_in_text_with_entity_marker": [33, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s3_BioInfer.d87.s3.p4", "text": "Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.", "text_with_entity_marker": "Thus, it is most likely that the association between [E1]E-cadherin[/E1] and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in [E2]beta-catenin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[53, 63]], "entity_1_idx_in_text_with_entity_marker": [57, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[172, 184]], "entity_2_idx_in_text_with_entity_marker": [185, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s4_BioInfer.d87.s4.p0", "text": "While alpha-catenin has been demonstrated to be crucial for cadherin function, the role of beta-catenin is not yet fully understood.", "text_with_entity_marker": "While [E1]alpha-catenin[/E1] has been demonstrated to be crucial for [E2]cadherin[/E2] function, the role of beta-catenin is not yet fully understood.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[6, 19]], "entity_1_idx_in_text_with_entity_marker": [10, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[60, 68]], "entity_2_idx_in_text_with_entity_marker": [73, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p0", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe rhp51+, rad22+ and [E1]rhp54+[/E1] genes are homologous to RAD51, RAD52 and [E2]RAD54[/E2] respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "rhp54+", "entity_1_idx": [[49, 55]], "entity_1_idx_in_text_with_entity_marker": [53, 59], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD54", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p10", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe [E1]rhp51+[/E1], rad22+ and rhp54+ genes are homologous to [E2]RAD51[/E2], RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "rhp51+", "entity_1_idx": [[30, 36]], "entity_1_idx_in_text_with_entity_marker": [34, 40], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD51", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d692.s0_BioInfer.d692.s0.p13", "text": "The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "text_with_entity_marker": "The Schizosaccharomyces pombe rhp51+, [E1]rad22+[/E1] and rhp54+ genes are homologous to RAD51, [E2]RAD52[/E2] and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "rad22+", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[87, 92]], "entity_2_idx_in_text_with_entity_marker": [100, 105], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d440.s0_BioInfer.d440.s0.p0", "text": "Most previous studies have focused on profilin itself rather than its complex with actin.", "text_with_entity_marker": "Most previous studies have focused on [E1]profilin[/E1] itself rather than its complex with [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[38, 46]], "entity_1_idx_in_text_with_entity_marker": [42, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[83, 88]], "entity_2_idx_in_text_with_entity_marker": [96, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d437.s1_BioInfer.d437.s1.p0", "text": "pH control of actin polymerization by cofilin.", "text_with_entity_marker": "pH control of [E1]actin[/E1] polymerization by [E2]cofilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[38, 45]], "entity_2_idx_in_text_with_entity_marker": [51, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s0_BioInfer.d430.s0.p2", "text": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.", "text_with_entity_marker": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the [E1]beta-catenin[/E1] is homologous to human [E2]plakoglobin[/E2] and the Drosophila gene product armadillo.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[115, 127]], "entity_1_idx_in_text_with_entity_marker": [119, 131], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[151, 162]], "entity_2_idx_in_text_with_entity_marker": [164, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s0_BioInfer.d430.s0.p8", "text": "Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.", "text_with_entity_marker": "Molecular cloning and primary structure analysis demonstrated that [E1]alpha-catenin[/E1] is homologous to [E2]vinculin[/E2] and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[67, 80]], "entity_1_idx_in_text_with_entity_marker": [71, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[98, 106]], "entity_2_idx_in_text_with_entity_marker": [111, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s1_BioInfer.d430.s1.p0", "text": "One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "One complex is composed of E-cadherin, alpha- and beta-catenin, the other of [E1]E-cadherin[/E1], alpha-catenin and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[77, 87]], "entity_1_idx_in_text_with_entity_marker": [81, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[107, 118]], "entity_2_idx_in_text_with_entity_marker": [120, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s1_BioInfer.d430.s1.p2", "text": "One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "One complex is composed of E-cadherin, alpha- and beta-catenin, the other of [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2] and plakoglobin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[77, 87]], "entity_1_idx_in_text_with_entity_marker": [81, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[89, 102]], "entity_2_idx_in_text_with_entity_marker": [102, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s1_BioInfer.d430.s1.p6", "text": "One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, [E1]alpha-catenin[/E1] and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[89, 102]], "entity_1_idx_in_text_with_entity_marker": [93, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[107, 118]], "entity_2_idx_in_text_with_entity_marker": [120, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s1_BioInfer.d430.s1.p10", "text": "One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "One complex is composed of [E1]E-cadherin[/E1], [E2]alpha-[/E2] and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-", "entity_2_idx": [[39, 45], [55, 62]], "entity_2_idx_in_text_with_entity_marker": [52, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s1_BioInfer.d430.s1.p11", "text": "One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "One complex is composed of E-cadherin, [E1]alpha-[/E1] and [E2]beta-catenin[/E2], the other of E-cadherin, alpha-catenin and plakoglobin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-", "entity_1_idx": [[39, 45], [55, 62]], "entity_1_idx_in_text_with_entity_marker": [43, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[50, 62]], "entity_2_idx_in_text_with_entity_marker": [63, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d430.s1_BioInfer.d430.s1.p14", "text": "One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "One complex is composed of [E1]E-cadherin[/E1], alpha- and [E2]beta-catenin[/E2], the other of E-cadherin, alpha-catenin and plakoglobin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[50, 62]], "entity_2_idx_in_text_with_entity_marker": [63, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d428.s0_BioInfer.d428.s0.p0", "text": "Modifying preselected sites on proteins: the stretch of residues 633-642 of the myosin heavy chain is part of the actin-binding site.", "text_with_entity_marker": "Modifying preselected sites on proteins: the stretch of residues 633-642 of the [E1]myosin heavy chain[/E1] is part of the [E2]actin[/E2]-binding site.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[80, 98]], "entity_1_idx_in_text_with_entity_marker": [84, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p0", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of [E1]histone[/E1] [E2]H3[/E2] and only inefficiently competed with DNA for binding of histone H1.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[124, 131]], "entity_1_idx_in_text_with_entity_marker": [128, 135], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[132, 134]], "entity_2_idx_in_text_with_entity_marker": [145, 147], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p11", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of [E1]histone[/E1] [E2]H1[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[191, 198]], "entity_1_idx_in_text_with_entity_marker": [195, 202], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H1", "entity_2_idx": [[199, 201]], "entity_2_idx_in_text_with_entity_marker": [212, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p12", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of [E1]histone[/E1] [E2]H4[/E2], it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[68, 75]], "entity_1_idx_in_text_with_entity_marker": [72, 79], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[76, 78]], "entity_2_idx_in_text_with_entity_marker": [89, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d738.s0_BioInfer.d738.s0.p0", "text": "This cadherin-catenin complex plays an indispensable role in construction of ordered multicellular structures such as polarized epithelium.", "text_with_entity_marker": "This [E1]cadherin[/E1]-[E2]catenin[/E2] complex plays an indispensable role in construction of ordered multicellular structures such as polarized epithelium.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[5, 13]], "entity_1_idx_in_text_with_entity_marker": [9, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenin", "entity_2_idx": [[14, 21]], "entity_2_idx_in_text_with_entity_marker": [27, 34], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d738.s1_BioInfer.d738.s1.p0", "text": "beta-catenin and plakoglobin possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified cadherin activities.", "text_with_entity_marker": "beta-catenin and [E1]plakoglobin[/E1] possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified [E2]cadherin[/E2] activities.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[17, 28]], "entity_1_idx_in_text_with_entity_marker": [21, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[143, 151]], "entity_2_idx_in_text_with_entity_marker": [156, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d738.s1_BioInfer.d738.s1.p1", "text": "beta-catenin and plakoglobin possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified cadherin activities.", "text_with_entity_marker": "[E1]beta-catenin[/E1] and plakoglobin possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified [E2]cadherin[/E2] activities.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[143, 151]], "entity_2_idx_in_text_with_entity_marker": [156, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p0", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the [E1]protein kinase[/E1] activity and stress fiber formation by [E2]LIMK2[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "protein kinase", "entity_1_idx": [[192, 206]], "entity_1_idx_in_text_with_entity_marker": [196, 210], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LIMK2", "entity_2_idx": [[246, 251]], "entity_2_idx_in_text_with_entity_marker": [259, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p9", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A [E1]LIMK2[/E1] mutant with replacement of threonine 505 by valine abolished LIMK2 activities for [E2]cofilin[/E2] phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LIMK2", "entity_1_idx": [[2, 7]], "entity_1_idx_in_text_with_entity_marker": [6, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p11", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A LIMK2 mutant with replacement of threonine 505 by valine abolished [E1]LIMK2[/E1] activities for [E2]cofilin[/E2] phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LIMK2", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p12", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A [E1]LIMK2[/E1] mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and [E2]actin[/E2] cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LIMK2", "entity_1_idx": [[2, 7]], "entity_1_idx_in_text_with_entity_marker": [6, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[118, 123]], "entity_2_idx_in_text_with_entity_marker": [131, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p14", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A LIMK2 mutant with replacement of threonine 505 by valine abolished [E1]LIMK2[/E1] activities for cofilin phosphorylation and [E2]actin[/E2] cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LIMK2", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[118, 123]], "entity_2_idx_in_text_with_entity_marker": [131, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s0_BioInfer.d713.s0.p5", "text": "These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "text_with_entity_marker": "These results suggest that [E1]LIMK2[/E1] functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of [E2]actin[/E2] filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LIMK2", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[127, 132]], "entity_2_idx_in_text_with_entity_marker": [140, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s0_BioInfer.d713.s0.p7", "text": "These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "text_with_entity_marker": "These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of [E1]actin[/E1] filaments and membrane structures, by phosphorylating [E2]cofilin/ADF[/E2] proteins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[127, 132]], "entity_1_idx_in_text_with_entity_marker": [131, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin/ADF", "entity_2_idx": [[187, 198]], "entity_2_idx_in_text_with_entity_marker": [200, 211], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s1_BioInfer.d713.s1.p0", "text": "We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "text_with_entity_marker": "We report here that LIMK1 and [E1]LIMK2[/E1] phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed [E2]cofilin[/E2] mutants as substrates.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LIMK2", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[208, 215]], "entity_2_idx_in_text_with_entity_marker": [221, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s1_BioInfer.d713.s1.p3", "text": "We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "text_with_entity_marker": "We report here that LIMK1 and [E1]LIMK2[/E1] phosphorylate both [E2]cofilin[/E2] and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LIMK2", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[55, 62]], "entity_2_idx_in_text_with_entity_marker": [68, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s1_BioInfer.d713.s1.p4", "text": "We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "text_with_entity_marker": "We report here that LIMK1 and [E1]LIMK2[/E1] phosphorylate both cofilin and [E2]actin-depolymerizing factor[/E2] (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "LIMK2", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-depolymerizing factor", "entity_2_idx": [[67, 94]], "entity_2_idx_in_text_with_entity_marker": [80, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s1_BioInfer.d713.s1.p5", "text": "We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "text_with_entity_marker": "We report here that [E1]LIMK1[/E1] and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed [E2]cofilin[/E2] mutants as substrates.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LIMK1", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[208, 215]], "entity_2_idx_in_text_with_entity_marker": [221, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s1_BioInfer.d713.s1.p10", "text": "We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "text_with_entity_marker": "We report here that [E1]LIMK1[/E1] and LIMK2 phosphorylate both [E2]cofilin[/E2] and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LIMK1", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[55, 62]], "entity_2_idx_in_text_with_entity_marker": [68, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s1_BioInfer.d713.s1.p11", "text": "We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "text_with_entity_marker": "We report here that [E1]LIMK1[/E1] and LIMK2 phosphorylate both cofilin and [E2]actin-depolymerizing factor[/E2] (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "LIMK1", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-depolymerizing factor", "entity_2_idx": [[67, 94]], "entity_2_idx_in_text_with_entity_marker": [80, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p1", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the [E1]actin[/E1] cytoskeleton and endocytic membrane flow, directing [E2]actin[/E2] and clathrin assembly to distinct membrane domains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[148, 153]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p2", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain profilin I and [E1]profilin II[/E1] complexes link the actin cytoskeleton and endocytic membrane flow, directing [E2]actin[/E2] and clathrin assembly to distinct membrane domains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin II", "entity_1_idx": [[59, 70]], "entity_1_idx_in_text_with_entity_marker": [63, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[148, 153]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p3", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain [E1]profilin I[/E1] and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing [E2]actin[/E2] and clathrin assembly to distinct membrane domains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin I", "entity_1_idx": [[44, 54]], "entity_1_idx_in_text_with_entity_marker": [48, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[148, 153]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p4", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the [E1]actin[/E1] cytoskeleton and endocytic membrane flow, directing actin and [E2]clathrin[/E2] assembly to distinct membrane domains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "clathrin", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p5", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain profilin I and [E1]profilin II[/E1] complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and [E2]clathrin[/E2] assembly to distinct membrane domains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin II", "entity_1_idx": [[59, 70]], "entity_1_idx_in_text_with_entity_marker": [63, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "clathrin", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p6", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain [E1]profilin I[/E1] and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and [E2]clathrin[/E2] assembly to distinct membrane domains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin I", "entity_1_idx": [[44, 54]], "entity_1_idx_in_text_with_entity_marker": [48, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "clathrin", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p7", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain profilin I and [E1]profilin II[/E1] complexes link the [E2]actin[/E2] cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin II", "entity_1_idx": [[59, 70]], "entity_1_idx_in_text_with_entity_marker": [63, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[90, 95]], "entity_2_idx_in_text_with_entity_marker": [103, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p8", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain [E1]profilin I[/E1] and profilin II complexes link the [E2]actin[/E2] cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin I", "entity_1_idx": [[44, 54]], "entity_1_idx_in_text_with_entity_marker": [48, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[90, 95]], "entity_2_idx_in_text_with_entity_marker": [103, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d195.s0_BioInfer.d195.s0.p0", "text": "Evidence for a conformational change in actin induced by fimbrin (N375) binding.", "text_with_entity_marker": "Evidence for a conformational change in actin induced by [E1]fimbrin[/E1] ([E2]N375[/E2]) binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[57, 64]], "entity_1_idx_in_text_with_entity_marker": [61, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N375", "entity_2_idx": [[66, 70]], "entity_2_idx_in_text_with_entity_marker": [79, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d195.s0_BioInfer.d195.s0.p2", "text": "Evidence for a conformational change in actin induced by fimbrin (N375) binding.", "text_with_entity_marker": "Evidence for a conformational change in [E1]actin[/E1] induced by fimbrin ([E2]N375[/E2]) binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[40, 45]], "entity_1_idx_in_text_with_entity_marker": [44, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N375", "entity_2_idx": [[66, 70]], "entity_2_idx_in_text_with_entity_marker": [79, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d23.s0_BioInfer.d23.s0.p0", "text": "Addition of Acanthamoeba profilin in molar ratios to actin of about 1.1:1 and 2.3:1 retarded the initial kinetics of assembly (induced by addition of 2mM Mg+2) and reduced the fraction of actin incorporated into filaments.", "text_with_entity_marker": "Addition of Acanthamoeba [E1]profilin[/E1] in molar ratios to actin of about 1.1:1 and 2.3:1 retarded the initial kinetics of assembly (induced by addition of 2mM Mg+2) and reduced the fraction of [E2]actin[/E2] incorporated into filaments.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[188, 193]], "entity_2_idx_in_text_with_entity_marker": [201, 206], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p2", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a [E1]alpha v beta 3[/E1] can be detected in focal contacts, colocalizing with vinculin, [E2]talin[/E2], and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha v beta 3", "entity_1_idx": [[91, 105]], "entity_1_idx_in_text_with_entity_marker": [95, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[169, 174]], "entity_2_idx_in_text_with_entity_marker": [182, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p6", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a [E1]alpha v beta 3[/E1] can be detected in focal contacts, colocalizing with [E2]vinculin[/E2], talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha v beta 3", "entity_1_idx": [[91, 105]], "entity_1_idx_in_text_with_entity_marker": [95, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[159, 167]], "entity_2_idx_in_text_with_entity_marker": [172, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p9", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a [E1]alpha v beta 3[/E1] can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of [E2]actin[/E2] filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha v beta 3", "entity_1_idx": [[91, 105]], "entity_1_idx_in_text_with_entity_marker": [95, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[192, 197]], "entity_2_idx_in_text_with_entity_marker": [205, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p13", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to [E1]vitronectin[/E1], only a [E2]alpha v beta 3[/E2] can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "vitronectin", "entity_1_idx": [[71, 82]], "entity_1_idx_in_text_with_entity_marker": [75, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha v beta 3", "entity_2_idx": [[91, 105]], "entity_2_idx_in_text_with_entity_marker": [104, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p14", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to [E1]vitronectin[/E1], only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while [E2]alpha v beta 5[/E2] shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "vitronectin", "entity_1_idx": [[71, 82]], "entity_1_idx_in_text_with_entity_marker": [75, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha v beta 5", "entity_2_idx": [[215, 229]], "entity_2_idx_in_text_with_entity_marker": [228, 242], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d753.s0_BioInfer.d753.s0.p0", "text": "Thus, profilin and actin expression are not co-regulated in all cells.", "text_with_entity_marker": "Thus, [E1]profilin[/E1] and [E2]actin[/E2] expression are not co-regulated in all cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[19, 24]], "entity_2_idx_in_text_with_entity_marker": [32, 37], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d75.s0_BioInfer.d75.s0.p3", "text": "A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble phospholipase C-gamma 1, but also the small soluble actin-binding protein profilin.", "text_with_entity_marker": "A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble phospholipase C-gamma 1, but also the small soluble [E1]actin-binding protein[/E1] [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[184, 205]], "entity_1_idx_in_text_with_entity_marker": [188, 209], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[206, 214]], "entity_2_idx_in_text_with_entity_marker": [219, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p0", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like actin, the actin-associated proteins filamin, [E1]talin[/E1] and the [E2]beta 1 integrin subunit[/E2] were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 1 integrin subunit", "entity_2_idx": [[65, 88]], "entity_2_idx_in_text_with_entity_marker": [78, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p1", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like actin, the actin-associated proteins [E1]filamin[/E1], talin and the [E2]beta 1 integrin subunit[/E2] were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "filamin", "entity_1_idx": [[42, 49]], "entity_1_idx_in_text_with_entity_marker": [46, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 1 integrin subunit", "entity_2_idx": [[65, 88]], "entity_2_idx_in_text_with_entity_marker": [78, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p2", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like actin, the [E1]actin[/E1]-associated proteins filamin, talin and the [E2]beta 1 integrin subunit[/E2] were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 1 integrin subunit", "entity_2_idx": [[65, 88]], "entity_2_idx_in_text_with_entity_marker": [78, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p3", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like [E1]actin[/E1], the actin-associated proteins filamin, talin and the [E2]beta 1 integrin subunit[/E2] were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[5, 10]], "entity_1_idx_in_text_with_entity_marker": [9, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 1 integrin subunit", "entity_2_idx": [[65, 88]], "entity_2_idx_in_text_with_entity_marker": [78, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p4", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like actin, the actin-associated proteins [E1]filamin[/E1], [E2]talin[/E2] and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "filamin", "entity_1_idx": [[42, 49]], "entity_1_idx_in_text_with_entity_marker": [46, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[51, 56]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p5", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like actin, the [E1]actin[/E1]-associated proteins filamin, [E2]talin[/E2] and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[51, 56]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p6", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like [E1]actin[/E1], the actin-associated proteins filamin, [E2]talin[/E2] and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[5, 10]], "entity_1_idx_in_text_with_entity_marker": [9, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[51, 56]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p7", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like actin, the [E1]actin[/E1]-associated proteins [E2]filamin[/E2], talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "filamin", "entity_2_idx": [[42, 49]], "entity_2_idx_in_text_with_entity_marker": [55, 62], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d402.s0_BioInfer.d402.s0.p8", "text": "Like actin, the actin-associated proteins filamin, talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "text_with_entity_marker": "Like [E1]actin[/E1], the actin-associated proteins [E2]filamin[/E2], talin and the beta 1 integrin subunit were also found to accumulate around entering bacteria.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[5, 10]], "entity_1_idx_in_text_with_entity_marker": [9, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "filamin", "entity_2_idx": [[42, 49]], "entity_2_idx_in_text_with_entity_marker": [55, 62], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p0", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, [E1]TRADD[/E1], FADD and [E2]RAIDD[/E2] - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[131, 136]], "entity_1_idx_in_text_with_entity_marker": [135, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAIDD", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p1", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 ([E1]TNFR1[/E1]) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, [E2]TRADD[/E2], FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p2", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the [E1]Fas[/E1] receptor recruit complexes formed by the interactions between RIP kinase, [E2]TRADD[/E2], FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[53, 56]], "entity_1_idx_in_text_with_entity_marker": [57, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p3", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The [E1]tumor necrosis factor receptor 1[/E1] (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, [E2]TRADD[/E2], FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "tumor necrosis factor receptor 1", "entity_1_idx": [[4, 36]], "entity_1_idx_in_text_with_entity_marker": [8, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p4", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between [E1]RIP kinase[/E1], [E2]TRADD[/E2], FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RIP kinase", "entity_1_idx": [[119, 129]], "entity_1_idx_in_text_with_entity_marker": [123, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p5", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, [E1]TRADD[/E1], [E2]FADD[/E2] and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[131, 136]], "entity_1_idx_in_text_with_entity_marker": [135, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p6", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 ([E1]TNFR1[/E1]) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and [E2]RAIDD[/E2] - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAIDD", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p7", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the [E1]Fas[/E1] receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and [E2]RAIDD[/E2] - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[53, 56]], "entity_1_idx_in_text_with_entity_marker": [57, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAIDD", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p8", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The [E1]tumor necrosis factor receptor 1[/E1] (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and [E2]RAIDD[/E2] - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "tumor necrosis factor receptor 1", "entity_1_idx": [[4, 36]], "entity_1_idx_in_text_with_entity_marker": [8, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAIDD", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p9", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between [E1]RIP kinase[/E1], TRADD, FADD and [E2]RAIDD[/E2] - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RIP kinase", "entity_1_idx": [[119, 129]], "entity_1_idx_in_text_with_entity_marker": [123, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAIDD", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d281.s0_BioInfer.d281.s0.p0", "text": "Human profilins are multifunctional, single-domain proteins which directly link the actin microfilament system to a variety of signalling pathways via two spatially distinct binding sites.", "text_with_entity_marker": "Human [E1]profilins[/E1] are multifunctional, single-domain proteins which directly link the [E2]actin[/E2] microfilament system to a variety of signalling pathways via two spatially distinct binding sites.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[6, 15]], "entity_1_idx_in_text_with_entity_marker": [10, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[84, 89]], "entity_2_idx_in_text_with_entity_marker": [97, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d193.s0_BioInfer.d193.s0.p0", "text": "Evaluation of the binding of Acanthamoeba profilin to pyrene-labeled actin by fluorescence enhancement.", "text_with_entity_marker": "Evaluation of the binding of Acanthamoeba [E1]profilin[/E1] to pyrene-labeled [E2]actin[/E2] by fluorescence enhancement.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[42, 50]], "entity_1_idx_in_text_with_entity_marker": [46, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p12", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of [E1]E-cadherin[/E1], [E2]beta-catenin[/E2], and alpha-catenin relative to Apc(+/+) controls.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[113, 123]], "entity_1_idx_in_text_with_entity_marker": [117, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[125, 137]], "entity_2_idx_in_text_with_entity_marker": [138, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p13", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, [E1]beta-catenin[/E1], and [E2]alpha-catenin[/E2] relative to Apc(+/+) controls.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[125, 137]], "entity_1_idx_in_text_with_entity_marker": [129, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[143, 156]], "entity_2_idx_in_text_with_entity_marker": [156, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d328.s0_BioInfer.d328.s0.p14", "text": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of E-cadherin, beta-catenin, and alpha-catenin relative to Apc(+/+) controls.", "text_with_entity_marker": "In contrast to the Apc(Min/+) enterocytes, Apc(Min/-) adenomas displayed increased expression and association of [E1]E-cadherin[/E1], beta-catenin, and [E2]alpha-catenin[/E2] relative to Apc(+/+) controls.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[113, 123]], "entity_1_idx_in_text_with_entity_marker": [117, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[143, 156]], "entity_2_idx_in_text_with_entity_marker": [156, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d784.s0_BioInfer.d784.s0.p0", "text": "Unmasking of this site serves as a molecular switch that initiates assembly of an actin-based motility complex containing VASP and profilin.", "text_with_entity_marker": "Unmasking of this site serves as a molecular switch that initiates assembly of an [E1]actin[/E1]-based motility complex containing [E2]VASP[/E2] and profilin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[82, 87]], "entity_1_idx_in_text_with_entity_marker": [86, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VASP", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d784.s0_BioInfer.d784.s0.p1", "text": "Unmasking of this site serves as a molecular switch that initiates assembly of an actin-based motility complex containing VASP and profilin.", "text_with_entity_marker": "Unmasking of this site serves as a molecular switch that initiates assembly of an actin-based motility complex containing [E1]VASP[/E1] and [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "VASP", "entity_1_idx": [[122, 126]], "entity_1_idx_in_text_with_entity_marker": [126, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[131, 139]], "entity_2_idx_in_text_with_entity_marker": [144, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d784.s0_BioInfer.d784.s0.p2", "text": "Unmasking of this site serves as a molecular switch that initiates assembly of an actin-based motility complex containing VASP and profilin.", "text_with_entity_marker": "Unmasking of this site serves as a molecular switch that initiates assembly of an [E1]actin[/E1]-based motility complex containing VASP and [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[82, 87]], "entity_1_idx_in_text_with_entity_marker": [86, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[131, 139]], "entity_2_idx_in_text_with_entity_marker": [144, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p0", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[97, 109]], "entity_2_idx_in_text_with_entity_marker": [110, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p1", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, [E2]paxillin[/E2] and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[97, 109]], "entity_1_idx_in_text_with_entity_marker": [101, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[232, 240]], "entity_2_idx_in_text_with_entity_marker": [245, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p2", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and [E2]talin[/E2], did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[97, 109]], "entity_1_idx_in_text_with_entity_marker": [101, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p3", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, [E1]beta-catenin[/E1], [E2]plakoglobin[/E2], vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[97, 109]], "entity_1_idx_in_text_with_entity_marker": [101, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[111, 122]], "entity_2_idx_in_text_with_entity_marker": [124, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p4", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, vinculin and [E2]alpha-actinin[/E2] appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[97, 109]], "entity_1_idx_in_text_with_entity_marker": [101, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-actinin", "entity_2_idx": [[137, 150]], "entity_2_idx_in_text_with_entity_marker": [150, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p5", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, [E2]vinculin[/E2] and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[97, 109]], "entity_1_idx_in_text_with_entity_marker": [101, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p6", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, [E1]cadherins[/E1], alpha-catenin, [E2]beta-catenin[/E2], plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cadherins", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[97, 109]], "entity_2_idx_in_text_with_entity_marker": [110, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p7", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, [E1]integrins[/E1], cadherins, alpha-catenin, [E2]beta-catenin[/E2], plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "integrins", "entity_1_idx": [[60, 69]], "entity_1_idx_in_text_with_entity_marker": [64, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[97, 109]], "entity_2_idx_in_text_with_entity_marker": [110, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p8", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, [E2]paxillin[/E2] and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[232, 240]], "entity_2_idx_in_text_with_entity_marker": [245, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p9", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and [E2]talin[/E2], did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d362.s0_BioInfer.d362.s0.p0", "text": "Interestingly, the regions that show the most structural diversity are located at or near the actin-binding site of profilin.", "text_with_entity_marker": "Interestingly, the regions that show the most structural diversity are located at or near the [E1]actin[/E1]-binding site of [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[94, 99]], "entity_1_idx_in_text_with_entity_marker": [98, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[116, 124]], "entity_2_idx_in_text_with_entity_marker": [129, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d79.s0_BioInfer.d79.s0.p0", "text": "A series of truncations was carried out at the C terminus of profilin, a region that has been implicated in actin binding.", "text_with_entity_marker": "A series of truncations was carried out at the C terminus of [E1]profilin[/E1], a region that has been implicated in [E2]actin[/E2] binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[61, 69]], "entity_1_idx_in_text_with_entity_marker": [65, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d79.s1_BioInfer.d79.s1.p0", "text": "Since our earlier studies of Acanthamoeba profilins suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and actin binding may be important for profilin function.", "text_with_entity_marker": "Since our earlier studies of Acanthamoeba profilins suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and [E1]actin[/E1] binding may be important for [E2]profilin[/E2] function.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[240, 248]], "entity_2_idx_in_text_with_entity_marker": [253, 261], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p4", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of [E1]extracellular signal-regulated protein kinases[/E1] [E2]ERK1[/E2] and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "extracellular signal-regulated protein kinases", "entity_1_idx": [[45, 91]], "entity_1_idx_in_text_with_entity_marker": [49, 95], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "ERK1", "entity_2_idx": [[92, 96]], "entity_2_idx_in_text_with_entity_marker": [105, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p8", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of [E1]extracellular signal-regulated protein kinases[/E1] ERK1 and [E2]ERK2[/E2], induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "extracellular signal-regulated protein kinases", "entity_1_idx": [[45, 91]], "entity_1_idx_in_text_with_entity_marker": [49, 95], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "ERK2", "entity_2_idx": [[101, 105]], "entity_2_idx_in_text_with_entity_marker": [114, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p48", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, [E1]histone[/E1] [E2]H[/E2]2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[205, 212]], "entity_1_idx_in_text_with_entity_marker": [209, 216], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H", "entity_2_idx": [[213, 214], [219, 221]], "entity_2_idx_in_text_with_entity_marker": [226, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p54", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, [E1]histone[/E1] [E2]H2A[/E2] + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[205, 212]], "entity_1_idx_in_text_with_entity_marker": [209, 216], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [226, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p67", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), [E1]histone[/E1] [E2]H1[/E2], histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[193, 200]], "entity_1_idx_in_text_with_entity_marker": [197, 204], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H1", "entity_2_idx": [[201, 203]], "entity_2_idx_in_text_with_entity_marker": [214, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p72", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and [E1]histone[/E1] [E2]H4[/E2], was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[239, 246]], "entity_1_idx_in_text_with_entity_marker": [243, 250], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[247, 249]], "entity_2_idx_in_text_with_entity_marker": [260, 262], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p90", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, [E1]histone[/E1] [E2]H3[/E2], and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[223, 230]], "entity_1_idx_in_text_with_entity_marker": [227, 234], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[231, 233]], "entity_2_idx_in_text_with_entity_marker": [244, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s0_BioInfer.d221.s0.p1", "text": "Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host WASP family proteins: an acidic stretch, an actin monomer-binding region, and a cofilin homology sequence.", "text_with_entity_marker": "Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host [E1]WASP[/E1] family proteins: an acidic stretch, an actin monomer-binding region, and a [E2]cofilin[/E2] homology sequence.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "WASP", "entity_1_idx": [[183, 187]], "entity_1_idx_in_text_with_entity_marker": [187, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[263, 270]], "entity_2_idx_in_text_with_entity_marker": [276, 283], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s0_BioInfer.d221.s0.p2", "text": "Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host WASP family proteins: an acidic stretch, an actin monomer-binding region, and a cofilin homology sequence.", "text_with_entity_marker": "Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host [E1]WASP[/E1] family proteins: an acidic stretch, an [E2]actin[/E2] monomer-binding region, and a cofilin homology sequence.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "WASP", "entity_1_idx": [[183, 187]], "entity_1_idx_in_text_with_entity_marker": [187, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[227, 232]], "entity_2_idx_in_text_with_entity_marker": [240, 245], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s1_BioInfer.d221.s1.p3", "text": "The cofilin homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "text_with_entity_marker": "The cofilin homology sequence is critical for stimulating [E1]actin[/E1] nucleation with the [E2]Arp2[/E2]/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[84, 88]], "entity_2_idx_in_text_with_entity_marker": [97, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s1_BioInfer.d221.s1.p5", "text": "The cofilin homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "text_with_entity_marker": "The [E1]cofilin[/E1] homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for [E2]actin[/E2] polymerization and motility in cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[130, 135]], "entity_2_idx_in_text_with_entity_marker": [143, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s1_BioInfer.d221.s1.p8", "text": "The cofilin homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "text_with_entity_marker": "The cofilin homology sequence is critical for stimulating [E1]actin[/E1] nucleation with the [E2]Arp[/E2]2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[84, 87], [89, 90]], "entity_2_idx_in_text_with_entity_marker": [97, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d221.s1_BioInfer.d221.s1.p9", "text": "The cofilin homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "text_with_entity_marker": "The [E1]cofilin[/E1] homology sequence is critical for stimulating [E2]actin[/E2] nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d590.s0_BioInfer.d590.s0.p0", "text": "The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.", "text_with_entity_marker": "The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the [E1]actin[/E1]- or ATP-binding capacities of two size-limited recombinant [E2]myosin heavy chain[/E2] fragments.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[114, 119]], "entity_1_idx_in_text_with_entity_marker": [118, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[179, 197]], "entity_2_idx_in_text_with_entity_marker": [192, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d590.s0_BioInfer.d590.s0.p1", "text": "The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.", "text_with_entity_marker": "The [E1]cardiac myosin heavy chain[/E1] Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the [E2]actin[/E2]- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[4, 30]], "entity_1_idx_in_text_with_entity_marker": [8, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d590.s0_BioInfer.d590.s0.p2", "text": "The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.", "text_with_entity_marker": "The [E1]cardiac myosin heavy chain[/E1] Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant [E2]myosin heavy chain[/E2] fragments.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[4, 30]], "entity_1_idx_in_text_with_entity_marker": [8, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[179, 197]], "entity_2_idx_in_text_with_entity_marker": [192, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d791.s0_BioInfer.d791.s0.p2", "text": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "text_with_entity_marker": "Vascular endothelial cadherin ([E1]VE-cadherin[/E1]) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with [E2]alpha-catenin[/E2], which is thought to link the complex to the peri-junctional actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "VE-cadherin", "entity_1_idx": [[31, 42]], "entity_1_idx_in_text_with_entity_marker": [35, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[140, 153]], "entity_2_idx_in_text_with_entity_marker": [153, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d791.s0_BioInfer.d791.s0.p3", "text": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "text_with_entity_marker": "Vascular endothelial cadherin ([E1]VE-cadherin[/E1]) clusters were co-localized with [E2]beta-catenin[/E2], an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "VE-cadherin", "entity_1_idx": [[31, 42]], "entity_1_idx_in_text_with_entity_marker": [35, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[76, 88]], "entity_2_idx_in_text_with_entity_marker": [89, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d791.s0_BioInfer.d791.s0.p5", "text": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "text_with_entity_marker": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with [E1]alpha-catenin[/E1], which is thought to link the complex to the peri-junctional [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[140, 153]], "entity_1_idx_in_text_with_entity_marker": [144, 157], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[215, 220]], "entity_2_idx_in_text_with_entity_marker": [228, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d791.s0_BioInfer.d791.s0.p7", "text": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "text_with_entity_marker": "[E1]Vascular endothelial cadherin[/E1] (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with [E2]alpha-catenin[/E2], which is thought to link the complex to the peri-junctional actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Vascular endothelial cadherin", "entity_1_idx": [[0, 29]], "entity_1_idx_in_text_with_entity_marker": [4, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[140, 153]], "entity_2_idx_in_text_with_entity_marker": [153, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d791.s0_BioInfer.d791.s0.p8", "text": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "text_with_entity_marker": "[E1]Vascular endothelial cadherin[/E1] (VE-cadherin) clusters were co-localized with [E2]beta-catenin[/E2], an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Vascular endothelial cadherin", "entity_1_idx": [[0, 29]], "entity_1_idx_in_text_with_entity_marker": [4, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[76, 88]], "entity_2_idx_in_text_with_entity_marker": [89, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d331.s0_BioInfer.d331.s0.p0", "text": "Increased interaction of beta1D integrin with the actin cytoskeleton is consistent with and might be mediated by its enhanced binding to talin.", "text_with_entity_marker": "Increased interaction of [E1]beta1D integrin[/E1] with the actin cytoskeleton is consistent with and might be mediated by its enhanced binding to [E2]talin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta1D integrin", "entity_1_idx": [[25, 40]], "entity_1_idx_in_text_with_entity_marker": [29, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[137, 142]], "entity_2_idx_in_text_with_entity_marker": [150, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d331.s0_BioInfer.d331.s0.p1", "text": "Increased interaction of beta1D integrin with the actin cytoskeleton is consistent with and might be mediated by its enhanced binding to talin.", "text_with_entity_marker": "Increased interaction of beta1D integrin with the [E1]actin[/E1] cytoskeleton is consistent with and might be mediated by its enhanced binding to [E2]talin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[50, 55]], "entity_1_idx_in_text_with_entity_marker": [54, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[137, 142]], "entity_2_idx_in_text_with_entity_marker": [150, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d331.s0_BioInfer.d331.s0.p2", "text": "Increased interaction of beta1D integrin with the actin cytoskeleton is consistent with and might be mediated by its enhanced binding to talin.", "text_with_entity_marker": "Increased interaction of [E1]beta1D integrin[/E1] with the [E2]actin[/E2] cytoskeleton is consistent with and might be mediated by its enhanced binding to talin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta1D integrin", "entity_1_idx": [[25, 40]], "entity_1_idx_in_text_with_entity_marker": [29, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[50, 55]], "entity_2_idx_in_text_with_entity_marker": [63, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p4", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and [E1]histone[/E1] [E2]H4[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[172, 179]], "entity_1_idx_in_text_with_entity_marker": [176, 183], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[180, 182]], "entity_2_idx_in_text_with_entity_marker": [193, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p5", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that HRG stimulation of the [E1]EF-1alpha[/E1] promoter involves increased physical interactions with acetylated histone [E2]H3[/E2] and histone H4.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "EF-1alpha", "entity_1_idx": [[81, 90]], "entity_1_idx_in_text_with_entity_marker": [85, 94], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "H3", "entity_2_idx": [[165, 167]], "entity_2_idx_in_text_with_entity_marker": [178, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p6", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that [E1]HRG[/E1] stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone [E2]H3[/E2] and histone H4.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "HRG", "entity_1_idx": [[58, 61]], "entity_1_idx_in_text_with_entity_marker": [62, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[165, 167]], "entity_2_idx_in_text_with_entity_marker": [178, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p7", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated [E1]histone[/E1] [E2]H3[/E2] and histone H4.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[157, 164]], "entity_1_idx_in_text_with_entity_marker": [161, 168], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[165, 167]], "entity_2_idx_in_text_with_entity_marker": [178, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p11", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that HRG stimulation of the [E1]EF-1alpha[/E1] promoter involves increased physical interactions with acetylated histone H3 and histone [E2]H4[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "EF-1alpha", "entity_1_idx": [[81, 90]], "entity_1_idx_in_text_with_entity_marker": [85, 94], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "H4", "entity_2_idx": [[180, 182]], "entity_2_idx_in_text_with_entity_marker": [193, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p13", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that [E1]HRG[/E1] stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone [E2]H4[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "HRG", "entity_1_idx": [[58, 61]], "entity_1_idx_in_text_with_entity_marker": [62, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[180, 182]], "entity_2_idx_in_text_with_entity_marker": [193, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d478.s0_BioInfer.d478.s0.p0", "text": "Overexpression of cyclin E and cyclin-dependent kinase inhibitor (p27Kip1): effect on cell cycle regulation in HeLa cells.", "text_with_entity_marker": "Overexpression of cyclin E and [E1]cyclin-dependent kinase inhibitor[/E1] ([E2]p27Kip1[/E2]): effect on cell cycle regulation in HeLa cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[31, 64]], "entity_1_idx_in_text_with_entity_marker": [35, 68], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27Kip1", "entity_2_idx": [[66, 73]], "entity_2_idx_in_text_with_entity_marker": [79, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d817.s0_BioInfer.d817.s0.p0", "text": "We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "We previously showed that [E1]actin[/E1] is transported in an unassembled form with its associated proteins actin depolymerizing factor, [E2]cofilin[/E2], and profilin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[128, 135]], "entity_2_idx_in_text_with_entity_marker": [141, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d817.s0_BioInfer.d817.s0.p1", "text": "We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "We previously showed that [E1]actin[/E1] is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[141, 149]], "entity_2_idx_in_text_with_entity_marker": [154, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d817.s0_BioInfer.d817.s0.p2", "text": "We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "We previously showed that [E1]actin[/E1] is transported in an unassembled form with its associated proteins [E2]actin depolymerizing factor[/E2], cofilin, and profilin.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[99, 126]], "entity_2_idx_in_text_with_entity_marker": [112, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s0_BioInfer.d643.s0.p0", "text": "The mechanism of profilin-promoted actin polymerization has been systematically reinvestigated.", "text_with_entity_marker": "The mechanism of [E1]profilin[/E1]-promoted [E2]actin[/E2] polymerization has been systematically reinvestigated.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[17, 25]], "entity_1_idx_in_text_with_entity_marker": [21, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[35, 40]], "entity_2_idx_in_text_with_entity_marker": [48, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s1_BioInfer.d643.s1.p0", "text": "When measured in the absence of profilin, actin assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.Actin).", "text_with_entity_marker": "When measured in the absence of profilin, actin assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for [E1]Thymosin-beta4[/E1].[E2]Actin[/E2]).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Thymosin-beta4", "entity_1_idx": [[178, 192]], "entity_1_idx_in_text_with_entity_marker": [182, 196], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Actin", "entity_2_idx": [[193, 198]], "entity_2_idx_in_text_with_entity_marker": [206, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d702.s0_BioInfer.d702.s0.p1", "text": "These phenotypes are similar to those of the mutant of PFY1, which encodes profilin, an actin-binding protein.", "text_with_entity_marker": "These phenotypes are similar to those of the mutant of [E1]PFY1[/E1], which encodes [E2]profilin[/E2], an actin-binding protein.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PFY1", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "profilin", "entity_2_idx": [[75, 83]], "entity_2_idx_in_text_with_entity_marker": [88, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d702.s0_BioInfer.d702.s0.p2", "text": "These phenotypes are similar to those of the mutant of PFY1, which encodes profilin, an actin-binding protein.", "text_with_entity_marker": "These phenotypes are similar to those of the mutant of PFY1, which encodes [E1]profilin[/E1], an [E2]actin-binding protein[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[75, 83]], "entity_1_idx_in_text_with_entity_marker": [79, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[88, 109]], "entity_2_idx_in_text_with_entity_marker": [101, 122], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p0", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that [E1]TNF-alpha[/E1] can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, [E2]TRADD[/E2], FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TNF-alpha", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[122, 127]], "entity_2_idx_in_text_with_entity_marker": [135, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p4", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through [E1]TNFR1[/E1]-linked apoptotic factors, [E2]TRADD[/E2], FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[122, 127]], "entity_2_idx_in_text_with_entity_marker": [135, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p5", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that [E1]TNF-alpha[/E1] can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and [E2]FLICE[/E2], and TNF-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TNF-alpha", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FLICE", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p6", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that [E1]TNF-alpha[/E1] can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, [E2]FADD[/E2], and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TNF-alpha", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[129, 133]], "entity_2_idx_in_text_with_entity_marker": [142, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p11", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through [E1]TNFR1[/E1]-linked apoptotic factors, TRADD, FADD, and [E2]FLICE[/E2], and TNF-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FLICE", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p13", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through [E1]TNFR1[/E1]-linked apoptotic factors, TRADD, [E2]FADD[/E2], and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[129, 133]], "entity_2_idx_in_text_with_entity_marker": [142, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d609.s0_BioInfer.d609.s0.p0", "text": "The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "text_with_entity_marker": "The effects of two adhesion substrates (serum and [E1]laminin[/E1]) and time in culture on the expression of genes encoding [E2]myosin heavy chain[/E2] (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "laminin", "entity_1_idx": [[50, 57]], "entity_1_idx_in_text_with_entity_marker": [54, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[115, 133]], "entity_2_idx_in_text_with_entity_marker": [128, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d609.s0_BioInfer.d609.s0.p1", "text": "The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "text_with_entity_marker": "The effects of two adhesion substrates (serum and [E1]laminin[/E1]) and time in culture on the expression of genes encoding myosin heavy chain ([E2]MHC[/E2]) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "laminin", "entity_1_idx": [[50, 57]], "entity_1_idx_in_text_with_entity_marker": [54, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d609.s0_BioInfer.d609.s0.p2", "text": "The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "text_with_entity_marker": "The effects of two adhesion substrates (serum and [E1]laminin[/E1]) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and [E2]alpha-skeletal actin[/E2] were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "laminin", "entity_1_idx": [[50, 57]], "entity_1_idx_in_text_with_entity_marker": [54, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-skeletal actin", "entity_2_idx": [[153, 173]], "entity_2_idx_in_text_with_entity_marker": [166, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d429.s0_BioInfer.d429.s0.p0", "text": "Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.", "text_with_entity_marker": "Molecular analysis of the [E1]cadherin[/E1]-catenin complex elucidated the central role of [E2]beta-catenin[/E2] in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[82, 94]], "entity_2_idx_in_text_with_entity_marker": [95, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d429.s0_BioInfer.d429.s0.p1", "text": "Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.", "text_with_entity_marker": "Molecular analysis of the cadherin-[E1]catenin[/E1] complex elucidated the central role of [E2]beta-catenin[/E2] in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "catenin", "entity_1_idx": [[35, 42]], "entity_1_idx_in_text_with_entity_marker": [39, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[82, 94]], "entity_2_idx_in_text_with_entity_marker": [95, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d429.s0_BioInfer.d429.s0.p2", "text": "Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.", "text_with_entity_marker": "Molecular analysis of the cadherin-catenin complex elucidated the central role of [E1]beta-catenin[/E1] in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[82, 94]], "entity_1_idx_in_text_with_entity_marker": [86, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[180, 193]], "entity_2_idx_in_text_with_entity_marker": [193, 206], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d429.s0_BioInfer.d429.s0.p3", "text": "Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.", "text_with_entity_marker": "Molecular analysis of the cadherin-catenin complex elucidated the central role of [E1]beta-catenin[/E1] in this adhesion complex, as it binds to the cytoplasmic domain of [E2]E-cadherin[/E2] and to alpha-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[82, 94]], "entity_1_idx_in_text_with_entity_marker": [86, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[162, 172]], "entity_2_idx_in_text_with_entity_marker": [175, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d429.s0_BioInfer.d429.s0.p4", "text": "Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.", "text_with_entity_marker": "Molecular analysis of the [E1]cadherin[/E1]-[E2]catenin[/E2] complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenin", "entity_2_idx": [[35, 42]], "entity_2_idx_in_text_with_entity_marker": [48, 55], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s0_BioInfer.d575.s0.p6", "text": "The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.", "text_with_entity_marker": "The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of [E1]beta-catenin[/E1] will independently associate with APC, although the amino-terminal half independently binds [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[115, 127]], "entity_1_idx_in_text_with_entity_marker": [119, 131], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[220, 233]], "entity_2_idx_in_text_with_entity_marker": [233, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p0", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The [E1]APC[/E1] protein and [E2]E-cadherin[/E2] form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "APC", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[20, 30]], "entity_2_idx_in_text_with_entity_marker": [33, 43], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p1", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The APC protein and [E1]E-cadherin[/E1] form similar but independent complexes with alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[20, 30]], "entity_1_idx_in_text_with_entity_marker": [24, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[108, 119]], "entity_2_idx_in_text_with_entity_marker": [121, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p2", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The APC protein and [E1]E-cadherin[/E1] form similar but independent complexes with [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[20, 30]], "entity_1_idx_in_text_with_entity_marker": [24, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[75, 88]], "entity_2_idx_in_text_with_entity_marker": [88, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p3", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The APC protein and [E1]E-cadherin[/E1] form similar but independent complexes with alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[20, 30]], "entity_1_idx_in_text_with_entity_marker": [24, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[90, 102]], "entity_2_idx_in_text_with_entity_marker": [103, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p4", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The [E1]APC[/E1] protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "APC", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[108, 119]], "entity_2_idx_in_text_with_entity_marker": [121, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p5", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The [E1]APC[/E1] protein and E-cadherin form similar but independent complexes with [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "APC", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[75, 88]], "entity_2_idx_in_text_with_entity_marker": [88, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p7", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The APC protein and E-cadherin form similar but independent complexes with [E1]alpha-catenin[/E1], beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[75, 88]], "entity_1_idx_in_text_with_entity_marker": [79, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[108, 119]], "entity_2_idx_in_text_with_entity_marker": [121, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p8", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, [E1]beta-catenin[/E1], and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[90, 102]], "entity_1_idx_in_text_with_entity_marker": [94, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[108, 119]], "entity_2_idx_in_text_with_entity_marker": [121, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s1_BioInfer.d575.s1.p9", "text": "The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The APC protein and E-cadherin form similar but independent complexes with [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[75, 88]], "entity_1_idx_in_text_with_entity_marker": [79, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[90, 102]], "entity_2_idx_in_text_with_entity_marker": [103, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d565.s0_BioInfer.d565.s0.p2", "text": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the helicase-primase complex, UL8 and UL52, indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "text_with_entity_marker": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the [E1]helicase-primase[/E1] complex, UL8 and [E2]UL52[/E2], indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[103, 119]], "entity_1_idx_in_text_with_entity_marker": [107, 123], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d565.s0_BioInfer.d565.s0.p5", "text": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the helicase-primase complex, UL8 and UL52, indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "text_with_entity_marker": "The ability of these three mutant UL5 proteins to form specific interactions with other members of the [E1]helicase-primase[/E1] complex, [E2]UL8[/E2] and UL52, indicates that the functional domains required for replication activity of UL5 are separable from domains responsible for protein-protein interactions.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[103, 119]], "entity_1_idx_in_text_with_entity_marker": [107, 123], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL8", "entity_2_idx": [[129, 132]], "entity_2_idx_in_text_with_entity_marker": [142, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d165.s0_BioInfer.d165.s0.p0", "text": "Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.", "text_with_entity_marker": "Deletion and overexpression studies demonstrate that [E1]SIR2[/E1], but not SIR1, [E2]SIR3[/E2] or SIR4, is required for this rDNA position effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SIR2", "entity_1_idx": [[53, 57]], "entity_1_idx_in_text_with_entity_marker": [57, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR3", "entity_2_idx": [[73, 77]], "entity_2_idx_in_text_with_entity_marker": [86, 90], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d165.s0_BioInfer.d165.s0.p1", "text": "Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.", "text_with_entity_marker": "Deletion and overexpression studies demonstrate that [E1]SIR2[/E1], but not [E2]SIR1[/E2], SIR3 or SIR4, is required for this rDNA position effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SIR2", "entity_1_idx": [[53, 57]], "entity_1_idx_in_text_with_entity_marker": [57, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR1", "entity_2_idx": [[67, 71]], "entity_2_idx_in_text_with_entity_marker": [80, 84], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d165.s0_BioInfer.d165.s0.p2", "text": "Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.", "text_with_entity_marker": "Deletion and overexpression studies demonstrate that [E1]SIR2[/E1], but not SIR1, SIR3 or [E2]SIR4[/E2], is required for this rDNA position effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SIR2", "entity_1_idx": [[53, 57]], "entity_1_idx_in_text_with_entity_marker": [57, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR4", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d165.s0_BioInfer.d165.s0.p3", "text": "Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.", "text_with_entity_marker": "Deletion and overexpression studies demonstrate that SIR2, but not [E1]SIR1[/E1], [E2]SIR3[/E2] or SIR4, is required for this rDNA position effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SIR1", "entity_1_idx": [[67, 71]], "entity_1_idx_in_text_with_entity_marker": [71, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR3", "entity_2_idx": [[73, 77]], "entity_2_idx_in_text_with_entity_marker": [86, 90], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d165.s0_BioInfer.d165.s0.p4", "text": "Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.", "text_with_entity_marker": "Deletion and overexpression studies demonstrate that SIR2, but not SIR1, [E1]SIR3[/E1] or [E2]SIR4[/E2], is required for this rDNA position effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SIR3", "entity_1_idx": [[73, 77]], "entity_1_idx_in_text_with_entity_marker": [77, 81], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR4", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d165.s0_BioInfer.d165.s0.p5", "text": "Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.", "text_with_entity_marker": "Deletion and overexpression studies demonstrate that SIR2, but not [E1]SIR1[/E1], SIR3 or [E2]SIR4[/E2], is required for this rDNA position effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SIR1", "entity_1_idx": [[67, 71]], "entity_1_idx_in_text_with_entity_marker": [71, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR4", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p0", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, [E1]myosin heavy chain[/E1], calmodulin, calponin, [E2]calcium vector protein[/E2], creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[124, 142]], "entity_1_idx_in_text_with_entity_marker": [128, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calcium vector protein", "entity_2_idx": [[166, 188]], "entity_2_idx_in_text_with_entity_marker": [179, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p1", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, [E1]calmodulin[/E1], calponin, [E2]calcium vector protein[/E2], creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calmodulin", "entity_1_idx": [[144, 154]], "entity_1_idx_in_text_with_entity_marker": [148, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calcium vector protein", "entity_2_idx": [[166, 188]], "entity_2_idx_in_text_with_entity_marker": [179, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p2", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, [E1]myosin regulatory light chain[/E1], myosin light chain kinase, myosin heavy chain, calmodulin, calponin, [E2]calcium vector protein[/E2], creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin regulatory light chain", "entity_1_idx": [[66, 95]], "entity_1_idx_in_text_with_entity_marker": [70, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calcium vector protein", "entity_2_idx": [[166, 188]], "entity_2_idx_in_text_with_entity_marker": [179, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p3", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, [E1]myosin light chain kinase[/E1], myosin heavy chain, calmodulin, calponin, [E2]calcium vector protein[/E2], creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain kinase", "entity_1_idx": [[97, 122]], "entity_1_idx_in_text_with_entity_marker": [101, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calcium vector protein", "entity_2_idx": [[166, 188]], "entity_2_idx_in_text_with_entity_marker": [179, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p4", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, [E1]tropomyosin[/E1], troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, [E2]calcium vector protein[/E2], creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[41, 52]], "entity_1_idx_in_text_with_entity_marker": [45, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calcium vector protein", "entity_2_idx": [[166, 188]], "entity_2_idx_in_text_with_entity_marker": [179, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p5", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, [E1]troponin I[/E1], myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, [E2]calcium vector protein[/E2], creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "troponin I", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calcium vector protein", "entity_2_idx": [[166, 188]], "entity_2_idx_in_text_with_entity_marker": [179, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p6", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included [E1]actin[/E1], tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, [E2]calcium vector protein[/E2], creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calcium vector protein", "entity_2_idx": [[166, 188]], "entity_2_idx_in_text_with_entity_marker": [179, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p7", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, [E1]calcium vector protein[/E1], creatine kinase, [E2]muscle LIM[/E2] protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calcium vector protein", "entity_1_idx": [[166, 188]], "entity_1_idx_in_text_with_entity_marker": [170, 192], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle LIM", "entity_2_idx": [[207, 217]], "entity_2_idx_in_text_with_entity_marker": [220, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p8", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, [E1]calponin[/E1], [E2]calcium vector protein[/E2], creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calponin", "entity_1_idx": [[156, 164]], "entity_1_idx_in_text_with_entity_marker": [160, 168], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calcium vector protein", "entity_2_idx": [[166, 188]], "entity_2_idx_in_text_with_entity_marker": [179, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p9", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, [E1]calcium vector protein[/E1], creatine kinase, muscle LIM protein, and [E2]SH3-binding glutamate-rich protein[/E2], suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calcium vector protein", "entity_1_idx": [[166, 188]], "entity_1_idx_in_text_with_entity_marker": [170, 192], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SH3-binding glutamate-rich protein", "entity_2_idx": [[231, 265]], "entity_2_idx_in_text_with_entity_marker": [244, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p20", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E2]RAD24[/E2], BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p21", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E2]RAD24[/E2], BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p22", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 [E1]MEC3[/E1], RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E2]RAD24[/E2], BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC3", "entity_1_idx": [[62, 66]], "entity_1_idx_in_text_with_entity_marker": [66, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p23", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E1]RAD24[/E1], [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD24", "entity_1_idx": [[189, 194]], "entity_1_idx_in_text_with_entity_marker": [193, 198], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p24", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E1]RAD24[/E1], BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD24", "entity_1_idx": [[189, 194]], "entity_1_idx_in_text_with_entity_marker": [193, 198], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p25", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and [E1]DUN1[/E1] increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DUN1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p26", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, [E1]CHK1[/E1], PDS1, and [E2]DUN1[/E2] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CHK1", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DUN1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p27", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, [E1]PDS1[/E1], and [E2]DUN1[/E2] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDS1", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DUN1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p28", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and [E1]DUN1[/E1] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DUN1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p29", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, [E1]RAD53[/E1], CHK1, PDS1, and [E2]DUN1[/E2] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD53", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DUN1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p0", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for [E1]pan-cadherin[/E1], E-cadherin, [E2]alpha-catenin[/E2], beta-catenin, and p120 was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "pan-cadherin", "entity_1_idx": [[21, 33]], "entity_1_idx_in_text_with_entity_marker": [25, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[47, 60]], "entity_2_idx_in_text_with_entity_marker": [60, 73], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p1", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for pan-cadherin, E-cadherin, [E1]alpha-catenin[/E1], beta-catenin, and [E2]p120[/E2] was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[47, 60]], "entity_1_idx_in_text_with_entity_marker": [51, 64], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p2", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for pan-cadherin, [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin, and p120 was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[35, 45]], "entity_1_idx_in_text_with_entity_marker": [39, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[47, 60]], "entity_2_idx_in_text_with_entity_marker": [60, 73], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p3", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for pan-cadherin, E-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and p120 was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[47, 60]], "entity_1_idx_in_text_with_entity_marker": [51, 64], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[62, 74]], "entity_2_idx_in_text_with_entity_marker": [75, 87], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p4", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for [E1]pan-cadherin[/E1], E-cadherin, alpha-catenin, beta-catenin, and [E2]p120[/E2] was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "pan-cadherin", "entity_1_idx": [[21, 33]], "entity_1_idx_in_text_with_entity_marker": [25, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p5", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for [E1]pan-cadherin[/E1], [E2]E-cadherin[/E2], alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "pan-cadherin", "entity_1_idx": [[21, 33]], "entity_1_idx_in_text_with_entity_marker": [25, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[35, 45]], "entity_2_idx_in_text_with_entity_marker": [48, 58], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p6", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for [E1]pan-cadherin[/E1], E-cadherin, alpha-catenin, [E2]beta-catenin[/E2], and p120 was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "pan-cadherin", "entity_1_idx": [[21, 33]], "entity_1_idx_in_text_with_entity_marker": [25, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[62, 74]], "entity_2_idx_in_text_with_entity_marker": [75, 87], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p7", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for pan-cadherin, [E1]E-cadherin[/E1], alpha-catenin, beta-catenin, and [E2]p120[/E2] was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[35, 45]], "entity_1_idx_in_text_with_entity_marker": [39, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p8", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, [E1]beta-catenin[/E1], and [E2]p120[/E2] was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[62, 74]], "entity_1_idx_in_text_with_entity_marker": [66, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p9", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for pan-cadherin, [E1]E-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2], and p120 was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[35, 45]], "entity_1_idx_in_text_with_entity_marker": [39, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[62, 74]], "entity_2_idx_in_text_with_entity_marker": [75, 87], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d191.s0_BioInfer.d191.s0.p0", "text": "Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, myogenin, desmin, and muscle-specific actin over a 240 h period in culture.", "text_with_entity_marker": "Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, [E1]myogenin[/E1], desmin, and [E2]muscle-specific actin[/E2] over a 240 h period in culture.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myogenin", "entity_1_idx": [[122, 130]], "entity_1_idx_in_text_with_entity_marker": [126, 134], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle-specific actin", "entity_2_idx": [[144, 165]], "entity_2_idx_in_text_with_entity_marker": [157, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d191.s0_BioInfer.d191.s0.p1", "text": "Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, myogenin, desmin, and muscle-specific actin over a 240 h period in culture.", "text_with_entity_marker": "Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, myogenin, [E1]desmin[/E1], and [E2]muscle-specific actin[/E2] over a 240 h period in culture.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[132, 138]], "entity_1_idx_in_text_with_entity_marker": [136, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle-specific actin", "entity_2_idx": [[144, 165]], "entity_2_idx_in_text_with_entity_marker": [157, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d191.s0_BioInfer.d191.s0.p2", "text": "Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, myogenin, desmin, and muscle-specific actin over a 240 h period in culture.", "text_with_entity_marker": "Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of [E1]myosin heavy chain[/E1], myogenin, desmin, and [E2]muscle-specific actin[/E2] over a 240 h period in culture.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[102, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 124], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle-specific actin", "entity_2_idx": [[144, 165]], "entity_2_idx_in_text_with_entity_marker": [157, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d191.s0_BioInfer.d191.s0.p3", "text": "Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, myogenin, desmin, and muscle-specific actin over a 240 h period in culture.", "text_with_entity_marker": "Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, [E1]myogenin[/E1], [E2]desmin[/E2], and muscle-specific actin over a 240 h period in culture.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myogenin", "entity_1_idx": [[122, 130]], "entity_1_idx_in_text_with_entity_marker": [126, 134], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[132, 138]], "entity_2_idx_in_text_with_entity_marker": [145, 151], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d191.s0_BioInfer.d191.s0.p4", "text": "Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, myogenin, desmin, and muscle-specific actin over a 240 h period in culture.", "text_with_entity_marker": "Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of [E1]myosin heavy chain[/E1], [E2]myogenin[/E2], desmin, and muscle-specific actin over a 240 h period in culture.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[102, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 124], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myogenin", "entity_2_idx": [[122, 130]], "entity_2_idx_in_text_with_entity_marker": [135, 143], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d191.s0_BioInfer.d191.s0.p5", "text": "Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, myogenin, desmin, and muscle-specific actin over a 240 h period in culture.", "text_with_entity_marker": "Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of [E1]myosin heavy chain[/E1], myogenin, [E2]desmin[/E2], and muscle-specific actin over a 240 h period in culture.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[102, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 124], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[132, 138]], "entity_2_idx_in_text_with_entity_marker": [145, 151], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d374.s0_BioInfer.d374.s0.p0", "text": "In this case, efficient repair does not require RAD1 and MSH2, consistent with our previous observations.", "text_with_entity_marker": "In this case, efficient repair does not require [E1]RAD1[/E1] and [E2]MSH2[/E2], consistent with our previous observations.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD1", "entity_1_idx": [[48, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[57, 61]], "entity_2_idx_in_text_with_entity_marker": [70, 74], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p0", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/[E1]MORT-1[/E1], RIP) and [E2]TRAF[/E2] domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MORT-1", "entity_1_idx": [[73, 79]], "entity_1_idx_in_text_with_entity_marker": [77, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAF", "entity_2_idx": [[90, 94]], "entity_2_idx_in_text_with_entity_marker": [103, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p1", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, [E1]FADD[/E1]/MORT-1, RIP) and [E2]TRAF[/E2] domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FADD", "entity_1_idx": [[68, 72]], "entity_1_idx_in_text_with_entity_marker": [72, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAF", "entity_2_idx": [[90, 94]], "entity_2_idx_in_text_with_entity_marker": [103, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p2", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and [E1]TRAF[/E1] domain-containing proteins (TRAF-1, [E2]TRAF-2[/E2], TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRAF", "entity_1_idx": [[90, 94]], "entity_1_idx_in_text_with_entity_marker": [94, 98], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF-2", "entity_2_idx": [[131, 137]], "entity_2_idx_in_text_with_entity_marker": [144, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p3", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and [E1]TRAF[/E1] domain-containing proteins ([E2]TRAF-1[/E2], TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRAF", "entity_1_idx": [[90, 94]], "entity_1_idx_in_text_with_entity_marker": [94, 98], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF-1", "entity_2_idx": [[123, 129]], "entity_2_idx_in_text_with_entity_marker": [136, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p4", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and [E1]TRAF[/E1] domain-containing proteins (TRAF-1, TRAF-2, [E2]TRAF-3[/E2]) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRAF", "entity_1_idx": [[90, 94]], "entity_1_idx_in_text_with_entity_marker": [94, 98], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF-3", "entity_2_idx": [[139, 145]], "entity_2_idx_in_text_with_entity_marker": [152, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p5", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain ([E1]TNF-RI[/E1], Fas, TRADD, FADD/MORT-1, RIP) and [E2]TRAF[/E2] domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-RI", "entity_1_idx": [[48, 54]], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF", "entity_2_idx": [[90, 94]], "entity_2_idx_in_text_with_entity_marker": [103, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p6", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, [E1]TRADD[/E1], FADD/MORT-1, RIP) and [E2]TRAF[/E2] domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRADD", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF", "entity_2_idx": [[90, 94]], "entity_2_idx_in_text_with_entity_marker": [103, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p7", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, [E1]Fas[/E1], TRADD, FADD/MORT-1, RIP) and [E2]TRAF[/E2] domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[56, 59]], "entity_1_idx_in_text_with_entity_marker": [60, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF", "entity_2_idx": [[90, 94]], "entity_2_idx_in_text_with_entity_marker": [103, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p8", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, [E1]RIP[/E1]) and [E2]TRAF[/E2] domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RIP", "entity_1_idx": [[81, 84]], "entity_1_idx_in_text_with_entity_marker": [85, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF", "entity_2_idx": [[90, 94]], "entity_2_idx_in_text_with_entity_marker": [103, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p9", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, [E1]FADD[/E1]/[E2]MORT-1[/E2], RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FADD", "entity_1_idx": [[68, 72]], "entity_1_idx_in_text_with_entity_marker": [72, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MORT-1", "entity_2_idx": [[73, 79]], "entity_2_idx_in_text_with_entity_marker": [86, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d5.s2_BioInfer.d5.s2.p0", "text": "Since the NH2 terminus of profilin is blocked, Edman degradation gave only the sequence of the conjugated actin CNBr fragment beginning with Trp-356.", "text_with_entity_marker": "Since the NH2 terminus of [E1]profilin[/E1] is blocked, Edman degradation gave only the sequence of the conjugated [E2]actin[/E2] CNBr fragment beginning with Trp-356.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[106, 111]], "entity_2_idx_in_text_with_entity_marker": [119, 124], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d286.s0_BioInfer.d286.s0.p0", "text": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, beta-catenin, and gamma-catenin (plakoglobin) in these cell lines.", "text_with_entity_marker": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, [E1]beta-catenin[/E1], and gamma-catenin ([E2]plakoglobin[/E2]) in these cell lines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[83, 95]], "entity_1_idx_in_text_with_entity_marker": [87, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[116, 127]], "entity_2_idx_in_text_with_entity_marker": [129, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d286.s0_BioInfer.d286.s0.p1", "text": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, beta-catenin, and gamma-catenin (plakoglobin) in these cell lines.", "text_with_entity_marker": "Immunoblot and Northern blot analyses also revealed the presence of [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and gamma-catenin (plakoglobin) in these cell lines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[68, 81]], "entity_1_idx_in_text_with_entity_marker": [72, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[83, 95]], "entity_2_idx_in_text_with_entity_marker": [96, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d286.s0_BioInfer.d286.s0.p2", "text": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, beta-catenin, and gamma-catenin (plakoglobin) in these cell lines.", "text_with_entity_marker": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, [E1]beta-catenin[/E1], and [E2]gamma-catenin[/E2] (plakoglobin) in these cell lines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[83, 95]], "entity_1_idx_in_text_with_entity_marker": [87, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[101, 114]], "entity_2_idx_in_text_with_entity_marker": [114, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d286.s0_BioInfer.d286.s0.p3", "text": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, beta-catenin, and gamma-catenin (plakoglobin) in these cell lines.", "text_with_entity_marker": "Immunoblot and Northern blot analyses also revealed the presence of [E1]alpha-catenin[/E1], beta-catenin, and gamma-catenin ([E2]plakoglobin[/E2]) in these cell lines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[68, 81]], "entity_1_idx_in_text_with_entity_marker": [72, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[116, 127]], "entity_2_idx_in_text_with_entity_marker": [129, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d286.s0_BioInfer.d286.s0.p4", "text": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, beta-catenin, and gamma-catenin (plakoglobin) in these cell lines.", "text_with_entity_marker": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, beta-catenin, and [E1]gamma-catenin[/E1] ([E2]plakoglobin[/E2]) in these cell lines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gamma-catenin", "entity_1_idx": [[101, 114]], "entity_1_idx_in_text_with_entity_marker": [105, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[116, 127]], "entity_2_idx_in_text_with_entity_marker": [129, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d286.s0_BioInfer.d286.s0.p5", "text": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, beta-catenin, and gamma-catenin (plakoglobin) in these cell lines.", "text_with_entity_marker": "Immunoblot and Northern blot analyses also revealed the presence of [E1]alpha-catenin[/E1], beta-catenin, and [E2]gamma-catenin[/E2] (plakoglobin) in these cell lines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[68, 81]], "entity_1_idx_in_text_with_entity_marker": [72, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[101, 114]], "entity_2_idx_in_text_with_entity_marker": [114, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d689.s0_BioInfer.d689.s0.p0", "text": "The Saccharomyces cerevisiae RAD51 and RAD54 genes are both required for the occurrence of homologous recombination and for the repair of double-stranded DNA breaks.", "text_with_entity_marker": "The Saccharomyces cerevisiae [E1]RAD51[/E1] and [E2]RAD54[/E2] genes are both required for the occurrence of homologous recombination and for the repair of double-stranded DNA breaks.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[29, 34]], "entity_1_idx_in_text_with_entity_marker": [33, 38], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[39, 44]], "entity_2_idx_in_text_with_entity_marker": [52, 57], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d486.s0_BioInfer.d486.s0.p0", "text": "Phosphoinositides bind to profilin and regulate actin-based cytoskeletal protein assembly.", "text_with_entity_marker": "Phosphoinositides bind to [E1]profilin[/E1] and regulate [E2]actin[/E2]-based cytoskeletal protein assembly.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[48, 53]], "entity_2_idx_in_text_with_entity_marker": [61, 66], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d530.s0_BioInfer.d530.s0.p0", "text": "Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (P) of phocid distemper virus, and editing of the P gene transcript.", "text_with_entity_marker": "Sequence analysis of the genes encoding the [E1]nucleocapsid protein[/E1] and phosphoprotein (P) of phocid distemper virus, and editing of the [E2]P[/E2] gene transcript.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P", "entity_2_idx": [[134, 135]], "entity_2_idx_in_text_with_entity_marker": [147, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d530.s0_BioInfer.d530.s0.p1", "text": "Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (P) of phocid distemper virus, and editing of the P gene transcript.", "text_with_entity_marker": "Sequence analysis of the genes encoding the [E1]nucleocapsid protein[/E1] and [E2]phosphoprotein[/E2] (P) of phocid distemper virus, and editing of the P gene transcript.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "phosphoprotein", "entity_2_idx": [[69, 83]], "entity_2_idx_in_text_with_entity_marker": [82, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d530.s0_BioInfer.d530.s0.p2", "text": "Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (P) of phocid distemper virus, and editing of the P gene transcript.", "text_with_entity_marker": "Sequence analysis of the genes encoding the [E1]nucleocapsid protein[/E1] and phosphoprotein ([E2]P[/E2]) of phocid distemper virus, and editing of the P gene transcript.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P", "entity_2_idx": [[85, 86]], "entity_2_idx_in_text_with_entity_marker": [98, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d530.s0_BioInfer.d530.s0.p3", "text": "Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (P) of phocid distemper virus, and editing of the P gene transcript.", "text_with_entity_marker": "Sequence analysis of the genes encoding the nucleocapsid protein and [E1]phosphoprotein[/E1] (P) of phocid distemper virus, and editing of the [E2]P[/E2] gene transcript.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[69, 83]], "entity_1_idx_in_text_with_entity_marker": [73, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[134, 135]], "entity_2_idx_in_text_with_entity_marker": [147, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d530.s0_BioInfer.d530.s0.p4", "text": "Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (P) of phocid distemper virus, and editing of the P gene transcript.", "text_with_entity_marker": "Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein ([E1]P[/E1]) of phocid distemper virus, and editing of the [E2]P[/E2] gene transcript.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[85, 86]], "entity_1_idx_in_text_with_entity_marker": [89, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[134, 135]], "entity_2_idx_in_text_with_entity_marker": [147, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d530.s0_BioInfer.d530.s0.p5", "text": "Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (P) of phocid distemper virus, and editing of the P gene transcript.", "text_with_entity_marker": "Sequence analysis of the genes encoding the nucleocapsid protein and [E1]phosphoprotein[/E1] ([E2]P[/E2]) of phocid distemper virus, and editing of the P gene transcript.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[69, 83]], "entity_1_idx_in_text_with_entity_marker": [73, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[85, 86]], "entity_2_idx_in_text_with_entity_marker": [98, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p50", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] (MHC), [E2]myosin light chain[/E2] (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin light chain", "entity_2_idx": [[102, 120]], "entity_2_idx_in_text_with_entity_marker": [115, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p51", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), [E2]desmin[/E2] and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p52", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), [E1]myosin light chain[/E1] (MLC), [E2]troponin I[/E2] (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain", "entity_1_idx": [[102, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "troponin I", "entity_2_idx": [[128, 138]], "entity_2_idx_in_text_with_entity_marker": [141, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p53", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), [E1]troponin I[/E1] (TnI) isoforms, connexin 43 (Cx43), [E2]desmin[/E2] and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "troponin I", "entity_1_idx": [[128, 138]], "entity_1_idx_in_text_with_entity_marker": [132, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p54", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), [E1]myosin light chain[/E1] (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), [E2]desmin[/E2] and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain", "entity_1_idx": [[102, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d186.s0_BioInfer.d186.s0.p0", "text": "Effects of mutations of RAD50, RAD51, RAD52, and related genes on illegitimate recombination in Saccharomyces cerevisiae.", "text_with_entity_marker": "Effects of mutations of [E1]RAD50[/E1], RAD51, [E2]RAD52[/E2], and related genes on illegitimate recombination in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD50", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[38, 43]], "entity_2_idx_in_text_with_entity_marker": [51, 56], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d186.s0_BioInfer.d186.s0.p1", "text": "Effects of mutations of RAD50, RAD51, RAD52, and related genes on illegitimate recombination in Saccharomyces cerevisiae.", "text_with_entity_marker": "Effects of mutations of [E1]RAD50[/E1], [E2]RAD51[/E2], RAD52, and related genes on illegitimate recombination in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD50", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[31, 36]], "entity_2_idx_in_text_with_entity_marker": [44, 49], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d186.s0_BioInfer.d186.s0.p2", "text": "Effects of mutations of RAD50, RAD51, RAD52, and related genes on illegitimate recombination in Saccharomyces cerevisiae.", "text_with_entity_marker": "Effects of mutations of RAD50, [E1]RAD51[/E1], [E2]RAD52[/E2], and related genes on illegitimate recombination in Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[38, 43]], "entity_2_idx_in_text_with_entity_marker": [51, 56], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d835.s0_BioInfer.d835.s0.p0", "text": "YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.", "text_with_entity_marker": "YACs containing [E1]color vision red pigment[/E1] gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or [E2]RAD52[/E2] loci.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "color vision red pigment", "entity_1_idx": [[16, 40]], "entity_1_idx_in_text_with_entity_marker": [20, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[155, 160]], "entity_2_idx_in_text_with_entity_marker": [168, 173], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d835.s0_BioInfer.d835.s0.p1", "text": "YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.", "text_with_entity_marker": "YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, [E1]RAD6[/E1], RAD51, or [E2]RAD52[/E2] loci.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD6", "entity_1_idx": [[139, 143]], "entity_1_idx_in_text_with_entity_marker": [143, 147], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[155, 160]], "entity_2_idx_in_text_with_entity_marker": [168, 173], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d835.s0_BioInfer.d835.s0.p2", "text": "YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.", "text_with_entity_marker": "YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, [E1]RAD51[/E1], or [E2]RAD52[/E2] loci.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[145, 150]], "entity_1_idx_in_text_with_entity_marker": [149, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[155, 160]], "entity_2_idx_in_text_with_entity_marker": [168, 173], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d835.s0_BioInfer.d835.s0.p3", "text": "YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.", "text_with_entity_marker": "YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the [E1]RAD1[/E1], RAD6, RAD51, or [E2]RAD52[/E2] loci.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD1", "entity_1_idx": [[133, 137]], "entity_1_idx_in_text_with_entity_marker": [137, 141], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[155, 160]], "entity_2_idx_in_text_with_entity_marker": [168, 173], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d835.s0_BioInfer.d835.s0.p4", "text": "YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.", "text_with_entity_marker": "YACs containing [E1]color vision red pigment[/E1] gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, [E2]RAD6[/E2], RAD51, or RAD52 loci.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "color vision red pigment", "entity_1_idx": [[16, 40]], "entity_1_idx_in_text_with_entity_marker": [20, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD6", "entity_2_idx": [[139, 143]], "entity_2_idx_in_text_with_entity_marker": [152, 156], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d835.s0_BioInfer.d835.s0.p5", "text": "YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.", "text_with_entity_marker": "YACs containing [E1]color vision red pigment[/E1] gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, [E2]RAD51[/E2], or RAD52 loci.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "color vision red pigment", "entity_1_idx": [[16, 40]], "entity_1_idx_in_text_with_entity_marker": [20, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[145, 150]], "entity_2_idx_in_text_with_entity_marker": [158, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d835.s0_BioInfer.d835.s0.p6", "text": "YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.", "text_with_entity_marker": "YACs containing [E1]color vision red pigment[/E1] gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the [E2]RAD1[/E2], RAD6, RAD51, or RAD52 loci.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "color vision red pigment", "entity_1_idx": [[16, 40]], "entity_1_idx_in_text_with_entity_marker": [20, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD1", "entity_2_idx": [[133, 137]], "entity_2_idx_in_text_with_entity_marker": [146, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d835.s0_BioInfer.d835.s0.p7", "text": "YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.", "text_with_entity_marker": "YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, [E1]RAD6[/E1], [E2]RAD51[/E2], or RAD52 loci.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD6", "entity_1_idx": [[139, 143]], "entity_1_idx_in_text_with_entity_marker": [143, 147], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[145, 150]], "entity_2_idx_in_text_with_entity_marker": [158, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d835.s0_BioInfer.d835.s0.p8", "text": "YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.", "text_with_entity_marker": "YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the [E1]RAD1[/E1], [E2]RAD6[/E2], RAD51, or RAD52 loci.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD1", "entity_1_idx": [[133, 137]], "entity_1_idx_in_text_with_entity_marker": [137, 141], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD6", "entity_2_idx": [[139, 143]], "entity_2_idx_in_text_with_entity_marker": [152, 156], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d835.s0_BioInfer.d835.s0.p9", "text": "YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.", "text_with_entity_marker": "YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the [E1]RAD1[/E1], RAD6, [E2]RAD51[/E2], or RAD52 loci.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD1", "entity_1_idx": [[133, 137]], "entity_1_idx_in_text_with_entity_marker": [137, 141], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[145, 150]], "entity_2_idx_in_text_with_entity_marker": [158, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d759.s0_BioInfer.d759.s0.p0", "text": "To approach the problem, we have constructed a carp genomic library and isolated 28 nonoverlapping clones containing sequences of different myosin heavy chain (MHC) isoforms along with a clone containing carp actin sequences.", "text_with_entity_marker": "To approach the problem, we have constructed a carp genomic library and isolated 28 nonoverlapping clones containing sequences of different myosin heavy chain ([E1]MHC[/E1]) isoforms along with a clone containing carp [E2]actin[/E2] sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MHC", "entity_1_idx": [[160, 163]], "entity_1_idx_in_text_with_entity_marker": [164, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[209, 214]], "entity_2_idx_in_text_with_entity_marker": [222, 227], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d759.s0_BioInfer.d759.s0.p1", "text": "To approach the problem, we have constructed a carp genomic library and isolated 28 nonoverlapping clones containing sequences of different myosin heavy chain (MHC) isoforms along with a clone containing carp actin sequences.", "text_with_entity_marker": "To approach the problem, we have constructed a carp genomic library and isolated 28 nonoverlapping clones containing sequences of different [E1]myosin heavy chain[/E1] (MHC) isoforms along with a clone containing carp [E2]actin[/E2] sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[140, 158]], "entity_1_idx_in_text_with_entity_marker": [144, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[209, 214]], "entity_2_idx_in_text_with_entity_marker": [222, 227], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d759.s0_BioInfer.d759.s0.p2", "text": "To approach the problem, we have constructed a carp genomic library and isolated 28 nonoverlapping clones containing sequences of different myosin heavy chain (MHC) isoforms along with a clone containing carp actin sequences.", "text_with_entity_marker": "To approach the problem, we have constructed a carp genomic library and isolated 28 nonoverlapping clones containing sequences of different [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]) isoforms along with a clone containing carp actin sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[140, 158]], "entity_1_idx_in_text_with_entity_marker": [144, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[160, 163]], "entity_2_idx_in_text_with_entity_marker": [173, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p20", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p21", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion ([E2]F[/E2]), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[65, 66]], "entity_2_idx_in_text_with_entity_marker": [78, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p22", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein (NP), phosphoprotein ([E2]P[/E2]) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[112, 113]], "entity_2_idx_in_text_with_entity_marker": [125, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p23", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein ([E2]NP[/E2]), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[91, 93]], "entity_2_idx_in_text_with_entity_marker": [104, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p24", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein (NP), phosphoprotein (P) and matrix ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p25", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein (NP), phosphoprotein (P) and [E2]matrix[/E2] (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[119, 125], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p26", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), [E2]fusion[/E2] (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion", "entity_2_idx": [[57, 63], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [70, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p27", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), [E2]nucleocapsid protein[/E2] (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[69, 89], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [82, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p28", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p29", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p20", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 [E1]rad54[/E1] and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rad54", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p21", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions [E1]RAD9[/E1], RAD17, [E2]RAD24[/E2], and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[150, 154]], "entity_1_idx_in_text_with_entity_marker": [154, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p22", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E1]RAD24[/E1], and [E2]MEC3[/E2], indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD24", "entity_1_idx": [[163, 168]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p23", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, [E1]RAD17[/E1], [E2]RAD24[/E2], and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD17", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p24", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E2]RAD24[/E2], and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p25", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta [E1]rad54Delta[/E1] and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E2]RAD24[/E2], and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rad54Delta", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p26", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and [E1]srs2Delta[/E1] rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E2]RAD24[/E2], and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p27", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta [E1]rdh54Delta[/E1] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E2]RAD24[/E2], and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rdh54Delta", "entity_1_idx": [[52, 62]], "entity_1_idx_in_text_with_entity_marker": [56, 66], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p28", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E1]RAD24[/E1], and MEC3, indicating that the srs2 rad54 and [E2]srs2[/E2] rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD24", "entity_1_idx": [[163, 168]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[215, 219]], "entity_2_idx_in_text_with_entity_marker": [228, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p29", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E1]RAD24[/E1], and MEC3, indicating that the srs2 rad54 and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD24", "entity_1_idx": [[163, 168]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p60", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and [E1]srs2Delta[/E1] [E2]rdh54Delta[/E2] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54Delta", "entity_2_idx": [[52, 62]], "entity_2_idx_in_text_with_entity_marker": [65, 75], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p61", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and [E1]srs2Delta[/E1] rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and [E2]srs2[/E2] rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[215, 219]], "entity_2_idx_in_text_with_entity_marker": [228, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p62", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and [E1]srs2Delta[/E1] rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p63", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta [E1]rdh54Delta[/E1] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and [E2]srs2[/E2] rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rdh54Delta", "entity_1_idx": [[52, 62]], "entity_1_idx_in_text_with_entity_marker": [56, 66], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[215, 219]], "entity_2_idx_in_text_with_entity_marker": [228, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p64", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta [E1]rdh54Delta[/E1] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rdh54Delta", "entity_1_idx": [[52, 62]], "entity_1_idx_in_text_with_entity_marker": [56, 66], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p65", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and [E1]srs2[/E1] [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2", "entity_1_idx": [[215, 219]], "entity_1_idx_in_text_with_entity_marker": [219, 223], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d409.s0_BioInfer.d409.s0.p0", "text": "Location of profilin at presynaptic sites in the cerebellar cortex; implication for the regulation of the actin-polymerization state during axonal elongation and synaptogenesis.", "text_with_entity_marker": "Location of [E1]profilin[/E1] at presynaptic sites in the cerebellar cortex; implication for the regulation of the [E2]actin[/E2]-polymerization state during axonal elongation and synaptogenesis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[106, 111]], "entity_2_idx_in_text_with_entity_marker": [119, 124], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d326.s0_BioInfer.d326.s0.p0", "text": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, alpha-catenin, and beta-catenin while plakoglobin was absent from these sites.", "text_with_entity_marker": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, [E1]alpha-catenin[/E1], and beta-catenin while [E2]plakoglobin[/E2] was absent from these sites.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[96, 109]], "entity_1_idx_in_text_with_entity_marker": [100, 113], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[134, 145]], "entity_2_idx_in_text_with_entity_marker": [147, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d326.s0_BioInfer.d326.s0.p1", "text": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, alpha-catenin, and beta-catenin while plakoglobin was absent from these sites.", "text_with_entity_marker": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, alpha-catenin, and [E1]beta-catenin[/E1] while [E2]plakoglobin[/E2] was absent from these sites.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[115, 127]], "entity_1_idx_in_text_with_entity_marker": [119, 131], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[134, 145]], "entity_2_idx_in_text_with_entity_marker": [147, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d326.s0_BioInfer.d326.s0.p2", "text": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, alpha-catenin, and beta-catenin while plakoglobin was absent from these sites.", "text_with_entity_marker": "In contrast, EC located immediately behind the migrating front retained junctional [E1]VE-cadherin[/E1], alpha-catenin, and beta-catenin while [E2]plakoglobin[/E2] was absent from these sites.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "VE-cadherin", "entity_1_idx": [[83, 94]], "entity_1_idx_in_text_with_entity_marker": [87, 98], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[134, 145]], "entity_2_idx_in_text_with_entity_marker": [147, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d326.s0_BioInfer.d326.s0.p3", "text": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, alpha-catenin, and beta-catenin while plakoglobin was absent from these sites.", "text_with_entity_marker": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, [E1]alpha-catenin[/E1], and [E2]beta-catenin[/E2] while plakoglobin was absent from these sites.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[96, 109]], "entity_1_idx_in_text_with_entity_marker": [100, 113], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[115, 127]], "entity_2_idx_in_text_with_entity_marker": [128, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d326.s0_BioInfer.d326.s0.p4", "text": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, alpha-catenin, and beta-catenin while plakoglobin was absent from these sites.", "text_with_entity_marker": "In contrast, EC located immediately behind the migrating front retained junctional [E1]VE-cadherin[/E1], [E2]alpha-catenin[/E2], and beta-catenin while plakoglobin was absent from these sites.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "VE-cadherin", "entity_1_idx": [[83, 94]], "entity_1_idx_in_text_with_entity_marker": [87, 98], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[96, 109]], "entity_2_idx_in_text_with_entity_marker": [109, 122], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d326.s0_BioInfer.d326.s0.p5", "text": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, alpha-catenin, and beta-catenin while plakoglobin was absent from these sites.", "text_with_entity_marker": "In contrast, EC located immediately behind the migrating front retained junctional [E1]VE-cadherin[/E1], alpha-catenin, and [E2]beta-catenin[/E2] while plakoglobin was absent from these sites.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "VE-cadherin", "entity_1_idx": [[83, 94]], "entity_1_idx_in_text_with_entity_marker": [87, 98], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[115, 127]], "entity_2_idx_in_text_with_entity_marker": [128, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p40", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, [E1]TRADD[/E1], RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for [E2]FAF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRADD", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[333, 336]], "entity_2_idx_in_text_with_entity_marker": [346, 349], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p41", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, [E1]TRADD[/E1], RIP, and caspase-8, and an up to twofold increase for [E2]FADD[/E2] and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRADD", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[287, 291]], "entity_2_idx_in_text_with_entity_marker": [300, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p42", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, [E1]Fas ligand[/E1], TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for [E2]FAF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas ligand", "entity_1_idx": [[199, 209]], "entity_1_idx_in_text_with_entity_marker": [203, 213], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[333, 336]], "entity_2_idx_in_text_with_entity_marker": [346, 349], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p43", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, [E1]Fas ligand[/E1], TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for [E2]FADD[/E2] and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas ligand", "entity_1_idx": [[199, 209]], "entity_1_idx_in_text_with_entity_marker": [203, 213], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[287, 291]], "entity_2_idx_in_text_with_entity_marker": [300, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p44", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for [E1]FADD[/E1] and FAP, but there was little change for [E2]FAF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FADD", "entity_1_idx": [[287, 291]], "entity_1_idx_in_text_with_entity_marker": [291, 295], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[333, 336]], "entity_2_idx_in_text_with_entity_marker": [346, 349], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p0", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, [E1]ribonuclease[/E1] protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, [E2]TRAIL[/E2], FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ribonuclease", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAIL", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p1", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, [E1]TRAIL[/E1], FADD, TRADD, RIP, [E2]FAF[/E2], FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRAIL", "entity_1_idx": [[160, 165]], "entity_1_idx_in_text_with_entity_marker": [164, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p2", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, [E1]TRAIL[/E1], FADD, TRADD, RIP, FAF, [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRAIL", "entity_1_idx": [[160, 165]], "entity_1_idx_in_text_with_entity_marker": [164, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p3", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, [E1]TRAIL[/E1], FADD, [E2]TRADD[/E2], RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRAIL", "entity_1_idx": [[160, 165]], "entity_1_idx_in_text_with_entity_marker": [164, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRADD", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p4", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, [E1]TRAIL[/E1], FADD, TRADD, [E2]RIP[/E2], FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRAIL", "entity_1_idx": [[160, 165]], "entity_1_idx_in_text_with_entity_marker": [164, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[180, 183]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p60", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not [E1]fibronectin[/E1] (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or [E2]paxillin[/E2]-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fibronectin", "entity_1_idx": [[202, 213]], "entity_1_idx_in_text_with_entity_marker": [206, 217], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "paxillin", "entity_2_idx": [[465, 473]], "entity_2_idx_in_text_with_entity_marker": [478, 486], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p61", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to [E1]laminin[/E1], but not [E2]fibronectin[/E2] (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "laminin", "entity_1_idx": [[185, 192]], "entity_1_idx_in_text_with_entity_marker": [189, 196], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fibronectin", "entity_2_idx": [[202, 213]], "entity_2_idx_in_text_with_entity_marker": [215, 226], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p62", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not [E1]fibronectin[/E1] (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a [E2]vinculin[/E2] (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fibronectin", "entity_1_idx": [[202, 213]], "entity_1_idx_in_text_with_entity_marker": [206, 217], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p63", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on [E1]gelatin[/E1] or laminin and grew as rounded colonies, although they were able to spread on [E2]fibronectin[/E2] (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gelatin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fibronectin", "entity_2_idx": [[142, 153]], "entity_2_idx_in_text_with_entity_marker": [155, 166], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p64", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on [E1]gelatin[/E1] or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of [E2]beta1 integrin[/E2], although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gelatin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta1 integrin", "entity_2_idx": [[251, 265]], "entity_2_idx_in_text_with_entity_marker": [264, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p65", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on [E1]gelatin[/E1] or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or [E2]paxillin[/E2]-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gelatin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "paxillin", "entity_2_idx": [[465, 473]], "entity_2_idx_in_text_with_entity_marker": [478, 486], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p66", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on [E1]gelatin[/E1] or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to [E2]laminin[/E2], but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gelatin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[185, 192]], "entity_2_idx_in_text_with_entity_marker": [198, 205], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p67", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on [E1]gelatin[/E1] or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a [E2]vinculin[/E2] (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gelatin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p68", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on [E1]fibronectin[/E1] (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of [E2]beta1 integrin[/E2], although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fibronectin", "entity_1_idx": [[142, 153]], "entity_1_idx_in_text_with_entity_marker": [146, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta1 integrin", "entity_2_idx": [[251, 265]], "entity_2_idx_in_text_with_entity_marker": [264, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p69", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on [E1]fibronectin[/E1] (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or [E2]paxillin[/E2]-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fibronectin", "entity_1_idx": [[142, 153]], "entity_1_idx_in_text_with_entity_marker": [146, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "paxillin", "entity_2_idx": [[465, 473]], "entity_2_idx_in_text_with_entity_marker": [478, 486], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d368.s0_BioInfer.d368.s0.p0", "text": "In the hippocampus, ATP gamma S, an ATP analogue more resistant to catabolism than ATP, was virtually devoid of effect on tritium release, and the effect of ATP was prevented by the ecto-5'-nucleotidase inhibitor alpha,beta-methylene ADP (100 microM), by adenosine deaminase (2 U/ml) and by the A1 adenosine receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 20 nM).", "text_with_entity_marker": "In the hippocampus, ATP gamma S, an ATP analogue more resistant to catabolism than ATP, was virtually devoid of effect on tritium release, and the effect of ATP was prevented by the [E1]ecto-5'-nucleotidase[/E1] inhibitor alpha,beta-methylene ADP (100 microM), by [E2]adenosine deaminase[/E2] (2 U/ml) and by the A1 adenosine receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 20 nM).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ecto-5'-nucleotidase", "entity_1_idx": [[182, 202]], "entity_1_idx_in_text_with_entity_marker": [186, 206], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "adenosine deaminase", "entity_2_idx": [[255, 274]], "entity_2_idx_in_text_with_entity_marker": [268, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d368.s0_BioInfer.d368.s0.p1", "text": "In the hippocampus, ATP gamma S, an ATP analogue more resistant to catabolism than ATP, was virtually devoid of effect on tritium release, and the effect of ATP was prevented by the ecto-5'-nucleotidase inhibitor alpha,beta-methylene ADP (100 microM), by adenosine deaminase (2 U/ml) and by the A1 adenosine receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 20 nM).", "text_with_entity_marker": "In the hippocampus, ATP gamma S, an ATP analogue more resistant to catabolism than ATP, was virtually devoid of effect on tritium release, and the effect of ATP was prevented by the ecto-5'-nucleotidase inhibitor alpha,beta-methylene ADP (100 microM), by [E1]adenosine deaminase[/E1] (2 U/ml) and by the [E2]A1 adenosine receptor[/E2] antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 20 nM).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "adenosine deaminase", "entity_1_idx": [[255, 274]], "entity_1_idx_in_text_with_entity_marker": [259, 278], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "A1 adenosine receptor", "entity_2_idx": [[295, 316]], "entity_2_idx_in_text_with_entity_marker": [308, 329], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d368.s0_BioInfer.d368.s0.p2", "text": "In the hippocampus, ATP gamma S, an ATP analogue more resistant to catabolism than ATP, was virtually devoid of effect on tritium release, and the effect of ATP was prevented by the ecto-5'-nucleotidase inhibitor alpha,beta-methylene ADP (100 microM), by adenosine deaminase (2 U/ml) and by the A1 adenosine receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 20 nM).", "text_with_entity_marker": "In the hippocampus, ATP gamma S, an ATP analogue more resistant to catabolism than ATP, was virtually devoid of effect on tritium release, and the effect of ATP was prevented by the [E1]ecto-5'-nucleotidase[/E1] inhibitor alpha,beta-methylene ADP (100 microM), by adenosine deaminase (2 U/ml) and by the [E2]A1 adenosine receptor[/E2] antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 20 nM).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ecto-5'-nucleotidase", "entity_1_idx": [[182, 202]], "entity_1_idx_in_text_with_entity_marker": [186, 206], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "A1 adenosine receptor", "entity_2_idx": [[295, 316]], "entity_2_idx_in_text_with_entity_marker": [308, 329], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d544.s0_BioInfer.d544.s0.p0", "text": "Smooth muscle alpha actin and myosin heavy chain expression in the vascular smooth muscle cells surrounding human endometrial arterioles.", "text_with_entity_marker": "[E1-E2]Smooth muscle[/E1] alpha actin[/E2] and myosin heavy chain expression in the vascular smooth muscle cells surrounding human endometrial arterioles.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Smooth muscle", "entity_1_idx": [[0, 13], [30, 48]], "entity_1_idx_in_text_with_entity_marker": [7, 20], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Smooth muscle[/E1] alpha actin", "entity_2_idx": [[0, 25]], "entity_2_idx_in_text_with_entity_marker": [7, 37], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p0", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein ([E1]L[/E1]), phosphoprotein (P), and nucleocapsid protein ([E2]NP[/E2]), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[96, 97]], "entity_1_idx_in_text_with_entity_marker": [100, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[146, 148]], "entity_2_idx_in_text_with_entity_marker": [159, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p1", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein ([E1]L[/E1]), phosphoprotein (P), and [E2]nucleocapsid protein[/E2] (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[96, 97]], "entity_1_idx_in_text_with_entity_marker": [100, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[124, 144]], "entity_2_idx_in_text_with_entity_marker": [137, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p2", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the [E1]large protein[/E1] ([E2]L[/E2]), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large protein", "entity_1_idx": [[81, 94]], "entity_1_idx_in_text_with_entity_marker": [85, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[96, 97]], "entity_2_idx_in_text_with_entity_marker": [109, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p3", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein ([E1]L[/E1]), phosphoprotein ([E2]P[/E2]), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[96, 97]], "entity_1_idx_in_text_with_entity_marker": [100, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[116, 117]], "entity_2_idx_in_text_with_entity_marker": [129, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p4", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein ([E1]L[/E1]), [E2]phosphoprotein[/E2] (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[96, 97]], "entity_1_idx_in_text_with_entity_marker": [100, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[100, 114]], "entity_2_idx_in_text_with_entity_marker": [113, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p5", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and [E1]nucleocapsid protein[/E1] ([E2]NP[/E2]), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[124, 144]], "entity_1_idx_in_text_with_entity_marker": [128, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[146, 148]], "entity_2_idx_in_text_with_entity_marker": [159, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p6", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the [E1]large protein[/E1] (L), phosphoprotein (P), and nucleocapsid protein ([E2]NP[/E2]), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large protein", "entity_1_idx": [[81, 94]], "entity_1_idx_in_text_with_entity_marker": [85, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[146, 148]], "entity_2_idx_in_text_with_entity_marker": [159, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p7", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein ([E1]P[/E1]), and nucleocapsid protein ([E2]NP[/E2]), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[116, 117]], "entity_1_idx_in_text_with_entity_marker": [120, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[146, 148]], "entity_2_idx_in_text_with_entity_marker": [159, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p8", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), [E1]phosphoprotein[/E1] (P), and nucleocapsid protein ([E2]NP[/E2]), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[100, 114]], "entity_1_idx_in_text_with_entity_marker": [104, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[146, 148]], "entity_2_idx_in_text_with_entity_marker": [159, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p9", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the [E1]large protein[/E1] (L), phosphoprotein (P), and [E2]nucleocapsid protein[/E2] (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large protein", "entity_1_idx": [[81, 94]], "entity_1_idx_in_text_with_entity_marker": [85, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[124, 144]], "entity_2_idx_in_text_with_entity_marker": [137, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p10", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein ([E1]P[/E1]), and [E2]nucleocapsid protein[/E2] (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[116, 117]], "entity_1_idx_in_text_with_entity_marker": [120, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[124, 144]], "entity_2_idx_in_text_with_entity_marker": [137, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p11", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), [E1]phosphoprotein[/E1] (P), and [E2]nucleocapsid protein[/E2] (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[100, 114]], "entity_1_idx_in_text_with_entity_marker": [104, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[124, 144]], "entity_2_idx_in_text_with_entity_marker": [137, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p12", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the [E1]large protein[/E1] (L), phosphoprotein ([E2]P[/E2]), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large protein", "entity_1_idx": [[81, 94]], "entity_1_idx_in_text_with_entity_marker": [85, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[116, 117]], "entity_2_idx_in_text_with_entity_marker": [129, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p13", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the [E1]large protein[/E1] (L), [E2]phosphoprotein[/E2] (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large protein", "entity_1_idx": [[81, 94]], "entity_1_idx_in_text_with_entity_marker": [85, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[100, 114]], "entity_2_idx_in_text_with_entity_marker": [113, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p14", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), [E1]phosphoprotein[/E1] ([E2]P[/E2]), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[100, 114]], "entity_1_idx_in_text_with_entity_marker": [104, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[116, 117]], "entity_2_idx_in_text_with_entity_marker": [129, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d640.s0_BioInfer.d640.s0.p0", "text": "The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for E-CD; 86 per cent for alpha-catenin; 91 per cent for beta-catenin) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.", "text_with_entity_marker": "The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for [E1]E-CD[/E1]; 86 per cent for [E2]alpha-catenin[/E2]; 91 per cent for beta-catenin) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-CD", "entity_1_idx": [[127, 131]], "entity_1_idx_in_text_with_entity_marker": [131, 135], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[149, 162]], "entity_2_idx_in_text_with_entity_marker": [162, 175], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d640.s0_BioInfer.d640.s0.p1", "text": "The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for E-CD; 86 per cent for alpha-catenin; 91 per cent for beta-catenin) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.", "text_with_entity_marker": "The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for E-CD; 86 per cent for [E1]alpha-catenin[/E1]; 91 per cent for [E2]beta-catenin[/E2]) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[149, 162]], "entity_1_idx_in_text_with_entity_marker": [153, 166], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[180, 192]], "entity_2_idx_in_text_with_entity_marker": [193, 205], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d640.s0_BioInfer.d640.s0.p2", "text": "The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for E-CD; 86 per cent for alpha-catenin; 91 per cent for beta-catenin) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.", "text_with_entity_marker": "The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for [E1]E-CD[/E1]; 86 per cent for alpha-catenin; 91 per cent for [E2]beta-catenin[/E2]) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-CD", "entity_1_idx": [[127, 131]], "entity_1_idx_in_text_with_entity_marker": [131, 135], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[180, 192]], "entity_2_idx_in_text_with_entity_marker": [193, 205], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d457.s0_BioInfer.d457.s0.p0", "text": "Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.", "text_with_entity_marker": "Of the five major structural proteins of MV, only [E1]nucleocapsid[/E1] ([E2]N[/E2]) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid", "entity_1_idx": [[50, 62], [67, 74]], "entity_1_idx_in_text_with_entity_marker": [54, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[64, 65]], "entity_2_idx_in_text_with_entity_marker": [77, 78], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d457.s0_BioInfer.d457.s0.p1", "text": "Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.", "text_with_entity_marker": "Of the five major structural proteins of MV, only [E1]nucleocapsid[/E1] (N) protein and [E2]phosphoprotein[/E2] (P protein) were consistently detected in diseased brain areas.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid", "entity_1_idx": [[50, 62], [67, 74]], "entity_1_idx_in_text_with_entity_marker": [54, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[79, 93]], "entity_2_idx_in_text_with_entity_marker": [92, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d457.s0_BioInfer.d457.s0.p2", "text": "Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.", "text_with_entity_marker": "Of the five major structural proteins of MV, only [E1]nucleocapsid[/E1] (N) protein and phosphoprotein ([E2]P protein[/E2]) were consistently detected in diseased brain areas.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid", "entity_1_idx": [[50, 62], [67, 74]], "entity_1_idx_in_text_with_entity_marker": [54, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P protein", "entity_2_idx": [[95, 104]], "entity_2_idx_in_text_with_entity_marker": [108, 117], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d457.s0_BioInfer.d457.s0.p3", "text": "Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.", "text_with_entity_marker": "Of the five major structural proteins of MV, only nucleocapsid ([E1]N[/E1]) protein and [E2]phosphoprotein[/E2] (P protein) were consistently detected in diseased brain areas.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[64, 65]], "entity_1_idx_in_text_with_entity_marker": [68, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[79, 93]], "entity_2_idx_in_text_with_entity_marker": [92, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d457.s0_BioInfer.d457.s0.p4", "text": "Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.", "text_with_entity_marker": "Of the five major structural proteins of MV, only nucleocapsid ([E1]N[/E1]) protein and phosphoprotein ([E2]P protein[/E2]) were consistently detected in diseased brain areas.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[64, 65]], "entity_1_idx_in_text_with_entity_marker": [68, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P protein", "entity_2_idx": [[95, 104]], "entity_2_idx_in_text_with_entity_marker": [108, 117], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d457.s0_BioInfer.d457.s0.p5", "text": "Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.", "text_with_entity_marker": "Of the five major structural proteins of MV, only nucleocapsid (N) protein and [E1]phosphoprotein[/E1] ([E2]P protein[/E2]) were consistently detected in diseased brain areas.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[79, 93]], "entity_1_idx_in_text_with_entity_marker": [83, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P protein", "entity_2_idx": [[95, 104]], "entity_2_idx_in_text_with_entity_marker": [108, 117], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d807.s0_BioInfer.d807.s0.p0", "text": "We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "text_with_entity_marker": "We have analyzed the expression levels of the genes encoding [E1]alpha-catenin[/E1], beta-catenin and [E2]plakoglobin[/E2] in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[61, 74]], "entity_1_idx_in_text_with_entity_marker": [65, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[93, 104]], "entity_2_idx_in_text_with_entity_marker": [106, 117], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d807.s0_BioInfer.d807.s0.p1", "text": "We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "text_with_entity_marker": "We have analyzed the expression levels of the genes encoding [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2] and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[61, 74]], "entity_1_idx_in_text_with_entity_marker": [65, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[76, 88]], "entity_2_idx_in_text_with_entity_marker": [89, 101], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d807.s0_BioInfer.d807.s0.p2", "text": "We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "text_with_entity_marker": "We have analyzed the expression levels of the genes encoding [E1]alpha-catenin[/E1], beta-catenin and plakoglobin in correlation to the [E2]E-cadherin[/E2] expression levels in cell lines derived from human cervical carcinomas.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[61, 74]], "entity_1_idx_in_text_with_entity_marker": [65, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[127, 137]], "entity_2_idx_in_text_with_entity_marker": [140, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d807.s0_BioInfer.d807.s0.p3", "text": "We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "text_with_entity_marker": "We have analyzed the expression levels of the genes encoding alpha-catenin, [E1]beta-catenin[/E1] and [E2]plakoglobin[/E2] in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[76, 88]], "entity_1_idx_in_text_with_entity_marker": [80, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[93, 104]], "entity_2_idx_in_text_with_entity_marker": [106, 117], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d807.s0_BioInfer.d807.s0.p4", "text": "We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "text_with_entity_marker": "We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and [E1]plakoglobin[/E1] in correlation to the [E2]E-cadherin[/E2] expression levels in cell lines derived from human cervical carcinomas.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "plakoglobin", "entity_1_idx": [[93, 104]], "entity_1_idx_in_text_with_entity_marker": [97, 108], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[127, 137]], "entity_2_idx_in_text_with_entity_marker": [140, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d807.s0_BioInfer.d807.s0.p5", "text": "We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.", "text_with_entity_marker": "We have analyzed the expression levels of the genes encoding alpha-catenin, [E1]beta-catenin[/E1] and plakoglobin in correlation to the [E2]E-cadherin[/E2] expression levels in cell lines derived from human cervical carcinomas.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[76, 88]], "entity_1_idx_in_text_with_entity_marker": [80, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[127, 137]], "entity_2_idx_in_text_with_entity_marker": [140, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d353.s0_BioInfer.d353.s0.p0", "text": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.", "text_with_entity_marker": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast [E1]RAD51[/E1], RAD52, and [E2]RAD54[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[140, 145]], "entity_1_idx_in_text_with_entity_marker": [144, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[158, 163]], "entity_2_idx_in_text_with_entity_marker": [171, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d353.s0_BioInfer.d353.s0.p1", "text": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.", "text_with_entity_marker": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, [E1]RAD52[/E1], and [E2]RAD54[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD52", "entity_1_idx": [[147, 152]], "entity_1_idx_in_text_with_entity_marker": [151, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[158, 163]], "entity_2_idx_in_text_with_entity_marker": [171, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d353.s0_BioInfer.d353.s0.p2", "text": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.", "text_with_entity_marker": "In search for genes which might participate in chicken [E1]immunoglobulin[/E1] gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and [E2]RAD54[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "immunoglobulin", "entity_1_idx": [[55, 69]], "entity_1_idx_in_text_with_entity_marker": [59, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[158, 163]], "entity_2_idx_in_text_with_entity_marker": [171, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d353.s0_BioInfer.d353.s0.p3", "text": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.", "text_with_entity_marker": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast [E1]RAD51[/E1], [E2]RAD52[/E2], and RAD54 genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[140, 145]], "entity_1_idx_in_text_with_entity_marker": [144, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d353.s0_BioInfer.d353.s0.p4", "text": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.", "text_with_entity_marker": "In search for genes which might participate in chicken [E1]immunoglobulin[/E1] gene conversion, we have identified chicken counterparts of the yeast [E2]RAD51[/E2], RAD52, and RAD54 genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "immunoglobulin", "entity_1_idx": [[55, 69]], "entity_1_idx_in_text_with_entity_marker": [59, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[140, 145]], "entity_2_idx_in_text_with_entity_marker": [153, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d353.s0_BioInfer.d353.s0.p5", "text": "In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.", "text_with_entity_marker": "In search for genes which might participate in chicken [E1]immunoglobulin[/E1] gene conversion, we have identified chicken counterparts of the yeast RAD51, [E2]RAD52[/E2], and RAD54 genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "immunoglobulin", "entity_1_idx": [[55, 69]], "entity_1_idx_in_text_with_entity_marker": [59, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d770.s0_BioInfer.d770.s0.p0", "text": "Total actin and myosin heavy chain mRNAs, and polyadenylated RNA, were determined using slot-blot assays.", "text_with_entity_marker": "Total [E1]actin[/E1] and [E2]myosin heavy chain[/E2] mRNAs, and polyadenylated RNA, were determined using slot-blot assays.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[16, 34]], "entity_2_idx_in_text_with_entity_marker": [29, 47], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p20", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein ([E1]NP[/E1]), [E2]phosphoprotein[/E2] (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[66, 68]], "entity_1_idx_in_text_with_entity_marker": [70, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[71, 85]], "entity_2_idx_in_text_with_entity_marker": [84, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p21", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P), V protein, [E2]matrix protein[/E2] (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix protein", "entity_2_idx": [[102, 116]], "entity_2_idx_in_text_with_entity_marker": [115, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p22", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, [E2]haemagglutinin-neuraminidase[/E2] (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "haemagglutinin-neuraminidase", "entity_2_idx": [[174, 202], [208, 215]], "entity_2_idx_in_text_with_entity_marker": [187, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p23", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] ([E2]P[/E2]), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[87, 88]], "entity_2_idx_in_text_with_entity_marker": [100, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p24", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic ([E2]SH[/E2]) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SH", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p25", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P), V protein, matrix protein (M), fusion protein ([E2]F[/E2]), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[138, 139]], "entity_2_idx_in_text_with_entity_marker": [151, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p26", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large ([E2]L[/E2]) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[227, 228]], "entity_2_idx_in_text_with_entity_marker": [240, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p27", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), [E1]fusion protein[/E1] (F), [E2]small hydrophobic[/E2] (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion protein", "entity_1_idx": [[122, 136]], "entity_1_idx_in_text_with_entity_marker": [126, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "small hydrophobic", "entity_2_idx": [[142, 159], [165, 172]], "entity_2_idx_in_text_with_entity_marker": [155, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p28", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein (M), [E2]fusion protein[/E2] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[122, 136]], "entity_2_idx_in_text_with_entity_marker": [135, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p29", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), [E1]fusion protein[/E1] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion protein", "entity_1_idx": [[122, 136]], "entity_1_idx_in_text_with_entity_marker": [126, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p100", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]), V protein, matrix protein (M), fusion protein ([E2]F[/E2]), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[87, 88]], "entity_1_idx_in_text_with_entity_marker": [91, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[138, 139]], "entity_2_idx_in_text_with_entity_marker": [151, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p101", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large ([E2]L[/E2]) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[87, 88]], "entity_1_idx_in_text_with_entity_marker": [91, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[227, 228]], "entity_2_idx_in_text_with_entity_marker": [240, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p102", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein ([E1]F[/E1]), small hydrophobic ([E2]SH[/E2]) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[138, 139]], "entity_1_idx_in_text_with_entity_marker": [142, 143], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SH", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p103", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic ([E1]SH[/E1]) protein, haemagglutinin-neuraminidase (HN) protein and large ([E2]L[/E2]) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SH", "entity_1_idx": [[161, 163]], "entity_1_idx_in_text_with_entity_marker": [165, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[227, 228]], "entity_2_idx_in_text_with_entity_marker": [240, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p104", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein ([E1]F[/E1]), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large ([E2]L[/E2]) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[138, 139]], "entity_1_idx_in_text_with_entity_marker": [142, 143], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[227, 228]], "entity_2_idx_in_text_with_entity_marker": [240, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d799.s0_BioInfer.d799.s0.p0", "text": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "text_with_entity_marker": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes ([E1]UL5[/E1], UL8, [E2]UL9[/E2] and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[177, 180]], "entity_1_idx_in_text_with_entity_marker": [181, 184], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[187, 190]], "entity_2_idx_in_text_with_entity_marker": [200, 203], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d799.s0_BioInfer.d799.s0.p1", "text": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "text_with_entity_marker": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes ([E1]UL5[/E1], [E2]UL8[/E2], UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[177, 180]], "entity_1_idx_in_text_with_entity_marker": [181, 184], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL8", "entity_2_idx": [[182, 185]], "entity_2_idx_in_text_with_entity_marker": [195, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d799.s0_BioInfer.d799.s0.p2", "text": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "text_with_entity_marker": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes ([E1]UL5[/E1], UL8, UL9 and [E2]UL52[/E2]) in the absence of any of the other proteins required for viral DNA synthesis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[177, 180]], "entity_1_idx_in_text_with_entity_marker": [181, 184], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d799.s0_BioInfer.d799.s0.p3", "text": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "text_with_entity_marker": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, [E1]UL8[/E1], [E2]UL9[/E2] and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[182, 185]], "entity_1_idx_in_text_with_entity_marker": [186, 189], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[187, 190]], "entity_2_idx_in_text_with_entity_marker": [200, 203], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d799.s0_BioInfer.d799.s0.p4", "text": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "text_with_entity_marker": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, [E1]UL9[/E1] and [E2]UL52[/E2]) in the absence of any of the other proteins required for viral DNA synthesis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL9", "entity_1_idx": [[187, 190]], "entity_1_idx_in_text_with_entity_marker": [191, 194], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d799.s0_BioInfer.d799.s0.p5", "text": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.", "text_with_entity_marker": "We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, [E1]UL8[/E1], UL9 and [E2]UL52[/E2]) in the absence of any of the other proteins required for viral DNA synthesis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[182, 185]], "entity_1_idx_in_text_with_entity_marker": [186, 189], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d72.s0_BioInfer.d72.s0.p0", "text": "RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "text_with_entity_marker": "RAD51, [E1]RAD52[/E1], RAD57, and [E2]RAD59[/E2] were required for efficient gap repair using either chromosomal or plasmid donors.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD52", "entity_1_idx": [[7, 12]], "entity_1_idx_in_text_with_entity_marker": [11, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD59", "entity_2_idx": [[25, 30]], "entity_2_idx_in_text_with_entity_marker": [38, 43], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d72.s0_BioInfer.d72.s0.p1", "text": "RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "text_with_entity_marker": "RAD51, RAD52, [E1]RAD57[/E1], and [E2]RAD59[/E2] were required for efficient gap repair using either chromosomal or plasmid donors.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD57", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD59", "entity_2_idx": [[25, 30]], "entity_2_idx_in_text_with_entity_marker": [38, 43], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d72.s0_BioInfer.d72.s0.p2", "text": "RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "text_with_entity_marker": "[E1]RAD51[/E1], RAD52, RAD57, and [E2]RAD59[/E2] were required for efficient gap repair using either chromosomal or plasmid donors.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD59", "entity_2_idx": [[25, 30]], "entity_2_idx_in_text_with_entity_marker": [38, 43], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d72.s0_BioInfer.d72.s0.p3", "text": "RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "text_with_entity_marker": "RAD51, [E1]RAD52[/E1], [E2]RAD57[/E2], and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD52", "entity_1_idx": [[7, 12]], "entity_1_idx_in_text_with_entity_marker": [11, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d72.s0_BioInfer.d72.s0.p4", "text": "RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "text_with_entity_marker": "[E1]RAD51[/E1], [E2]RAD52[/E2], RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[7, 12]], "entity_2_idx_in_text_with_entity_marker": [20, 25], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d72.s0_BioInfer.d72.s0.p5", "text": "RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "text_with_entity_marker": "[E1]RAD51[/E1], RAD52, [E2]RAD57[/E2], and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p40", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and [E1]CD34[/E1], but negative for [E2]desmin[/E2], calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD34", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[116, 122]], "entity_2_idx_in_text_with_entity_marker": [129, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p41", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for [E1]desmin[/E1], calponin, [E2]high molecular weight caldesmon[/E2], smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[116, 122]], "entity_1_idx_in_text_with_entity_marker": [120, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "high molecular weight caldesmon", "entity_2_idx": [[134, 165]], "entity_2_idx_in_text_with_entity_marker": [147, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p42", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for [E1]desmin[/E1], [E2]calponin[/E2], high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[116, 122]], "entity_1_idx_in_text_with_entity_marker": [120, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p43", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for [E1]desmin[/E1], calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, [E2]collagen type IV[/E2], laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[116, 122]], "entity_1_idx_in_text_with_entity_marker": [120, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "collagen type IV", "entity_2_idx": [[201, 217]], "entity_2_idx_in_text_with_entity_marker": [214, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p44", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for [E1]desmin[/E1], calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[116, 122]], "entity_1_idx_in_text_with_entity_marker": [120, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p45", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and [E1]CD34[/E1], but negative for desmin, calponin, [E2]high molecular weight caldesmon[/E2], smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD34", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "high molecular weight caldesmon", "entity_2_idx": [[134, 165]], "entity_2_idx_in_text_with_entity_marker": [147, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p46", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and [E1]CD34[/E1], but negative for desmin, [E2]calponin[/E2], high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD34", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p47", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and [E1]CD34[/E1], but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, [E2]collagen type IV[/E2], laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD34", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "collagen type IV", "entity_2_idx": [[201, 217]], "entity_2_idx_in_text_with_entity_marker": [214, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p48", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and [E1]CD34[/E1], but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD34", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p49", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, [E1]calponin[/E1], [E2]high molecular weight caldesmon[/E2], smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calponin", "entity_1_idx": [[124, 132]], "entity_1_idx_in_text_with_entity_marker": [128, 136], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "high molecular weight caldesmon", "entity_2_idx": [[134, 165]], "entity_2_idx_in_text_with_entity_marker": [147, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p10", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including [E1]MLH1[/E1], MSH2, MSH3, MSH6, and PMS1, did not rescue [E2]mgt1[/E2]delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MLH1", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "mgt1", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p11", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, [E1]MSH6[/E1], and [E2]PMS1[/E2], did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH6", "entity_1_idx": [[164, 168]], "entity_1_idx_in_text_with_entity_marker": [168, 172], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PMS1", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p12", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, [E1]MSH2[/E1], MSH3, [E2]MSH6[/E2], and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[152, 156]], "entity_1_idx_in_text_with_entity_marker": [156, 160], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p13", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, [E1]MSH3[/E1], [E2]MSH6[/E2], and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH3", "entity_1_idx": [[158, 162]], "entity_1_idx_in_text_with_entity_marker": [162, 166], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p14", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including [E1]MLH1[/E1], MSH2, MSH3, [E2]MSH6[/E2], and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MLH1", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p15", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, [E1]MSH2[/E1], MSH3, MSH6, and [E2]PMS1[/E2], did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[152, 156]], "entity_1_idx_in_text_with_entity_marker": [156, 160], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PMS1", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p16", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, [E1]MSH3[/E1], MSH6, and [E2]PMS1[/E2], did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH3", "entity_1_idx": [[158, 162]], "entity_1_idx_in_text_with_entity_marker": [162, 166], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PMS1", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p17", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including [E1]MLH1[/E1], MSH2, MSH3, MSH6, and [E2]PMS1[/E2], did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MLH1", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PMS1", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p18", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, [E1]MSH2[/E1], [E2]MSH3[/E2], MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[152, 156]], "entity_1_idx_in_text_with_entity_marker": [156, 160], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p19", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including [E1]MLH1[/E1], [E2]MSH2[/E2], MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MLH1", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[152, 156]], "entity_2_idx_in_text_with_entity_marker": [165, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d380.s0_BioInfer.d380.s0.p0", "text": "In this study we aimed to determine which type of expression abnormalities for E-cadherin, beta-catenin and alpha-catenin correlate with clinico-pathological features and survival in gastric cancer.", "text_with_entity_marker": "In this study we aimed to determine which type of expression abnormalities for [E1]E-cadherin[/E1], beta-catenin and [E2]alpha-catenin[/E2] correlate with clinico-pathological features and survival in gastric cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[79, 89]], "entity_1_idx_in_text_with_entity_marker": [83, 93], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[108, 121]], "entity_2_idx_in_text_with_entity_marker": [121, 134], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d380.s0_BioInfer.d380.s0.p1", "text": "In this study we aimed to determine which type of expression abnormalities for E-cadherin, beta-catenin and alpha-catenin correlate with clinico-pathological features and survival in gastric cancer.", "text_with_entity_marker": "In this study we aimed to determine which type of expression abnormalities for [E1]E-cadherin[/E1], [E2]beta-catenin[/E2] and alpha-catenin correlate with clinico-pathological features and survival in gastric cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[79, 89]], "entity_1_idx_in_text_with_entity_marker": [83, 93], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[91, 103]], "entity_2_idx_in_text_with_entity_marker": [104, 116], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d380.s0_BioInfer.d380.s0.p2", "text": "In this study we aimed to determine which type of expression abnormalities for E-cadherin, beta-catenin and alpha-catenin correlate with clinico-pathological features and survival in gastric cancer.", "text_with_entity_marker": "In this study we aimed to determine which type of expression abnormalities for E-cadherin, [E1]beta-catenin[/E1] and [E2]alpha-catenin[/E2] correlate with clinico-pathological features and survival in gastric cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[91, 103]], "entity_1_idx_in_text_with_entity_marker": [95, 107], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[108, 121]], "entity_2_idx_in_text_with_entity_marker": [121, 134], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "HPRD50.d38.s0_HPRD50.d38.s0.p0", "text": "Subsequent amino acid sequencing revealed many peptides involving involucrin cross-linked either to itself or to a variety of other known CE protein components, including cystatin alpha, desmoplakin, elafin, keratins, members of the small proline-rich superfamily, loricrin, and unknown proteins related to the desmoplakin family", "text_with_entity_marker": "Subsequent amino acid sequencing revealed many peptides involving [E1]involucrin[/E1] cross-linked either to itself or to a variety of other known CE protein components, including [E2]cystatin alpha[/E2], desmoplakin, elafin, keratins, members of the small proline-rich superfamily, loricrin, and unknown proteins related to the desmoplakin family", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "involucrin", "entity_1_idx": [[66, 76]], "entity_1_idx_in_text_with_entity_marker": [70, 80], "entity_1_type": "pm0104308", "entity_1_type_id": 139, "entity_2": "cystatin alpha", "entity_2_idx": [[171, 185]], "entity_2_idx_in_text_with_entity_marker": [184, 198], "entity_2_type": "pm0104526", "entity_2_type_id": 140}], "directed": false, "reverse": false}
{"id": "HPRD50.d38.s0_HPRD50.d38.s0.p1", "text": "Subsequent amino acid sequencing revealed many peptides involving involucrin cross-linked either to itself or to a variety of other known CE protein components, including cystatin alpha, desmoplakin, elafin, keratins, members of the small proline-rich superfamily, loricrin, and unknown proteins related to the desmoplakin family", "text_with_entity_marker": "Subsequent amino acid sequencing revealed many peptides involving [E1]involucrin[/E1] cross-linked either to itself or to a variety of other known CE protein components, including cystatin alpha, [E2]desmoplakin[/E2], elafin, keratins, members of the small proline-rich superfamily, loricrin, and unknown proteins related to the desmoplakin family", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "involucrin", "entity_1_idx": [[66, 76]], "entity_1_idx_in_text_with_entity_marker": [70, 80], "entity_1_type": "pm0104308", "entity_1_type_id": 139, "entity_2": "desmoplakin", "entity_2_idx": [[187, 198]], "entity_2_idx_in_text_with_entity_marker": [200, 211], "entity_2_type": "pm0110549", "entity_2_type_id": 141}], "directed": false, "reverse": false}
{"id": "HPRD50.d38.s0_HPRD50.d38.s0.p2", "text": "Subsequent amino acid sequencing revealed many peptides involving involucrin cross-linked either to itself or to a variety of other known CE protein components, including cystatin alpha, desmoplakin, elafin, keratins, members of the small proline-rich superfamily, loricrin, and unknown proteins related to the desmoplakin family", "text_with_entity_marker": "Subsequent amino acid sequencing revealed many peptides involving [E1]involucrin[/E1] cross-linked either to itself or to a variety of other known CE protein components, including cystatin alpha, desmoplakin, [E2]elafin[/E2], keratins, members of the small proline-rich superfamily, loricrin, and unknown proteins related to the desmoplakin family", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "involucrin", "entity_1_idx": [[66, 76]], "entity_1_idx_in_text_with_entity_marker": [70, 80], "entity_1_type": "pm0104308", "entity_1_type_id": 139, "entity_2": "elafin", "entity_2_idx": [[200, 206]], "entity_2_idx_in_text_with_entity_marker": [213, 219], "entity_2_type": "pm0114270", "entity_2_type_id": 142}], "directed": false, "reverse": false}
{"id": "HPRD50.d38.s0_HPRD50.d38.s0.p3", "text": "Subsequent amino acid sequencing revealed many peptides involving involucrin cross-linked either to itself or to a variety of other known CE protein components, including cystatin alpha, desmoplakin, elafin, keratins, members of the small proline-rich superfamily, loricrin, and unknown proteins related to the desmoplakin family", "text_with_entity_marker": "Subsequent amino acid sequencing revealed many peptides involving [E1]involucrin[/E1] cross-linked either to itself or to a variety of other known CE protein components, including cystatin alpha, desmoplakin, elafin, keratins, members of the small proline-rich superfamily, [E2]loricrin[/E2], and unknown proteins related to the desmoplakin family", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "involucrin", "entity_1_idx": [[66, 76]], "entity_1_idx_in_text_with_entity_marker": [70, 80], "entity_1_type": "pm0104308", "entity_1_type_id": 139, "entity_2": "loricrin", "entity_2_idx": [[265, 273]], "entity_2_idx_in_text_with_entity_marker": [278, 286], "entity_2_type": "pm0103809", "entity_2_type_id": 143}], "directed": false, "reverse": false}
{"id": "HPRD50.d38.s0_HPRD50.d38.s0.p4", "text": "Subsequent amino acid sequencing revealed many peptides involving involucrin cross-linked either to itself or to a variety of other known CE protein components, including cystatin alpha, desmoplakin, elafin, keratins, members of the small proline-rich superfamily, loricrin, and unknown proteins related to the desmoplakin family", "text_with_entity_marker": "Subsequent amino acid sequencing revealed many peptides involving [E1]involucrin[/E1] cross-linked either to itself or to a variety of other known CE protein components, including cystatin alpha, desmoplakin, elafin, keratins, members of the small proline-rich superfamily, loricrin, and unknown proteins related to the [E2]desmoplakin[/E2] family", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "involucrin", "entity_1_idx": [[66, 76]], "entity_1_idx_in_text_with_entity_marker": [70, 80], "entity_1_type": "pm0104308", "entity_1_type_id": 139, "entity_2": "desmoplakin", "entity_2_idx": [[311, 322]], "entity_2_idx_in_text_with_entity_marker": [324, 335], "entity_2_type": "pm0110549", "entity_2_type_id": 141}], "directed": false, "reverse": false}
{"id": "HPRD50.d18.s0_HPRD50.d18.s0.p1", "text": "The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120(ctn)", "text_with_entity_marker": "The transmembrane [E1]receptor protein tyrosine phosphatase[/E1] DEP1 interacts with [E2]p120(ctn)[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "receptor protein tyrosine phosphatase", "entity_1_idx": [[18, 55]], "entity_1_idx_in_text_with_entity_marker": [22, 59], "entity_1_type": "pm0104157", "entity_1_type_id": 58, "entity_2": "p120(ctn)", "entity_2_idx": [[76, 85]], "entity_2_idx_in_text_with_entity_marker": [89, 98], "entity_2_type": "pm0101886", "entity_2_type_id": 60}], "directed": false, "reverse": false}
{"id": "HPRD50.d18.s0_HPRD50.d18.s0.p2", "text": "The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120(ctn)", "text_with_entity_marker": "The transmembrane receptor protein tyrosine phosphatase [E1]DEP1[/E1] interacts with [E2]p120(ctn)[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DEP1", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "pm0115917", "entity_1_type_id": 59, "entity_2": "p120(ctn)", "entity_2_idx": [[76, 85]], "entity_2_idx_in_text_with_entity_marker": [89, 98], "entity_2_type": "pm0101886", "entity_2_type_id": 60}], "directed": false, "reverse": false}
{"id": "HPRD50.d28.s0_HPRD50.d28.s0.p0", "text": "We report that MSH2 (MutS homolog 2) protein interacts with the ATR (ATM- and Rad3-related) kinase to form a signaling module and regulate the phosphorylation of Chk1 and SMC1 (structure maintenance of chromosome 1)", "text_with_entity_marker": "We report that [E1]MSH2[/E1] (MutS homolog 2) protein interacts with the ATR (ATM- and Rad3-related) kinase to form a signaling module and regulate the phosphorylation of [E2]Chk1[/E2] and SMC1 (structure maintenance of chromosome 1)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[15, 19]], "entity_1_idx_in_text_with_entity_marker": [19, 23], "entity_1_type": "pm0121865", "entity_1_type_id": 99, "entity_2": "Chk1", "entity_2_idx": [[162, 166]], "entity_2_idx_in_text_with_entity_marker": [175, 179], "entity_2_type": "pm0113524", "entity_2_type_id": 100}], "directed": false, "reverse": false}
{"id": "HPRD50.d28.s0_HPRD50.d28.s0.p1", "text": "We report that MSH2 (MutS homolog 2) protein interacts with the ATR (ATM- and Rad3-related) kinase to form a signaling module and regulate the phosphorylation of Chk1 and SMC1 (structure maintenance of chromosome 1)", "text_with_entity_marker": "We report that [E1]MSH2[/E1] (MutS homolog 2) protein interacts with the ATR (ATM- and Rad3-related) kinase to form a signaling module and regulate the phosphorylation of Chk1 and [E2]SMC1[/E2] (structure maintenance of chromosome 1)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[15, 19]], "entity_1_idx_in_text_with_entity_marker": [19, 23], "entity_1_type": "pm0121865", "entity_1_type_id": 99, "entity_2": "SMC1", "entity_2_idx": [[171, 175]], "entity_2_idx_in_text_with_entity_marker": [184, 188], "entity_2_type": "pm0116233", "entity_2_type_id": 101}], "directed": false, "reverse": false}
{"id": "HPRD50.d28.s1_HPRD50.d28.s1.p0", "text": "We found that phosphorylation of Chk1 by ATR also requires checkpoint proteins Rad17 and replication protein A", "text_with_entity_marker": "We found that phosphorylation of [E1]Chk1[/E1] by ATR also requires checkpoint proteins [E2]Rad17[/E2] and replication protein A", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Chk1", "entity_1_idx": [[33, 37]], "entity_1_idx_in_text_with_entity_marker": [37, 41], "entity_1_type": "pm0113524", "entity_1_type_id": 100, "entity_2": "Rad17", "entity_2_idx": [[79, 84]], "entity_2_idx_in_text_with_entity_marker": [92, 97], "entity_2_type": "pm0117336", "entity_2_type_id": 102}], "directed": false, "reverse": false}
{"id": "HPRD50.d14.s0_HPRD50.d14.s0.p0", "text": "Megalin and cubilin: multifunctional endocytic receptors", "text_with_entity_marker": "[E1]Megalin[/E1] and [E2]cubilin[/E2]: multifunctional endocytic receptors", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Megalin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "pm0100604", "entity_1_type_id": 46, "entity_2": "cubilin", "entity_2_idx": [[12, 19]], "entity_2_idx_in_text_with_entity_marker": [25, 32], "entity_2_type": "pm0100963", "entity_2_type_id": 47}], "directed": false, "reverse": false}
{"id": "HPRD50.d22.s4_HPRD50.d22.s4.p0", "text": "This work led to identification of a novel GTPase-activating protein (GAP) for Rho family GTPases", "text_with_entity_marker": "This work led to identification of a novel [E1]GTPase-activating protein[/E1] ([E2]GAP[/E2]) for Rho family GTPases", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "GTPase-activating protein", "entity_1_idx": [[43, 68]], "entity_1_idx_in_text_with_entity_marker": [47, 72], "entity_1_type": "pm0112603", "entity_1_type_id": 74, "entity_2": "GAP", "entity_2_idx": [[70, 73]], "entity_2_idx_in_text_with_entity_marker": [83, 86], "entity_2_type": "pm0112603||pm0113293", "entity_2_type_id": 81}], "directed": false, "reverse": false}
{"id": "IEPA.d149.s362_IEPA.d149.s362.p0", "text": "Furthermore, in SN-56/OBR cells both CNTF and leptin produce changes in neurotransmitter and neuropeptide phenotype characteristic of cholinergic neurons, such as an increase in choline acetyltransferase and vasoactive intestinal polypeptide, and a decrease in neuropeptide Y expression", "text_with_entity_marker": "Furthermore, in SN-56/OBR cells both CNTF and [E1]leptin[/E1] produce changes in neurotransmitter and neuropeptide phenotype characteristic of cholinergic neurons, such as an increase in choline acetyltransferase and vasoactive intestinal polypeptide, and a decrease in [E2]neuropeptide Y[/E2] expression", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[46, 52]], "entity_1_idx_in_text_with_entity_marker": [50, 56], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[261, 275]], "entity_2_idx_in_text_with_entity_marker": [274, 288], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d107.s247_IEPA.d107.s247.p0", "text": "Molecular characterization of catalytic-subunit cDNA sequences encoding protein phosphatases 1 and 2A and study of their roles in the gibberellin-dependent Osamy-c expression in rice", "text_with_entity_marker": "Molecular characterization of catalytic-subunit cDNA sequences encoding protein phosphatases 1 and 2A and study of their roles in the [E1]gibberellin[/E1]-dependent [E2]Osamy-c[/E2] expression in rice", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "gibberellin", "entity_1_idx": [[134, 145]], "entity_1_idx_in_text_with_entity_marker": [138, 149], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "Osamy-c", "entity_2_idx": [[156, 163]], "entity_2_idx_in_text_with_entity_marker": [169, 176], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d107.s248_IEPA.d107.s248.p0", "text": "To understand the molecular mechanism of gibberellin-dependent gene regulation, the effect of three phosphatase inhibitors on the germination of rice seeds and the expression of a target gene, the alpha-amylase gene, Osamy-c, were measured", "text_with_entity_marker": "To understand the molecular mechanism of [E1]gibberellin[/E1]-dependent gene regulation, the effect of three phosphatase inhibitors on the germination of rice seeds and the expression of a target gene, the [E2]alpha-amylase[/E2] gene, Osamy-c, were measured", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "gibberellin", "entity_1_idx": [[41, 52]], "entity_1_idx_in_text_with_entity_marker": [45, 56], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[197, 210]], "entity_2_idx_in_text_with_entity_marker": [210, 223], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d107.s249_IEPA.d107.s249.p0", "text": "To further understand the possible role of protein phosphatases 1 and 2A in the GA-dependent expression of Osamy-c, we isolated cDNA clones encoding protein phosphatase 1 and protein phosphatase 2A from a rice aleurone cDNA library", "text_with_entity_marker": "To further understand the possible role of protein phosphatases 1 and 2A in the [E1]GA[/E1]-dependent expression of [E2]Osamy-c[/E2], we isolated cDNA clones encoding protein phosphatase 1 and protein phosphatase 2A from a rice aleurone cDNA library", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[80, 82]], "entity_1_idx_in_text_with_entity_marker": [84, 86], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "Osamy-c", "entity_2_idx": [[107, 114]], "entity_2_idx_in_text_with_entity_marker": [120, 127], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d107.s250_IEPA.d107.s250.p0", "text": "Taken together, our results suggest that protein phosphatases PP1 or PP2A are involved in the GA-dependent expression of the rice Osamy-c gene, though the PP1 or/and PP2A enzymatic activities as well as mRNA levels do not increase upon GA3 treatment", "text_with_entity_marker": "Taken together, our results suggest that protein phosphatases PP1 or PP2A are involved in the [E1]GA[/E1]-dependent expression of the rice [E2]Osamy-c[/E2] gene, though the PP1 or/and PP2A enzymatic activities as well as mRNA levels do not increase upon GA3 treatment", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[94, 96]], "entity_1_idx_in_text_with_entity_marker": [98, 100], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "Osamy-c", "entity_2_idx": [[130, 137]], "entity_2_idx_in_text_with_entity_marker": [143, 150], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d87.s206_IEPA.d87.s206.p0", "text": "These findings led us to conclude that inositol trisphosphate [corrected] causes Ca2+ mobilization by muscarinic activation of PLC, leading to intracellular translocation of insulin granules to the ready-releasable pool in pancreatic beta-cells via Ca2+/calmodulin-dependent phosphorylation of myosin light chains", "text_with_entity_marker": "These findings led us to conclude that inositol trisphosphate [corrected] causes Ca2+ mobilization by muscarinic activation of [E1]PLC[/E1], leading to intracellular translocation of [E2]insulin[/E2] granules to the ready-releasable pool in pancreatic beta-cells via Ca2+/calmodulin-dependent phosphorylation of myosin light chains", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PLC", "entity_1_idx": [[127, 130]], "entity_1_idx_in_text_with_entity_marker": [131, 134], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[174, 181]], "entity_2_idx_in_text_with_entity_marker": [187, 194], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d178.s429_IEPA.d178.s429.p0", "text": "A caveolin-1-dependent coupling of PrPc to the tyrosine kinase Fyn was observed", "text_with_entity_marker": "A caveolin-1-dependent coupling of [E1]PrPc[/E1] to the [E2]tyrosine kinase Fyn[/E2] was observed", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PrPc", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "tyrosine kinase Fyn", "entity_2_idx": [[47, 66]], "entity_2_idx_in_text_with_entity_marker": [60, 79], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d173.s421_IEPA.d173.s421.p0", "text": "Overall, our data indicate that the normal processing of PrP(c) is up-regulated by protein kinase C but not protein kinase A in human cells and murine neurons", "text_with_entity_marker": "Overall, our data indicate that the normal processing of [E1]PrP(c)[/E1] is up-regulated by [E2]protein kinase C[/E2] but not protein kinase A in human cells and murine neurons", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PrP(c)", "entity_1_idx": [[57, 63]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[83, 99]], "entity_2_idx_in_text_with_entity_marker": [96, 112], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d53.s137_IEPA.d53.s137.p1", "text": "During luteinization of bovine granulosa cells in vitro in the presence of insulin, or insulin plus forskolin, there is a massive upregulation not only of progesterone production, but also of the gene for the peptide hormone oxytocin, with secretion of the peptide into the medium", "text_with_entity_marker": "During luteinization of bovine granulosa cells in vitro in the presence of [E1]insulin[/E1], or insulin plus forskolin, there is a massive upregulation not only of progesterone production, but also of the gene for the peptide hormone [E2]oxytocin[/E2], with secretion of the peptide into the medium", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[75, 82]], "entity_1_idx_in_text_with_entity_marker": [79, 86], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[225, 233]], "entity_2_idx_in_text_with_entity_marker": [238, 246], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d53.s137_IEPA.d53.s137.p2", "text": "During luteinization of bovine granulosa cells in vitro in the presence of insulin, or insulin plus forskolin, there is a massive upregulation not only of progesterone production, but also of the gene for the peptide hormone oxytocin, with secretion of the peptide into the medium", "text_with_entity_marker": "During luteinization of bovine granulosa cells in vitro in the presence of insulin, or [E1]insulin[/E1] plus forskolin, there is a massive upregulation not only of progesterone production, but also of the gene for the peptide hormone [E2]oxytocin[/E2], with secretion of the peptide into the medium", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[87, 94]], "entity_1_idx_in_text_with_entity_marker": [91, 98], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[225, 233]], "entity_2_idx_in_text_with_entity_marker": [238, 246], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d49.s126_IEPA.d49.s126.p0", "text": "Leptin upregulates the expression of uncoupling protein-2 (UCP-2) mRNA in islets of normal rats, but has no effect in islets of obese Zucker Diabetic Fatty (ZDF) rats with mutated leptin receptors", "text_with_entity_marker": "[E1]Leptin[/E1] upregulates the expression of [E2]uncoupling protein-2[/E2] (UCP-2) mRNA in islets of normal rats, but has no effect in islets of obese Zucker Diabetic Fatty (ZDF) rats with mutated leptin receptors", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein-2", "entity_2_idx": [[37, 57]], "entity_2_idx_in_text_with_entity_marker": [50, 70], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d74.s176_IEPA.d74.s176.p0", "text": "Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins", "text_with_entity_marker": "Chronic central [E1]leptin[/E1] infusion enhances insulin-stimulated glucose metabolism and favors the expression of [E2]uncoupling proteins[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[16, 22]], "entity_1_idx_in_text_with_entity_marker": [20, 26], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling proteins", "entity_2_idx": [[108, 127]], "entity_2_idx_in_text_with_entity_marker": [121, 140], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d74.s177_IEPA.d74.s177.p0", "text": "In marked contrast, intracerebroventricular leptin administration was accompanied by the maintenance of high UCP1, UCP2, and UCP3 expression in all these tissues", "text_with_entity_marker": "In marked contrast, intracerebroventricular [E1]leptin[/E1] administration was accompanied by the maintenance of high [E2]UCP1[/E2], UCP2, and UCP3 expression in all these tissues", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[44, 50]], "entity_1_idx_in_text_with_entity_marker": [48, 54], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP1", "entity_2_idx": [[109, 113]], "entity_2_idx_in_text_with_entity_marker": [122, 126], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d74.s177_IEPA.d74.s177.p1", "text": "In marked contrast, intracerebroventricular leptin administration was accompanied by the maintenance of high UCP1, UCP2, and UCP3 expression in all these tissues", "text_with_entity_marker": "In marked contrast, intracerebroventricular [E1]leptin[/E1] administration was accompanied by the maintenance of high UCP1, [E2]UCP2[/E2], and UCP3 expression in all these tissues", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[44, 50]], "entity_1_idx_in_text_with_entity_marker": [48, 54], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[115, 119]], "entity_2_idx_in_text_with_entity_marker": [128, 132], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d74.s177_IEPA.d74.s177.p2", "text": "In marked contrast, intracerebroventricular leptin administration was accompanied by the maintenance of high UCP1, UCP2, and UCP3 expression in all these tissues", "text_with_entity_marker": "In marked contrast, intracerebroventricular [E1]leptin[/E1] administration was accompanied by the maintenance of high UCP1, UCP2, and [E2]UCP3[/E2] expression in all these tissues", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[44, 50]], "entity_1_idx_in_text_with_entity_marker": [48, 54], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[125, 129]], "entity_2_idx_in_text_with_entity_marker": [138, 142], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d74.s178_IEPA.d74.s178.p0", "text": "While leptin maintains or favors energy-dissipating mechanisms (UCP1, UCP2, and UCP3), the latter are markedly depressed in pair-fed rats", "text_with_entity_marker": "While [E1]leptin[/E1] maintains or favors energy-dissipating mechanisms ([E2]UCP1[/E2], UCP2, and UCP3), the latter are markedly depressed in pair-fed rats", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[6, 12]], "entity_1_idx_in_text_with_entity_marker": [10, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP1", "entity_2_idx": [[64, 68]], "entity_2_idx_in_text_with_entity_marker": [77, 81], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d74.s178_IEPA.d74.s178.p1", "text": "While leptin maintains or favors energy-dissipating mechanisms (UCP1, UCP2, and UCP3), the latter are markedly depressed in pair-fed rats", "text_with_entity_marker": "While [E1]leptin[/E1] maintains or favors energy-dissipating mechanisms (UCP1, [E2]UCP2[/E2], and UCP3), the latter are markedly depressed in pair-fed rats", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[6, 12]], "entity_1_idx_in_text_with_entity_marker": [10, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[70, 74]], "entity_2_idx_in_text_with_entity_marker": [83, 87], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d74.s178_IEPA.d74.s178.p2", "text": "While leptin maintains or favors energy-dissipating mechanisms (UCP1, UCP2, and UCP3), the latter are markedly depressed in pair-fed rats", "text_with_entity_marker": "While [E1]leptin[/E1] maintains or favors energy-dissipating mechanisms (UCP1, UCP2, and [E2]UCP3[/E2]), the latter are markedly depressed in pair-fed rats", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[6, 12]], "entity_1_idx_in_text_with_entity_marker": [10, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d46.s115_IEPA.d46.s115.p0", "text": "Amyloid beta protein (25-35) stimulation of phospholipase C in LA-N-2 cells", "text_with_entity_marker": "[E1]Amyloid[/E1] beta protein (25-35) stimulation of [E2]phospholipase C[/E2] in LA-N-2 cells", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Amyloid", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[44, 59]], "entity_2_idx_in_text_with_entity_marker": [57, 72], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d46.s116_IEPA.d46.s116.p0", "text": "This phospholipase C stimulation by amyloid beta protein appeared to be pertussis toxin sensitive", "text_with_entity_marker": "This [E1]phospholipase C[/E1] stimulation by [E2]amyloid[/E2] beta protein appeared to be pertussis toxin sensitive", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "phospholipase C", "entity_1_idx": [[5, 20]], "entity_1_idx_in_text_with_entity_marker": [9, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "amyloid", "entity_2_idx": [[36, 43]], "entity_2_idx_in_text_with_entity_marker": [49, 56], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d46.s117_IEPA.d46.s117.p0", "text": "It is possible that this phospholipase C stimulation by amyloid beta protein is a receptor-mediated process", "text_with_entity_marker": "It is possible that this [E1]phospholipase C[/E1] stimulation by [E2]amyloid[/E2] beta protein is a receptor-mediated process", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "phospholipase C", "entity_1_idx": [[25, 40]], "entity_1_idx_in_text_with_entity_marker": [29, 44], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "amyloid", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d46.s118_IEPA.d46.s118.p0", "text": "Amyloid beta protein stimulation of phospholipase C was absent from LA-N-2 cells previously treated with norepinephrine, trans-1-amino-1,3-cyclopentanedicarboxylic acid (t-ACPD), bombesin, or amyloid beta peptide", "text_with_entity_marker": "[E1]Amyloid[/E1] beta protein stimulation of [E2]phospholipase C[/E2] was absent from LA-N-2 cells previously treated with norepinephrine, trans-1-amino-1,3-cyclopentanedicarboxylic acid (t-ACPD), bombesin, or amyloid beta peptide", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Amyloid", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[36, 51]], "entity_2_idx_in_text_with_entity_marker": [49, 64], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d46.s119_IEPA.d46.s119.p0", "text": "It is suggested that this observed amyloid beta protein stimulation of phospholipase C may be responsible for the elevated quantity of inositol seen in the brains of Alzheimer's disease patients", "text_with_entity_marker": "It is suggested that this observed [E1]amyloid[/E1] beta protein stimulation of [E2]phospholipase C[/E2] may be responsible for the elevated quantity of inositol seen in the brains of Alzheimer's disease patients", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "amyloid", "entity_1_idx": [[35, 42]], "entity_1_idx_in_text_with_entity_marker": [39, 46], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[71, 86]], "entity_2_idx_in_text_with_entity_marker": [84, 99], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d128.s303_IEPA.d128.s303.p0", "text": "A neurotoxic fragment of amyloid, Abeta 25-35, incubated in the presence of endogenous Ca2+, increased significantly the PI-PLC activity of normoxic brain", "text_with_entity_marker": "A neurotoxic fragment of [E1]amyloid[/E1], Abeta 25-35, incubated in the presence of endogenous Ca2+, increased significantly the [E2]PI-PLC[/E2] activity of normoxic brain", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "amyloid", "entity_1_idx": [[25, 32]], "entity_1_idx_in_text_with_entity_marker": [29, 36], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PI-PLC", "entity_2_idx": [[121, 127]], "entity_2_idx_in_text_with_entity_marker": [134, 140], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d128.s304_IEPA.d128.s304.p0", "text": "In its non-aggregated form, Abeta 25-35 activates PI-PLC but in the aggregated form the enzymatic activity decreased", "text_with_entity_marker": "In its non-aggregated form, [E1]Abeta 25-35[/E1] activates [E2]PI-PLC[/E2] but in the aggregated form the enzymatic activity decreased", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Abeta 25-35", "entity_1_idx": [[28, 39]], "entity_1_idx_in_text_with_entity_marker": [32, 43], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PI-PLC", "entity_2_idx": [[50, 56]], "entity_2_idx_in_text_with_entity_marker": [63, 69], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d48.s123_IEPA.d48.s123.p0", "text": "Leptin increases uncoupling protein expression and energy expenditure", "text_with_entity_marker": "[E1]Leptin[/E1] increases [E2]uncoupling protein[/E2] expression and energy expenditure", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein", "entity_2_idx": [[17, 35]], "entity_2_idx_in_text_with_entity_marker": [30, 48], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d48.s124_IEPA.d48.s124.p0", "text": "Leptin increased BAT UCP mRNA levels greater than twofold in both ad libitum-fed and food-restricted rats", "text_with_entity_marker": "[E1]Leptin[/E1] increased BAT [E2]UCP[/E2] mRNA levels greater than twofold in both ad libitum-fed and food-restricted rats", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP", "entity_2_idx": [[21, 24]], "entity_2_idx_in_text_with_entity_marker": [34, 37], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d48.s125_IEPA.d48.s125.p2", "text": "These data demonstrate a leptin-induced increase in energy expenditure in nonmutant rodents and suggest that one mechanism by which leptin increases energy expenditure is through increased thermogenesis in BAT, including increased expression of UCP", "text_with_entity_marker": "These data demonstrate a leptin-induced increase in energy expenditure in nonmutant rodents and suggest that one mechanism by which [E1]leptin[/E1] increases energy expenditure is through increased thermogenesis in BAT, including increased expression of [E2]UCP[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[132, 138]], "entity_1_idx_in_text_with_entity_marker": [136, 142], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP", "entity_2_idx": [[245, 248]], "entity_2_idx_in_text_with_entity_marker": [258, 261], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d71.s172_IEPA.d71.s172.p0", "text": "HvSPY coexpression largely abolished GA3-induced activity of an alpha-amylase promoter.", "text_with_entity_marker": "HvSPY coexpression largely abolished [E1]GA3[/E1]-induced activity of an [E2]alpha-amylase[/E2] promoter.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GA3", "entity_1_idx": [[37, 40]], "entity_1_idx_in_text_with_entity_marker": [41, 44], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[64, 77]], "entity_2_idx_in_text_with_entity_marker": [77, 90], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d32.s68_IEPA.d32.s68.p0", "text": "AVP and OT secretory patterns during insulin (0.15 IU/kg, i.v.)-tolerance tests (ITT) were examined in seven normal male subjects with (experimental tests) and without (control test) concomitant treatment with L-NAME (40 micrograms/kg injected plus 50 micrograms/kg infused, i.v.), the GABAergic agent sodium valproate (600 mg in three divided doses orally) or the combination of L-NAME and sodium valproate", "text_with_entity_marker": "AVP and [E1]OT[/E1] secretory patterns during [E2]insulin[/E2] (0.15 IU/kg, i.v.)-tolerance tests (ITT) were examined in seven normal male subjects with (experimental tests) and without (control test) concomitant treatment with L-NAME (40 micrograms/kg injected plus 50 micrograms/kg infused, i.v.), the GABAergic agent sodium valproate (600 mg in three divided doses orally) or the combination of L-NAME and sodium valproate", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "OT", "entity_1_idx": [[8, 10]], "entity_1_idx_in_text_with_entity_marker": [12, 14], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[37, 44]], "entity_2_idx_in_text_with_entity_marker": [50, 57], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d185.s442_IEPA.d185.s442.p0", "text": "The ARC NPY neurones are stimulated by starvation, probably mediated by falls in circulating leptin and insulin (which both inhibit these neurones), and contribute to the increased hunger in this and other conditions of energy deficit", "text_with_entity_marker": "The ARC [E1]NPY[/E1] neurones are stimulated by starvation, probably mediated by falls in circulating [E2]leptin[/E2] and insulin (which both inhibit these neurones), and contribute to the increased hunger in this and other conditions of energy deficit", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NPY", "entity_1_idx": [[8, 11]], "entity_1_idx_in_text_with_entity_marker": [12, 15], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[93, 99]], "entity_2_idx_in_text_with_entity_marker": [106, 112], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d185.s443_IEPA.d185.s443.p0", "text": "ARC NPY neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which leptin inhibition is lost through mutations affecting leptin or its receptor", "text_with_entity_marker": "ARC [E1]NPY[/E1] neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which [E2]leptin[/E2] inhibition is lost through mutations affecting leptin or its receptor", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NPY", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[106, 112]], "entity_2_idx_in_text_with_entity_marker": [119, 125], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d185.s443_IEPA.d185.s443.p1", "text": "ARC NPY neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which leptin inhibition is lost through mutations affecting leptin or its receptor", "text_with_entity_marker": "ARC [E1]NPY[/E1] neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which leptin inhibition is lost through mutations affecting [E2]leptin[/E2] or its receptor", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NPY", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[160, 166]], "entity_2_idx_in_text_with_entity_marker": [173, 179], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d185.s443_IEPA.d185.s443.p2", "text": "ARC NPY neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which leptin inhibition is lost through mutations affecting leptin or its receptor", "text_with_entity_marker": "ARC NPY neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which [E1]leptin[/E1] inhibition is lost through mutations affecting [E2]leptin[/E2] or its receptor", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[106, 112]], "entity_1_idx_in_text_with_entity_marker": [110, 116], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[160, 166]], "entity_2_idx_in_text_with_entity_marker": [173, 179], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d115.s277_IEPA.d115.s277.p0", "text": "Overexpression of G11alpha and isoforms of phospholipase C in islet  beta-cells reveals a lack of correlation between inositol phosphate  accumulation and insulin secretion.", "text_with_entity_marker": "Overexpression of G11alpha and isoforms of [E1]phospholipase C[/E1] in islet  beta-cells reveals a lack of correlation between inositol phosphate  accumulation and [E2]insulin[/E2] secretion.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phospholipase C", "entity_1_idx": [[43, 58]], "entity_1_idx_in_text_with_entity_marker": [47, 62], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[155, 162]], "entity_2_idx_in_text_with_entity_marker": [168, 175], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d115.s280_IEPA.d115.s280.p0", "text": "Adenovirus-mediated overexpression of PLC-delta1, -beta1, or  -beta3 in INS-1 or betaG 40/110 cells results in little or no enhancement  in inositol phosphate (IP) accumulation and no improvement in insulin  secretion when the cells are stimulated with glucose or carbachol, despite  the fact that the overexpressed proteins are fully active in cell  extracts.", "text_with_entity_marker": "Adenovirus-mediated overexpression of [E1]PLC[/E1]-delta1, -beta1, or  -beta3 in INS-1 or betaG 40/110 cells results in little or no enhancement  in inositol phosphate (IP) accumulation and no improvement in [E2]insulin[/E2]  secretion when the cells are stimulated with glucose or carbachol, despite  the fact that the overexpressed proteins are fully active in cell  extracts.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PLC", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[199, 206]], "entity_2_idx_in_text_with_entity_marker": [212, 219], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d115.s281_IEPA.d115.s281.p0", "text": "Overexpression of PLC-beta1 or -beta3 in normal rat islets  elicits a larger increase in IP accumulation but, again, has no effect on  insulin secretion.", "text_with_entity_marker": "Overexpression of [E1]PLC[/E1]-beta1 or -beta3 in normal rat islets  elicits a larger increase in IP accumulation but, again, has no effect on  [E2]insulin[/E2] secretion.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PLC", "entity_1_idx": [[18, 21]], "entity_1_idx_in_text_with_entity_marker": [22, 25], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[135, 142]], "entity_2_idx_in_text_with_entity_marker": [148, 155], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d115.s283_IEPA.d115.s283.p0", "text": "Overexpression of G11alpha enhances IP accumulation, an effect  slightly potentiated by co-overexpression of PLC-beta1 or -beta3, but  these maneuvers do not affect glucose or carbachol-stimulated insulin  secretion.", "text_with_entity_marker": "Overexpression of G11alpha enhances IP accumulation, an effect  slightly potentiated by co-overexpression of [E1]PLC[/E1]-beta1 or -beta3, but  these maneuvers do not affect glucose or carbachol-stimulated [E2]insulin[/E2]  secretion.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PLC", "entity_1_idx": [[109, 112]], "entity_1_idx_in_text_with_entity_marker": [113, 116], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[197, 204]], "entity_2_idx_in_text_with_entity_marker": [210, 217], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d186.s444_IEPA.d186.s444.p0", "text": "Insulin secretion, inositol phosphate levels, and phospholipase C isozymes in rodent pancreatic islets", "text_with_entity_marker": "[E1]Insulin[/E1] secretion, inositol phosphate levels, and [E2]phospholipase C[/E2] isozymes in rodent pancreatic islets", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Insulin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[50, 65]], "entity_2_idx_in_text_with_entity_marker": [63, 78], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d36.s87_IEPA.d36.s87.p0", "text": "Wortmannin converts insulin but not oxytocin from an antilipolytic to a lipolytic agent in the presence of forskolin", "text_with_entity_marker": "Wortmannin converts [E1]insulin[/E1] but not [E2]oxytocin[/E2] from an antilipolytic to a lipolytic agent in the presence of forskolin", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin", "entity_1_idx": [[20, 27]], "entity_1_idx_in_text_with_entity_marker": [24, 31], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[36, 44]], "entity_2_idx_in_text_with_entity_marker": [49, 57], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d36.s88_IEPA.d36.s88.p0", "text": "The present studies compared the effects of insulin in rat adipocytes with the effects of oxytocin and peroxovanadate, which mimic some effects of insulin", "text_with_entity_marker": "The present studies compared the effects of [E1]insulin[/E1] in rat adipocytes with the effects of [E2]oxytocin[/E2] and peroxovanadate, which mimic some effects of insulin", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin", "entity_1_idx": [[44, 51]], "entity_1_idx_in_text_with_entity_marker": [48, 55], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[90, 98]], "entity_2_idx_in_text_with_entity_marker": [103, 111], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d36.s88_IEPA.d36.s88.p1", "text": "The present studies compared the effects of insulin in rat adipocytes with the effects of oxytocin and peroxovanadate, which mimic some effects of insulin", "text_with_entity_marker": "The present studies compared the effects of [E1]insulin[/E1] in rat adipocytes with the effects of oxytocin and peroxovanadate, which mimic some effects of [E2]insulin[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin", "entity_1_idx": [[44, 51]], "entity_1_idx_in_text_with_entity_marker": [48, 55], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[147, 154]], "entity_2_idx_in_text_with_entity_marker": [160, 167], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d36.s88_IEPA.d36.s88.p2", "text": "The present studies compared the effects of insulin in rat adipocytes with the effects of oxytocin and peroxovanadate, which mimic some effects of insulin", "text_with_entity_marker": "The present studies compared the effects of insulin in rat adipocytes with the effects of [E1]oxytocin[/E1] and peroxovanadate, which mimic some effects of [E2]insulin[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "oxytocin", "entity_1_idx": [[90, 98]], "entity_1_idx_in_text_with_entity_marker": [94, 102], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[147, 154]], "entity_2_idx_in_text_with_entity_marker": [160, 167], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d36.s89_IEPA.d36.s89.p0", "text": "The antilipolytic effects of peroxovanadate and oxytocin were unaffected by 500 nmol/L wortmannin, which blocked the antilipolytic action of insulin", "text_with_entity_marker": "The antilipolytic effects of peroxovanadate and [E1]oxytocin[/E1] were unaffected by 500 nmol/L wortmannin, which blocked the antilipolytic action of [E2]insulin[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "oxytocin", "entity_1_idx": [[48, 56]], "entity_1_idx_in_text_with_entity_marker": [52, 60], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[141, 148]], "entity_2_idx_in_text_with_entity_marker": [154, 161], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d36.s90_IEPA.d36.s90.p0", "text": "The data provide additional support for the hypothesis that oxytocin and peroxovanadate affect adipose tissue metabolism by mechanisms distinctly different from those involved in insulin action", "text_with_entity_marker": "The data provide additional support for the hypothesis that [E1]oxytocin[/E1] and peroxovanadate affect adipose tissue metabolism by mechanisms distinctly different from those involved in [E2]insulin[/E2] action", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "oxytocin", "entity_1_idx": [[60, 68]], "entity_1_idx_in_text_with_entity_marker": [64, 72], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[179, 186]], "entity_2_idx_in_text_with_entity_marker": [192, 199], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p0", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of [E1]UCP3[/E1] and [E2]UCP2[/E2] in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP3", "entity_1_idx": [[50, 54]], "entity_1_idx_in_text_with_entity_marker": [54, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[59, 63]], "entity_2_idx_in_text_with_entity_marker": [72, 76], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p1", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of [E1]UCP3[/E1] and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with [E2]leptin[/E2] receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP3", "entity_1_idx": [[50, 54]], "entity_1_idx_in_text_with_entity_marker": [54, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[290, 296]], "entity_2_idx_in_text_with_entity_marker": [303, 309], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p2", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of [E1]UCP3[/E1] and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding [E2]UCP3[/E2] and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP3", "entity_1_idx": [[50, 54]], "entity_1_idx_in_text_with_entity_marker": [54, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[364, 368]], "entity_2_idx_in_text_with_entity_marker": [377, 381], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p3", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of [E1]UCP3[/E1] and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and [E2]UCP2[/E2] in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP3", "entity_1_idx": [[50, 54]], "entity_1_idx_in_text_with_entity_marker": [54, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[373, 377]], "entity_2_idx_in_text_with_entity_marker": [386, 390], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p4", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of UCP3 and [E1]UCP2[/E1] in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with [E2]leptin[/E2] receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP2", "entity_1_idx": [[59, 63]], "entity_1_idx_in_text_with_entity_marker": [63, 67], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[290, 296]], "entity_2_idx_in_text_with_entity_marker": [303, 309], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p5", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of UCP3 and [E1]UCP2[/E1] in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding [E2]UCP3[/E2] and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP2", "entity_1_idx": [[59, 63]], "entity_1_idx_in_text_with_entity_marker": [63, 67], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[364, 368]], "entity_2_idx_in_text_with_entity_marker": [377, 381], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p6", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of UCP3 and [E1]UCP2[/E1] in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and [E2]UCP2[/E2] in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP2", "entity_1_idx": [[59, 63]], "entity_1_idx_in_text_with_entity_marker": [63, 67], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[373, 377]], "entity_2_idx_in_text_with_entity_marker": [386, 390], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p7", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with [E1]leptin[/E1] receptor defect, and investigated expression of the genes encoding [E2]UCP3[/E2] and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[290, 296]], "entity_1_idx_in_text_with_entity_marker": [294, 300], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[364, 368]], "entity_2_idx_in_text_with_entity_marker": [377, 381], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p8", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with [E1]leptin[/E1] receptor defect, and investigated expression of the genes encoding UCP3 and [E2]UCP2[/E2] in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[290, 296]], "entity_1_idx_in_text_with_entity_marker": [294, 300], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[373, 377]], "entity_2_idx_in_text_with_entity_marker": [386, 390], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p9", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding [E1]UCP3[/E1] and [E2]UCP2[/E2] in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP3", "entity_1_idx": [[364, 368]], "entity_1_idx_in_text_with_entity_marker": [368, 372], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[373, 377]], "entity_2_idx_in_text_with_entity_marker": [386, 390], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s208_IEPA.d88.s208.p0", "text": "These results clearly demonstrate that UCP3 gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with leptin receptor defect, and that adipose UCP3 gene expression is increased in response to TZDs in vitro", "text_with_entity_marker": "These results clearly demonstrate that [E1]UCP3[/E1] gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with [E2]leptin[/E2] receptor defect, and that adipose UCP3 gene expression is increased in response to TZDs in vitro", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP3", "entity_1_idx": [[39, 43]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s208_IEPA.d88.s208.p1", "text": "These results clearly demonstrate that UCP3 gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with leptin receptor defect, and that adipose UCP3 gene expression is increased in response to TZDs in vitro", "text_with_entity_marker": "These results clearly demonstrate that [E1]UCP3[/E1] gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with leptin receptor defect, and that adipose [E2]UCP3[/E2] gene expression is increased in response to TZDs in vitro", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP3", "entity_1_idx": [[39, 43]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[185, 189]], "entity_2_idx_in_text_with_entity_marker": [198, 202], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s208_IEPA.d88.s208.p2", "text": "These results clearly demonstrate that UCP3 gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with leptin receptor defect, and that adipose UCP3 gene expression is increased in response to TZDs in vitro", "text_with_entity_marker": "These results clearly demonstrate that UCP3 gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with [E1]leptin[/E1] receptor defect, and that adipose [E2]UCP3[/E2] gene expression is increased in response to TZDs in vitro", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[144, 150]], "entity_1_idx_in_text_with_entity_marker": [148, 154], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[185, 189]], "entity_2_idx_in_text_with_entity_marker": [198, 202], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d108.s254_IEPA.d108.s254.p0", "text": "When the alpha2-adrenoreceptor agonist clonidine (2.5 microgram/kg intracerebroventricularly) was administered 3 days after the 5-day treatment period with oxytocin or saline, plasma levels of insulin and CCK increased significantly (p < 0.05) in the oxytocin-treated rats, when compared to saline-treated controls receiving clonidine only", "text_with_entity_marker": "When the alpha2-adrenoreceptor agonist clonidine (2.5 microgram/kg intracerebroventricularly) was administered 3 days after the 5-day treatment period with [E1]oxytocin[/E1] or saline, plasma levels of [E2]insulin[/E2] and CCK increased significantly (p < 0.05) in the oxytocin-treated rats, when compared to saline-treated controls receiving clonidine only", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "oxytocin", "entity_1_idx": [[156, 164]], "entity_1_idx_in_text_with_entity_marker": [160, 168], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[193, 200]], "entity_2_idx_in_text_with_entity_marker": [206, 213], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d108.s254_IEPA.d108.s254.p1", "text": "When the alpha2-adrenoreceptor agonist clonidine (2.5 microgram/kg intracerebroventricularly) was administered 3 days after the 5-day treatment period with oxytocin or saline, plasma levels of insulin and CCK increased significantly (p < 0.05) in the oxytocin-treated rats, when compared to saline-treated controls receiving clonidine only", "text_with_entity_marker": "When the alpha2-adrenoreceptor agonist clonidine (2.5 microgram/kg intracerebroventricularly) was administered 3 days after the 5-day treatment period with [E1]oxytocin[/E1] or saline, plasma levels of insulin and CCK increased significantly (p < 0.05) in the [E2]oxytocin[/E2]-treated rats, when compared to saline-treated controls receiving clonidine only", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "oxytocin", "entity_1_idx": [[156, 164]], "entity_1_idx_in_text_with_entity_marker": [160, 168], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[251, 259]], "entity_2_idx_in_text_with_entity_marker": [264, 272], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d108.s254_IEPA.d108.s254.p2", "text": "When the alpha2-adrenoreceptor agonist clonidine (2.5 microgram/kg intracerebroventricularly) was administered 3 days after the 5-day treatment period with oxytocin or saline, plasma levels of insulin and CCK increased significantly (p < 0.05) in the oxytocin-treated rats, when compared to saline-treated controls receiving clonidine only", "text_with_entity_marker": "When the alpha2-adrenoreceptor agonist clonidine (2.5 microgram/kg intracerebroventricularly) was administered 3 days after the 5-day treatment period with oxytocin or saline, plasma levels of [E1]insulin[/E1] and CCK increased significantly (p < 0.05) in the [E2]oxytocin[/E2]-treated rats, when compared to saline-treated controls receiving clonidine only", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin", "entity_1_idx": [[193, 200]], "entity_1_idx_in_text_with_entity_marker": [197, 204], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[251, 259]], "entity_2_idx_in_text_with_entity_marker": [264, 272], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s386_IEPA.d161.s386.p0", "text": "Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion", "text_with_entity_marker": "Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, [E1]leptin[/E1], [E2]uncoupling proteins 2[/E2] and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[93, 99]], "entity_1_idx_in_text_with_entity_marker": [97, 103], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling proteins 2", "entity_2_idx": [[101, 122]], "entity_2_idx_in_text_with_entity_marker": [114, 135], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s386_IEPA.d161.s386.p1", "text": "Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion", "text_with_entity_marker": "Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, [E1]leptin[/E1], uncoupling proteins 2 and [E2]3[/E2], and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[93, 99]], "entity_1_idx_in_text_with_entity_marker": [97, 103], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "3", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s386_IEPA.d161.s386.p2", "text": "Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion", "text_with_entity_marker": "Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, [E1]uncoupling proteins 2[/E1] and [E2]3[/E2], and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "uncoupling proteins 2", "entity_1_idx": [[101, 122]], "entity_1_idx_in_text_with_entity_marker": [105, 126], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "3", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s387_IEPA.d161.s387.p0", "text": "Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, leptin, uncoupling protein (UCP)-2 and UCP-3, and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia", "text_with_entity_marker": "Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, [E1]leptin[/E1], [E2]uncoupling protein (UCP)-2[/E2] and UCP-3, and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[135, 141]], "entity_1_idx_in_text_with_entity_marker": [139, 145], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein (UCP)-2", "entity_2_idx": [[143, 169]], "entity_2_idx_in_text_with_entity_marker": [156, 182], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s387_IEPA.d161.s387.p1", "text": "Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, leptin, uncoupling protein (UCP)-2 and UCP-3, and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia", "text_with_entity_marker": "Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, [E1]leptin[/E1], uncoupling protein (UCP)-2 and [E2]UCP-3[/E2], and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[135, 141]], "entity_1_idx_in_text_with_entity_marker": [139, 145], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s387_IEPA.d161.s387.p2", "text": "Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, leptin, uncoupling protein (UCP)-2 and UCP-3, and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia", "text_with_entity_marker": "Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, leptin, [E1]uncoupling protein (UCP)-2[/E1] and [E2]UCP-3[/E2], and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "uncoupling protein (UCP)-2", "entity_1_idx": [[143, 169]], "entity_1_idx_in_text_with_entity_marker": [147, 173], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s388_IEPA.d161.s388.p0", "text": "Marked increases in FAT/CD36 (724+/-18%; P < 0.05), PPAR-gamma2 (200+/-8%; P < 0.05), leptin (110+/-13%; P < 0.05), UCP-2 (120+/-7%; P < 0.05), UCP-3 (80+/-5%; P < 0.05), and TNF-alpha mRNA (130+/-12%; P < 0.05) were observed in comparison with pretreatment levels, whereas there was no change after saline infusion", "text_with_entity_marker": "Marked increases in FAT/CD36 (724+/-18%; P < 0.05), PPAR-gamma2 (200+/-8%; P < 0.05), [E1]leptin[/E1] (110+/-13%; P < 0.05), [E2]UCP-2[/E2] (120+/-7%; P < 0.05), UCP-3 (80+/-5%; P < 0.05), and TNF-alpha mRNA (130+/-12%; P < 0.05) were observed in comparison with pretreatment levels, whereas there was no change after saline infusion", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[86, 92]], "entity_1_idx_in_text_with_entity_marker": [90, 96], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[116, 121]], "entity_2_idx_in_text_with_entity_marker": [129, 134], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s388_IEPA.d161.s388.p1", "text": "Marked increases in FAT/CD36 (724+/-18%; P < 0.05), PPAR-gamma2 (200+/-8%; P < 0.05), leptin (110+/-13%; P < 0.05), UCP-2 (120+/-7%; P < 0.05), UCP-3 (80+/-5%; P < 0.05), and TNF-alpha mRNA (130+/-12%; P < 0.05) were observed in comparison with pretreatment levels, whereas there was no change after saline infusion", "text_with_entity_marker": "Marked increases in FAT/CD36 (724+/-18%; P < 0.05), PPAR-gamma2 (200+/-8%; P < 0.05), [E1]leptin[/E1] (110+/-13%; P < 0.05), UCP-2 (120+/-7%; P < 0.05), [E2]UCP-3[/E2] (80+/-5%; P < 0.05), and TNF-alpha mRNA (130+/-12%; P < 0.05) were observed in comparison with pretreatment levels, whereas there was no change after saline infusion", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[86, 92]], "entity_1_idx_in_text_with_entity_marker": [90, 96], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[144, 149]], "entity_2_idx_in_text_with_entity_marker": [157, 162], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s388_IEPA.d161.s388.p2", "text": "Marked increases in FAT/CD36 (724+/-18%; P < 0.05), PPAR-gamma2 (200+/-8%; P < 0.05), leptin (110+/-13%; P < 0.05), UCP-2 (120+/-7%; P < 0.05), UCP-3 (80+/-5%; P < 0.05), and TNF-alpha mRNA (130+/-12%; P < 0.05) were observed in comparison with pretreatment levels, whereas there was no change after saline infusion", "text_with_entity_marker": "Marked increases in FAT/CD36 (724+/-18%; P < 0.05), PPAR-gamma2 (200+/-8%; P < 0.05), leptin (110+/-13%; P < 0.05), [E1]UCP-2[/E1] (120+/-7%; P < 0.05), [E2]UCP-3[/E2] (80+/-5%; P < 0.05), and TNF-alpha mRNA (130+/-12%; P < 0.05) were observed in comparison with pretreatment levels, whereas there was no change after saline infusion", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP-2", "entity_1_idx": [[116, 121]], "entity_1_idx_in_text_with_entity_marker": [120, 125], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[144, 149]], "entity_2_idx_in_text_with_entity_marker": [157, 162], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s389_IEPA.d161.s389.p0", "text": "These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, leptin, UCP-2, UCP-3, and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins", "text_with_entity_marker": "These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, [E1]leptin[/E1], [E2]UCP-2[/E2], UCP-3, and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[78, 84]], "entity_1_idx_in_text_with_entity_marker": [82, 88], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[86, 91]], "entity_2_idx_in_text_with_entity_marker": [99, 104], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s389_IEPA.d161.s389.p1", "text": "These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, leptin, UCP-2, UCP-3, and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins", "text_with_entity_marker": "These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, [E1]leptin[/E1], UCP-2, [E2]UCP-3[/E2], and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[78, 84]], "entity_1_idx_in_text_with_entity_marker": [82, 88], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s389_IEPA.d161.s389.p2", "text": "These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, leptin, UCP-2, UCP-3, and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins", "text_with_entity_marker": "These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, leptin, [E1]UCP-2[/E1], [E2]UCP-3[/E2], and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP-2", "entity_1_idx": [[86, 91]], "entity_1_idx_in_text_with_entity_marker": [90, 95], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d169.s409_IEPA.d169.s409.p0", "text": "The body mass index (BMI), leptin, plasma neuropeptide Y (NPY), serotonin, thyroxine (T4), triiodothyronine (T3) and reverse triiodothyronine (rT3) in serum were evaluated for each subject", "text_with_entity_marker": "The body mass index (BMI), [E1]leptin[/E1], plasma [E2]neuropeptide Y[/E2] (NPY), serotonin, thyroxine (T4), triiodothyronine (T3) and reverse triiodothyronine (rT3) in serum were evaluated for each subject", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[27, 33]], "entity_1_idx_in_text_with_entity_marker": [31, 37], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[42, 56]], "entity_2_idx_in_text_with_entity_marker": [55, 69], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d8.s0_LLL.d8.s0.p0", "text": "Our results indicate that the level of KatX level in outgrowing spores depends mainly on EsigmaF, because sigB mutants show normal KatX activity in dormant and outgrowing spores.", "text_with_entity_marker": "Our results indicate that the level of [E1]KatX[/E1] level in outgrowing spores depends mainly on [E2]EsigmaF[/E2], because sigB mutants show normal KatX activity in dormant and outgrowing spores.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "KatX", "entity_1_idx": [[39, 43]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "EsigmaF", "entity_2_idx": [[89, 96]], "entity_2_idx_in_text_with_entity_marker": [102, 109], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d8.s1_LLL.d8.s1.p0", "text": "Therefore, the physiological role of sigmaB-dependent katX expression remains obscure.", "text_with_entity_marker": "Therefore, the physiological role of [E1]sigmaB[/E1]-dependent [E2]katX[/E2] expression remains obscure.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaB", "entity_1_idx": [[37, 43]], "entity_1_idx_in_text_with_entity_marker": [41, 47], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "katX", "entity_2_idx": [[54, 58]], "entity_2_idx_in_text_with_entity_marker": [67, 71], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d8.s2_LLL.d8.s2.p1", "text": "The -10 and -35 sequences of the sigmaB- and sigmaF-dependent promoters of katX overlap, and the transcriptional start points used by EsigmaB and EsigmaF differ by only one nucleotide.", "text_with_entity_marker": "The -10 and -35 sequences of the [E1]sigmaB[/E1]- and sigmaF-dependent promoters of [E2]katX[/E2] overlap, and the transcriptional start points used by EsigmaB and EsigmaF differ by only one nucleotide.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaB", "entity_1_idx": [[33, 39]], "entity_1_idx_in_text_with_entity_marker": [37, 43], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "katX", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d8.s2_LLL.d8.s2.p2", "text": "The -10 and -35 sequences of the sigmaB- and sigmaF-dependent promoters of katX overlap, and the transcriptional start points used by EsigmaB and EsigmaF differ by only one nucleotide.", "text_with_entity_marker": "The -10 and -35 sequences of the sigmaB- and [E1]sigmaF[/E1]-dependent promoters of [E2]katX[/E2] overlap, and the transcriptional start points used by EsigmaB and EsigmaF differ by only one nucleotide.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaF", "entity_1_idx": [[45, 51]], "entity_1_idx_in_text_with_entity_marker": [49, 55], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "katX", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d8.s3_LLL.d8.s3.p0", "text": "We demonstrated that katX is also a sigmaB-dependent general stress gene, since it is strongly induced by heat, salt and ethanol stress, as well as by energy depletion.", "text_with_entity_marker": "We demonstrated that [E1]katX[/E1] is also a [E2]sigmaB[/E2]-dependent general stress gene, since it is strongly induced by heat, salt and ethanol stress, as well as by energy depletion.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "katX", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaB", "entity_2_idx": [[36, 42]], "entity_2_idx_in_text_with_entity_marker": [49, 55], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d14.s0_LLL.d14.s0.p1", "text": "The first stage, which involves the phosphatase function of SpoIIE, depends on the cell division protein FtsZ and could correspond to the FtsZ-dependent assembly of SpoIIE into E-rings.", "text_with_entity_marker": "The first stage, which involves the phosphatase function of [E1]SpoIIE[/E1], depends on the cell division protein [E2]FtsZ[/E2] and could correspond to the FtsZ-dependent assembly of SpoIIE into E-rings.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SpoIIE", "entity_1_idx": [[60, 66]], "entity_1_idx_in_text_with_entity_marker": [64, 70], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "FtsZ", "entity_2_idx": [[105, 109]], "entity_2_idx_in_text_with_entity_marker": [118, 122], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d14.s0_LLL.d14.s0.p4", "text": "The first stage, which involves the phosphatase function of SpoIIE, depends on the cell division protein FtsZ and could correspond to the FtsZ-dependent assembly of SpoIIE into E-rings.", "text_with_entity_marker": "The first stage, which involves the phosphatase function of SpoIIE, depends on the cell division protein FtsZ and could correspond to the [E1]FtsZ[/E1]-dependent assembly of [E2]SpoIIE[/E2] into E-rings.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FtsZ", "entity_1_idx": [[138, 142]], "entity_1_idx_in_text_with_entity_marker": [142, 146], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "SpoIIE", "entity_2_idx": [[165, 171]], "entity_2_idx_in_text_with_entity_marker": [178, 184], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d14.s1_LLL.d14.s1.p0", "text": "Evidence based on the use of modified and mutant forms of the phosphatase protein indicates that SpoIIE blocks the capacity of unphosphorylated SpoIIAA to activate sigmaF until formation of the polar septum is completed.", "text_with_entity_marker": "Evidence based on the use of modified and mutant forms of the phosphatase protein indicates that [E1]SpoIIE[/E1] blocks the capacity of unphosphorylated [E2]SpoIIAA[/E2] to activate sigmaF until formation of the polar septum is completed.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SpoIIE", "entity_1_idx": [[97, 103]], "entity_1_idx_in_text_with_entity_marker": [101, 107], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "SpoIIAA", "entity_2_idx": [[144, 151]], "entity_2_idx_in_text_with_entity_marker": [157, 164], "entity_2_type": "agent/target", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "LLL.d14.s1_LLL.d14.s1.p2", "text": "Evidence based on the use of modified and mutant forms of the phosphatase protein indicates that SpoIIE blocks the capacity of unphosphorylated SpoIIAA to activate sigmaF until formation of the polar septum is completed.", "text_with_entity_marker": "Evidence based on the use of modified and mutant forms of the phosphatase protein indicates that SpoIIE blocks the capacity of unphosphorylated [E1]SpoIIAA[/E1] to activate [E2]sigmaF[/E2] until formation of the polar septum is completed.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SpoIIAA", "entity_1_idx": [[144, 151]], "entity_1_idx_in_text_with_entity_marker": [148, 155], "entity_1_type": "agent/target", "entity_1_type_id": 2, "entity_2": "sigmaF", "entity_2_idx": [[164, 170]], "entity_2_idx_in_text_with_entity_marker": [177, 183], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d14.s2_LLL.d14.s2.p0", "text": "Cell-specific activation of transcription factor sigmaF during sporulation in Bacillus subtilis requires the formation of the polar septum and the activity of a serine phosphatase (SpoIIE) located in the septum.", "text_with_entity_marker": "Cell-specific activation of transcription factor [E1]sigmaF[/E1] during sporulation in Bacillus subtilis requires the formation of the polar septum and the activity of a serine phosphatase ([E2]SpoIIE[/E2]) located in the septum.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaF", "entity_1_idx": [[49, 55]], "entity_1_idx_in_text_with_entity_marker": [53, 59], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "SpoIIE", "entity_2_idx": [[181, 187]], "entity_2_idx_in_text_with_entity_marker": [194, 200], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d14.s3_LLL.d14.s3.p0", "text": "The SpoIIE phosphatase indirectly activates sigmaF by dephosphorylating a protein (SpoIIAA-P) in the pathway that controls the activity of the transcription factor.", "text_with_entity_marker": "The [E1]SpoIIE[/E1] phosphatase indirectly activates sigmaF by dephosphorylating a protein ([E2]SpoIIAA-P[/E2]) in the pathway that controls the activity of the transcription factor.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SpoIIE", "entity_1_idx": [[4, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "SpoIIAA-P", "entity_2_idx": [[83, 92]], "entity_2_idx_in_text_with_entity_marker": [96, 105], "entity_2_type": "agent/target", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "LLL.d14.s3_LLL.d14.s3.p1", "text": "The SpoIIE phosphatase indirectly activates sigmaF by dephosphorylating a protein (SpoIIAA-P) in the pathway that controls the activity of the transcription factor.", "text_with_entity_marker": "The [E1]SpoIIE[/E1] phosphatase indirectly activates [E2]sigmaF[/E2] by dephosphorylating a protein (SpoIIAA-P) in the pathway that controls the activity of the transcription factor.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SpoIIE", "entity_1_idx": [[4, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "sigmaF", "entity_2_idx": [[44, 50]], "entity_2_idx_in_text_with_entity_marker": [57, 63], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d14.s3_LLL.d14.s3.p2", "text": "The SpoIIE phosphatase indirectly activates sigmaF by dephosphorylating a protein (SpoIIAA-P) in the pathway that controls the activity of the transcription factor.", "text_with_entity_marker": "The SpoIIE phosphatase indirectly activates [E1]sigmaF[/E1] by dephosphorylating a protein ([E2]SpoIIAA-P[/E2]) in the pathway that controls the activity of the transcription factor.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaF", "entity_1_idx": [[44, 50]], "entity_1_idx_in_text_with_entity_marker": [48, 54], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "SpoIIAA-P", "entity_2_idx": [[83, 92]], "entity_2_idx_in_text_with_entity_marker": [96, 105], "entity_2_type": "agent/target", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "LLL.d0.s0_LLL.d0.s0.p1", "text": "In vivo studies of the activity of four of the kinases, KinA, KinC, KinD (ykvD) and KinE (ykrQ), using abrB transcription as an indicator of Spo0A~P level, revealed that KinC and KinD were responsible for Spo0A~P production during the exponential phase of growth in the absence of KinA and KinB.", "text_with_entity_marker": "In vivo studies of the activity of four of the kinases, KinA, KinC, KinD (ykvD) and KinE (ykrQ), using abrB transcription as an indicator of Spo0A~P level, revealed that [E1]KinC[/E1] and KinD were responsible for [E2]Spo0A~P[/E2] production during the exponential phase of growth in the absence of KinA and KinB.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "KinC", "entity_1_idx": [[170, 174]], "entity_1_idx_in_text_with_entity_marker": [174, 178], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "Spo0A~P", "entity_2_idx": [[205, 212]], "entity_2_idx_in_text_with_entity_marker": [218, 225], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d0.s0_LLL.d0.s0.p2", "text": "In vivo studies of the activity of four of the kinases, KinA, KinC, KinD (ykvD) and KinE (ykrQ), using abrB transcription as an indicator of Spo0A~P level, revealed that KinC and KinD were responsible for Spo0A~P production during the exponential phase of growth in the absence of KinA and KinB.", "text_with_entity_marker": "In vivo studies of the activity of four of the kinases, KinA, KinC, KinD (ykvD) and KinE (ykrQ), using abrB transcription as an indicator of Spo0A~P level, revealed that KinC and [E1]KinD[/E1] were responsible for [E2]Spo0A~P[/E2] production during the exponential phase of growth in the absence of KinA and KinB.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "KinD", "entity_1_idx": [[179, 183]], "entity_1_idx_in_text_with_entity_marker": [183, 187], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "Spo0A~P", "entity_2_idx": [[205, 212]], "entity_2_idx_in_text_with_entity_marker": [218, 225], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d35.s0_LLL.d35.s0.p1", "text": "The Bacillus subtilis clpC operon is regulated by two stress induction pathways relying on either sigmaB or a class III stress induction mechanism acting at a sigmaA-like promoter.", "text_with_entity_marker": "The Bacillus subtilis [E1]clpC[/E1] operon is regulated by two stress induction pathways relying on either [E2]sigmaB[/E2] or a class III stress induction mechanism acting at a sigmaA-like promoter.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "clpC", "entity_1_idx": [[22, 26]], "entity_1_idx_in_text_with_entity_marker": [26, 30], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaB", "entity_2_idx": [[98, 104]], "entity_2_idx_in_text_with_entity_marker": [111, 117], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d35.s0_LLL.d35.s0.p2", "text": "The Bacillus subtilis clpC operon is regulated by two stress induction pathways relying on either sigmaB or a class III stress induction mechanism acting at a sigmaA-like promoter.", "text_with_entity_marker": "The Bacillus subtilis [E1]clpC[/E1] operon is regulated by two stress induction pathways relying on either sigmaB or a class III stress induction mechanism acting at a [E2]sigmaA[/E2]-like promoter.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "clpC", "entity_1_idx": [[22, 26]], "entity_1_idx_in_text_with_entity_marker": [26, 30], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaA", "entity_2_idx": [[159, 165]], "entity_2_idx_in_text_with_entity_marker": [172, 178], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d35.s1_LLL.d35.s1.p2", "text": "Our data demonstrate that the CtsR protein acts as a global repressor of the clpC operon, as well as other class III heat shock genes, by preventing unstressed transcription from either the sigmaB- or sigmaA-dependent promoter and might be inactivated or dissociate under inducing stress conditions.", "text_with_entity_marker": "Our data demonstrate that the [E1]CtsR[/E1] protein acts as a global repressor of the [E2]clpC[/E2] operon, as well as other class III heat shock genes, by preventing unstressed transcription from either the sigmaB- or sigmaA-dependent promoter and might be inactivated or dissociate under inducing stress conditions.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CtsR", "entity_1_idx": [[30, 34]], "entity_1_idx_in_text_with_entity_marker": [34, 38], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "clpC", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d35.s1_LLL.d35.s1.p4", "text": "Our data demonstrate that the CtsR protein acts as a global repressor of the clpC operon, as well as other class III heat shock genes, by preventing unstressed transcription from either the sigmaB- or sigmaA-dependent promoter and might be inactivated or dissociate under inducing stress conditions.", "text_with_entity_marker": "Our data demonstrate that the CtsR protein acts as a global repressor of the [E1]clpC[/E1] operon, as well as other class III heat shock genes, by preventing unstressed transcription from either the [E2]sigmaB[/E2]- or sigmaA-dependent promoter and might be inactivated or dissociate under inducing stress conditions.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "clpC", "entity_1_idx": [[77, 81]], "entity_1_idx_in_text_with_entity_marker": [81, 85], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaB", "entity_2_idx": [[190, 196]], "entity_2_idx_in_text_with_entity_marker": [203, 209], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d35.s1_LLL.d35.s1.p5", "text": "Our data demonstrate that the CtsR protein acts as a global repressor of the clpC operon, as well as other class III heat shock genes, by preventing unstressed transcription from either the sigmaB- or sigmaA-dependent promoter and might be inactivated or dissociate under inducing stress conditions.", "text_with_entity_marker": "Our data demonstrate that the CtsR protein acts as a global repressor of the [E1]clpC[/E1] operon, as well as other class III heat shock genes, by preventing unstressed transcription from either the sigmaB- or [E2]sigmaA[/E2]-dependent promoter and might be inactivated or dissociate under inducing stress conditions.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "clpC", "entity_1_idx": [[77, 81]], "entity_1_idx_in_text_with_entity_marker": [81, 85], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaA", "entity_2_idx": [[201, 207]], "entity_2_idx_in_text_with_entity_marker": [214, 220], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d42.s0_LLL.d42.s0.p0", "text": "Finally, we show that proper localization of SpoIVA required the expression of one or more genes which, like spoIVA, are under the control of the mother cell transcription factor sigmaE.", "text_with_entity_marker": "Finally, we show that proper localization of SpoIVA required the expression of one or more genes which, like [E1]spoIVA[/E1], are under the control of the mother cell transcription factor [E2]sigmaE[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "spoIVA", "entity_1_idx": [[109, 115]], "entity_1_idx_in_text_with_entity_marker": [113, 119], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaE", "entity_2_idx": [[179, 185]], "entity_2_idx_in_text_with_entity_marker": [192, 198], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
